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1 
 1  Introduction 
 
 
 1.1  Transition metal-catalyzed asymmetric hydrogenation 
 
Nowadays, the synthesis of chiral compounds is one of the major tasks in organic synthesis and 
among all the developed asymmetric catalytic methods[1] hydrogenation of double bonds became 
one of the most powerful tools.[2] Normally, high conversions and excellent enantioselectivities can 
be obtained at low catalyst loadings, together with a perfect atom economy which guarantee that the 
asymmetric hydrogenation is also applied in industrial processes.[3] After Wilkinson's and Coffey's 
pioneering work on phosphine based rhodium catalysts for the homogeneous hydrogenation of 
alkenes and alkynes[4] the first asymmetric versions were reported two years later[5], but only poor 
enantioselectivities were achieved. Further ligand development led to the introduction of C2-
symmetric bidentate bisphosphine ligands which showed better selectivities compared to 
monodentate ligands like (S)-CAMP.[6] In 1971, Kagan published the first example of rhodium-
catalyzed asymmetric hydrogenation using a bidentate ligand (DIOP).[6a] Some years later Knowles 
introduced the bisphosphine ligand DIPAMP for the asymmetric reduction of dehydroamino acids 
yielding the corresponding products in high selectivities.[6c] Due to its high efficiency for this 
substrate class it was employed in the industrial synthesis of L-DOPA.[7] 
 
Figure 1: Structure of the first phosphine and bisphosphine ligands used in rhodium-catalyzed 
asymmetric hydrogenation reactions. 
 
However, research was mainly focused on rhodium catalyzed hydrogenation and the substrate scope 
was limited to dehydroamino acids.[8] In 1988, Noyori discovered that ruthenium can also be 
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applied for asymmetric hydrogenation.[9] In his catalytic system a biaryl phosphine ligand (BINAP) 
was used to successfully reduce different types of alkenes and thereby broadened the scope of this 
reaction. For example in the synthesis of citronellol both enantiomers can be obtained by 
asymmetric ruthenium-catalyzed hydrogenation of geraniol or nerol, respectively (Scheme 1).[10] 
The double bond close to the hydroxy group is reduced by the catalyst while the remote double 
bond remains untouched. 
 
Scheme 1: Ruthenium-catalyzed hydrogenation of geraniol and nerol. 
 
Furthermore, he could not only reduce carbon carbon double bonds but also ketones which allowed 
the synthesis of numerous chiral alcohols. For their pioneering work in the field of asymmetric 
hydrogenation Knowles and Noyori were awarded the Nobel Prize in 2001. 
In the 1990's many more ligands were developed so that the scope for rhodium-catalyzed 
hydrogenation could also be improved.[11] Both, rhodium- and ruthenium-catalysts usually need a 
coordinating group in the substrate like an alcohol, amine or carbonyl group. This requirement 
limits the scope as only a few examples of hydrogenations of unfunctionalized olefins are 
known.[12]  
To reduce unfunctionalized olefins other transition metals like platinum[13], titanium[14], 
zirconium[15] or iridium[2a,e,f,16] are normally employed. Pioneering work in this field was done by 
Kagan who used a titanium cyclopentadienyl complex to reduce 2-phenyl-1-butene in an 
asymmetric fashion, albeit with low selectivity.[17] More than ten years later Buchwald reported the 
reduction of unfunctionalized olefins and enamines by a titanium cyclopentadienyl complex with 
high ee's.[14a] However, this catalyst is very air- and moisture-sensitive and a strong base like n-butyl 
lithium is necessary to activate the precatalyst. Today, iridium complexes are mostly used for the 
reduction of unfunctionalized olefins. 
 
OH
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0.2 mol% Ru(S)-BINAP(OAc)2
30 atm H2, 20 °C, 12 h, MeOH
OH
OH
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(S)-Citronellol
99% ee
98% ee
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 1.2  Iridium-catalyzed asymmetric hydrogenation 
 
In 1977, Crabtree reported the first application of iridium catalysts in the hydrogenation of double 
bonds.[18] Before, rhodium was the metal of choice since the iridium analogs showed lower 
reactivity. Crabtree assumed that this low activity was due to the strong binding affinity of iridium 
to coordinating solvents. He proposed that this strong interaction avoids the dissociation of a 
solvent molecule which prevents coordination of the substrate to the metal center. To inhibit 
deactivation of the catalyst he investigated the reactivity of [Ir(COD)L2]PF6 complexes in various 
non-coordinating solvents and observed high activity in chloroform and methylene chloride. He 
found that [Ir(COD)PCy3(py)]PF6, the so called Crabtree catalyst, gave the best results for the 
hydrogenation of unfunctionalized olefins. This catalyst even allowed the reduction of 
tetrasubstituted double bonds which could not be reduced by rhodium complexes. 
However, conversions were often low even though he observed high initial turnover frequency 
(TOF). The high reactivity also resulted in destabilization of the catalyst. The lack of a coordinating 
solvent which could stabilize the complex means that only the substrate can stabilize it. When most 
of the substrate is consumed or the olefin is weakly coordinating the metal complex forms a stable 
inactive trinuclear iridium complex (Figure 2). 
 
Figure 2: Structure of inactive iridium trimer formed during the hydrogenation with Crabtree's 
catalyst.[19] 
 
In 1997, the first asymmetric iridium-catalyzed hydrogenation was published by our group. In our 
approach, chiral phosphinooxazoline (PHOX) ligand L1 was used for the iridium-catalyzed 
hydrogenation of imine 1 to yield the corresponding chiral amine 2 with high enantioselectivity 
(Scheme 2).[20] 
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Scheme 2: First example of asymmetric iridium-catalyzed hydrogenation. 
 
The ligand employed consists of a tertiary phosphine and a chiral oxazoline moiety derived from an 
amino acid, which form a coordination sphere similar to that of Crabtree's catalyst. The catalyst 
showed good results for substrates with an aryl group attached to the newly formed stereogenic 
center but low ee's for imines with two alkyl groups. 
One year later our group showed that this ligand class also gives excellent results in the asymmetric 
reduction of unfunctionalized olefins (Scheme 3).[21] 
 
Scheme 3: Asymmetric hydrogenation of unfunctionalized olefin 3 with an Ir-PHOX complex. 
 
Several alkenes could be reduced using oxazoline L2 as chiral ligand for the reduction with very 
good enantioselectivities. However, high catalyst loading was necessary to obtain good conversions. 
Even though the catalyst showed high initial TOF, it was deactivated within short time. The reason 
for the deactivation is that the complex forms, like in the case of Crabtree's catalyst, a stable 
trinuclear species which cannot be converted back to an active complex .[22] 
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 1.2.1  Effect of the counterion 
 
Numerous conditions were screened to improve the stability of the catalyst during the reaction but 
none was successful. The use of coordinating solvents or additives such as amines inhibited the 
reaction. However, when the counterion was exchanged for BArF the stability could be increased 
tremendously and much lower catalyst loadings were necessary (Scheme 4).[23] 
 
Scheme 4: Asymmetric hydrogenation of olefin 3 with BArF as counterion. 
 
With only 0.02 mol% catalyst loading full conversion was observed with slightly better ee. 
Numerous other alkenes could be reduced with full conversion as well.[21] Iridium catalysts with 
BArF as anion give not only better conversions but they are also more stable towards air and 
moisture than the PF6 analogs. The bulky BArF anion is only weakly coordinating which facilitates 
coordination of the substrate to the metal center so that the hydrogenation pathway is favored over 
deactivation.[24] Today, most cationic iridium catalysts for hydrogenation use the BArF anion as 
counterion of choice. 
 
 1.2.2  N,P-Ligands for asymmetric hydrogenation 
 
Although PHOX ligands showed excellent results in asymmetric hydrogenation reactions the 
substrate scope was only limited. Therefore, much work was invested to find other ligands to 
broaden the scope. In the following years, many other N,P-ligands with similar structures were 
developed in our group which allowed the selective reduction of various other substrates. The most 
successful ligands are shown below (Figure 3). 
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Figure 3: Selected N,P-ligands developed in the Pfaltz group. 
 
Starting from the methyl ester of threonine the ThrePHOX ligands can be synthesized in a few 
steps.[25] Different substituents at the phosphorus atom, the backbone or the oxazoline moiety can 
simply be introduced by using different acid derivatives, Grignard reagents or phosphine chlorides 
during the synthesis which gives access to a wide library of ligands and allows fine tuning for 
different substrates. This ligand class has two stereogenic centers of which one is at the backbone. 
Furthermore, it consists of a phosphinite moiety instead of a phosphine which changes the 
electronic properties of the ligand. The ThrePHOX ligands allowed the hydrogenation of 2-aryl-2-
butenes with high enantioselectivities for the first time.[26] In addition, excellent ee's could be 
observed for the asymmetric reduction of terminal alkenes and flavene 5 (Figure 4). 
 
Figure 4: Selection of substrates that can be reduced with ThrePHOX ligands. 
 
Another easily accessible class are the SimplePHOX ligands which can be synthesized from chiral 
α-amino alcohols in two steps.[27] It showed lower selectivities for unfunctionalized olefins than the 
ThrePHOX ligands but gave excellent results for acrylic esters and allylic alcohols. In addition, this 
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ligand class was very effective for cyclic substrates. Harmata and Hong used SimplePHOX ligand 
L5 in the synthesis of antibiotic pseudopteroxazole.[28] They reduced the tricyclic intermediate 6 
with perfect stereocontrol and obtained the reduced product 7 in 90% yield together with some 
over-hydrogenated product (Scheme 5). The reason that the exocyclic double bond does not react is 
explained by the methyl group attached to the phenyl ring which blocks the side of the double bond 
from where the catalyst would preferentially attack in an unhindered system. 
 
Scheme 5: Regioselective asymmetric hydrogenation in the synthesis of pseudopteraxole. 
 
A ligand class with a different structural motif are the bicyclic pyridine-phosphinite ligands. Instead 
of an oxazoline moiety they have a pyridine ring which mimics the coordination sphere of 
Crabtree's catalyst. These ligands have a very rigid structure and turned out to be one of the most 
powerful ligands for the asymmetric iridium-catalyzed hydrogenation. The pyridine-phosphinite 
ligands can be used to reduce a broad range of substrates with full conversion and excellent 
enantioselectivities. Not only unfunctionalized olefins[29] can be hydrogenated, but also α,β-
unsaturated esters, vinyl borates[30] and even heteroaromatic compounds like furans[29a,31] which are 
normally tough substrates due to the aromaticity (Figure 5). 
 
Figure 5: Selection of substrates that can be reduced with pyridine-phosphinite ligands. 
 
Due to its broad substrate scope, this ligand class found application in the synthesis of many natural 
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products.[29b,31,32] A nice example for the utility of this ligand class is the synthesis of a tocopherol 
derivative. One of the key steps is the hydrogenation of γ-tocotrienyl acetate (8) where three double 
bonds are reduced in one step and two new stereogenic centers are created to form γ-tocopheryl 
acetate (9) (Scheme 6).[29b] Among the four possible isomers the desired R,R,R-isomer is formed 
with more than 98%. Before, the side chain had to be synthesized stepwise by sequential 
elongation-hydrogenation protocols.[33] 
 
Scheme 6: Asymmetric hydrogenation in the synthesis of γ-tocopherol derivative. 
 
For the hydrogenation of tetrasubstituted olefins phosphanyl-methyloxazoline ligands proved to be 
the most effective.[34] This ligand class was originally reported by Helmchen and Sprinz and was 
initially applied in asymmetric allylic substitution.[35] Unlike the ligand classes described above, 
theses ligands form only a five-membered chelate ring with the metal and not a six-membered ring. 
The phosphanyl-methyloxazoline ligands allowed the asymmetric hydrogenation of several 
substrates with low to moderate catalyst loading and hydrogen pressure within short reaction times 
(Scheme 7). Noteworthy, it was observed in some cases that reducing hydrogen pressure results in 
better selectivity while Buchwald described the opposite trend for his zirconocene catalyst.[15c]  
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Scheme 7: Hydrogenation of a tetrasubstituted olefin with a phosphanyl-methyloxazoline ligand. 
 
Other groups as well developed many different N,P-ligands which also give excellent results in 
iridium-catalyzed asymmetric hydrogenation. Zhou synthesized pyridine-phosphinite ligands very 
similar to ours which reduced functionalized and unfunctionalized olefins efficiently.[36] Anderson 
reported the use of phosphinite oxazole, phosphine thiazole and 2-azanorbornane-oxazoline ligands 
to hydrogenate successfully various substrate classes among vinylsilanes[37], fluorinated olefins[38] 
and phosphinates.[39]  
Two other efficient ligand classes for the iridium-catalyzed hydrogenation were developed by Ding 
(SpinPHOX)[40] and Zhou (SiPHOX).[41] The scope of these phosphine oxazoline ligands with a 
spirocyclic backbone is largely complementary to that of the P,N ligands described above 
(Figure 6). 
 
Figure 6: General structure of spirocyclic SpinPHOX and SiPHOX ligands. 
 
α,β-Unsaturated carboxylic acids were reduced with these ligands with high enantiomeric 
excess.[41,42] Furthermore, the reduction of imines could be performed with excellent ee's.[40] A 
structurally related spirocyclic phosphine amino pyridine ligand was used for the reduction of C=O 
bonds[43] which are normally hard to reduce efficiently. Interestingly, with ligand L9 this 
methodology can be used to reduce chemoselectively the carbonyl group of α,β-unsaturated ketone 
12 while the olefinic double bond remains untouched (Scheme 8).[44] 
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Scheme 8: Chemoselective reduction of a carbonyl group in presence of a C=C double bond. 
 
Even though there are numerous of different ligands which give excellent results for the asymmetric 
hydrogenation of various substrate classes, there is still a need for further improvement of catalyst 
efficiency. It is highly desirable to develop catalytic systems which allow to decrease catalyst 
loadings to make hydrogenation reactions more attractive for industrial applications. Furthermore, 
new catalysts have to be found to broaden the scope so that even challenging substrates can be 
reduced with good conversions and high enantiomeric excess. 
 
 1.3  Aim of this work 
 
Chapter 2 deals with the development of a new ligand class based on the pyridine-phosphinite 
ligands which can complex two iridium atoms to form dimeric complexes. These catalysts should 
be tested in the asymmetric hydrogenation of different substrates. The third chapter discusses the 
synthesis of several chiral cyclohexenes by enantioselective Diels-Alder reactions. These 
cyclohexenes and derivatives thereof were tested in the diastereoselective reduction by a chiral 
iridium catalyst. In Chapter 4, some results of enantioselective palladium-catalyzed allylic 
substitution reactions and asymmetric iridium-catalyzed hydrogenation with different NeoPHOX 
ligands are presented.
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 2  Development of pyrazine-phosphinite ligands and formation of 
their iridium complexes 
 
 
 2.1  Introduction 
 
Among the N,P-ligand classes developed in our research group, the pyridine-phosphinite ligand 
class proved to be the most efficient (see Figure 5).[29-32] Their structure can be easily modified by 
the introduction of different substitutents at the phosphorus unit or the pyridine ring. Furthermore, 
either a five- or a six-membered carbocycle in the backbone can be introduced giving access to a 
broad library of ligands which allows the selective reduction of many substrates. However, the 
synthesis for ligands with a substituent at the pyridine ring includes many steps which make the 
formation of these compounds expensive (Scheme 9).[29a] 
 
 
Scheme 9: Synthesis of phenyl subtstituted pyridine-phosphinite ligands. 
 
For ligands with a phenyl moiety on the pyridine ring, the synthesis starts from acetophenone (14). 
In the first step, ammonium chloride 15 is formed by a Mannich reaction. Next, the ammonium 
species reacts with the corresponding enamine to give diketone 16 with either a five- or a six-
membered carbocycle. After treatment with hydroxyl ammonium chloride, bicyclic pyridine 17 is 
formed which can be converted to pyridyl alcohol 18 after formation of the N-oxide followed by 
Development of pyrazine-phosphinite ligands                                                                                                                                              
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Boekelheide rearrangement. In the last step, phosphinite 19 can be obtained by nucleophilic 
substitution with a phosphine chloride. For ligands with no substituent on the pyridine ring the 
synthesis can be started with the formation of the N-oxide from the corresponding commercially 
available bicyclic pyridine. 
Since ligands with a phenyl moiety on the pyridne ring usually gave the best results in the 
asymmetric hydrogenation the synthesis was optimized for this type of ligands. Therefore, pyridyl 
alcohol 18 and other aryl derivatives were synthesized by a Suzuki-coupling of the chloride 
precursor with the corresponding boronic acid.[45] The pyridyl chlorides are mostly commercially 
available which reduces the necessary number of steps for the formation of the ligands. 
One possibility to improve the efficiency of the synthesis of ligands of this type could be the 
introduction of a second N,P-functionalization into the molecule which would allow the 
complexation of two iridium atoms (Figure 7). Assuming that the iridium complexes of this novel 
ligand class show the same activity and selectivity as the monomeric complexes, the necessary 
amount of catalyst for the hydrogenation could be cut in half. 
 
Figure 7: Structure of pyridine-phosphinite ligands (left) and new target pyrazine-diphosphinite 
ligands (right). 
 
The proposed new ligand class consists of a pyrazine ring instead of a pyridine ring and a 
carbocycle with two phosphinite moieties instead of only one. Due to the C2-symmetry it should be 
possible to introduce the functional groups on both sides in the same reaction which avoids the need 
of additional steps. The retrosynthetic strategy is based on the synthesis of the pyridine-phosphinite 
ligands and is identical for the last steps (Scheme 10). 
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Scheme 10: Retrosynthetic analysis for pyrazine-diphosphinite ligands. 
 
Condensation of a cyclic diamine with a diketone followed by oxidation should give the bicyclic 
pyrazine. Next, the pyrazine can be oxidized to the bis N-oxide followed by Boekelheide 
rearrangement as before to form the pyridyl diol. In the last step the phosphinite is formed by a 
nucleophilic substitution reaction between the hydroxy group and a phosphine chloride to form the 
desired ligand. 
 
 2.2  Synthesis of complexes with a six-membered carbocycle 
 
 2.2.1  Synthesis of pyrazine diols via Boekelheide rearrangement 
 
First, we tried to synthesize several tetrahydroquinoxalines with different substituents at the 
pyrazine ring. We started with the synthesis of tetrahydroquinoxaline 22 with two phenyl groups 
(Scheme 11). 
 
Scheme 11: Synthesis of tetrahydroquinoxaline 22. 
 
1,2-Cyclohexanediamin (20) was treated with benzil (21) in THF under acidic conditions to form 
the diimine precursor. After purification by recrystalization, the diimine was oxidized using DDQ to 
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give pyrazine 22 in 66% yield over two steps. 
Next, we wanted to synthesize tetrahydroquinoxaline 24 with two methyl groups at the pyrazine 
ring (Scheme 12). 
 
Scheme 12: Attempted synthesis of tetrahydroquinoxaline 24. 
 
Therefore, 1,2-Cyclohexanediamin (20) was treated with 2,3-butanedione (23) under the same 
conditions as before to form the diimine. After two hours complete product formation was observed 
by GCMS. However, after recrystalization the desired product could not be isolated. Purification by 
column chromatography only gave low yield of the hexahydroquinoxaline. We assume that the 
diimine might be unstable and decomposes during purification. Therefore, we tried to oxidize it to 
pyrazine 24 immediately after formation of the diimine without any purification of the diimine 
(Scheme 13). 
 
Scheme 13: Attempted synthesis of tetrahydroquinoxaline 24 without purification of the diimine. 
 
Unfortunately, this new synthetic procedure was not successful either and the final product was not 
isolated. Since the residue turned black during removal of the solvent after the first step, which 
might be an indication for decomposition of the diimine, we also tried a one pot procedure without 
change of solvent. Unfortunately, still no pyrazine formation was observed. We do not know why 
the oxidation did not work but decided to put no more effort into the synthesis of pyrazine 24. Next,  
we investigated the oxidation of commercially available unsubstituted pyrazine 22 to its bis-N-oxide 
25 (Table 1). 
 
Table 1: Screening of conditions for the oxidation of pyrazine 22 to bis-N-oxide 25. 
NH2
NH2
O
O
+
N
N
20 23 24
1) AcOH
THF, reflux, 2 h
2) DDQ
toluene, reflux, 3 h
NH2
NH2
O
O
+
AcOH
THF, reflux, 2 h
then: DDQ
toluene or THF, reflux, 3 h
N
N
20 23 24
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Entry Solvent Oxidant (eq.) Additive (eq.) Observed Product 
1 CH2Cl2 H2O2 (4.0) MTO (0.04) Monooxide 
2 AcOH H2O2 (4.0) No additive Monooxide 
3 CHCl3 m-CPBA (2.3) NaHCO3 (20.0) No reaction 
4 CHCl3 m-CPBA (4.6) No additive No reaction 
5 EtOAc m-CPBA (2.2) No additive Monooxide 
6 MeOH Oxone (2.3) NaHCO3 (5.0) No reaction 
7 CH2Cl2 Oxone (2.3) NaHCO3 (5.0) No reaction 
 
First, we tried to oxidize the pyrazine using conditions for the synthesis of the pyridine-phosphinite 
ligands described by Kaiser .[29a] Methyltrioxorhenium (MTO) was employed as a catalyst and 
aqueous hydrogen peroxide solution as oxidant (entry 1). However, we only observed formation of 
the mono-N-oxide 26 and no bis-N-oxide 25. After an extended literature search we tested further 
oxidation methods for the synthesis of pyrazine-bis-N-oxides[46] but none of them worked. When 
the reaction was performed in acetic acid with hydrogen peroxide as oxidant only the monooxide 
was detected again (entry 2). By switching to chloroform as solvent and m-CPBA as oxidant the 
reactivity was totally inhibited even if sodium bicarbonate was added as additive (entry 3 and 4). 
Using ethyl acetate instead of chloroform led only to the formation of mono-N-oxide 26 (entry 5). 
Last, we tried oxone as oxidant together with sodium bicarbonate as additive in methanol or 
methylene chloride (entry 6 and 7). However, both procedures failed and no conversion was 
observed.  
We decided to change the substrate to see if the phenyl moieties are the reason for the inhibited 
reactivity and investigated the oxidation of unsubstituted tetrahydroquinoxaline 27 (Scheme 14). 
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Scheme 14: Attempted synthesis of 29 by Boekelheide rearrangement. 
 
Pyrazine 27 was treated with an excess of oxone and sodium bicarbonate in a 2:1 methanol/water 
mixture to yield the desired bis-N-oxide 28 in 83%. Under related conditions no reaction was 
observed for the phenyl substituted pyrazine (Table 1, entry 6) which indicates that the phenyl rings 
inhibit the reactivity. A similar behavior was observed in the synthesis of the pyridine-phosphinite 
ligands in which the oxidation of substituted pyridines was more difficult.[29a] 
Next, we investigated the Boekelheide rearrangement of bis-N-oxide 28 to diol 29. An excess of 
trifluoroacetic anhydride was added to the oxide followed by in situ hydrolysis with lithium 
hydroxide but only decomposition of the intermediate could be observed. Alternatively, a milder 
protocol in acetic anhydride was tested but it did not lead to product formation either. 
 
 2.2.2  Synthesis of pyrazine diols via condensation reaction 
 
Since the strategy involving a Boekelheide rearrangement did not succeed we decided to try another 
synthetic route which was previously applied in our group for the synthesis of N,P ligands 
(Scheme 15).[47]  
 
Scheme 15: Synthesis of pyridyl ketones by A. Ganic for the development of N,P-ligands.
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A condensation between bicyclic pyridines 30 and benzaldehyde led to formation of olefins 31. 
These products were transformed to ketones 32 by ozonolysis. We thought that the same strategy 
should be applicable to our system using quinoxaline 27 or 22 as starting material. Reduction of the 
formed ketone or reductive workup after ozonolysis should give the desired diol. 
 
Table 2: Condensation reaction of pyrazines 22 and 27 with benzaldehyde. 
Entry R T (°C) t (days) Yield mono (%) Yield di (%) 
1 H 120 1 42 0 
2 H 180 5 34 63 
3 Ph 120 1 0 0 
 
We used a modified protocol published by Jahng[48] for the condensation between the pyrazines and 
benzaldehyde. However, treatment of tetrahydroquinoxaline 27 with an excess of benzaldehyde 
under these conditions led only to the monoolefin 35 (entry 1). Very high temperature (180 °C) and 
a long reaction time (5 days) were necessary to obtain the diolefin 33 in good yield (63%) together 
with the monoolefin (entry 2). After five days the reaction was stopped since no more product 
generation could be observed. Because pyrazine 22 with two phenyl groups at the pyrazine ring 
turned out to be even less reactive, no diolefin 34 or monoolefin 36 was formed under standard 
conditions. Since not even the monoolefin was observed we decided not to test the synthesis at 
higher temperature. 
With diolefin 33 in hand we investigated the ozonolysis step next (Scheme 16). 
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Scheme 16: Attempted ozonolysis of diolefin 33. 
 
First, we tried to synthesize diketone 37 by reductive workup with dimethyl sulfide but the desired 
product could not be isolated and only an unidentifiable mixture was obtained. Also changing the 
solvent for the ozonolysis from methylene chloride to methanol did not result in product formation. 
We tried to form diol 29 directly by adding sodium borohydride after ozonolysis but again, the 
desired product could not be detected. 
Because diol 29 was not accessible by ozonolysis we tried to synthesize diketone 37 by transition 
metal catalyzed oxidative cleavage and tested various procedures (Table 3).[49,50] 
 
Table 3: Attempted synthesis of diketone 37 by oxidative cleavage of diolefin 33. 
Entry [M] Oxidant Additive Solvent 
1 OsO4 Oxone NaHCO3 DMF 
2 OsO4 NaIO4 NaHCO3 DMF 
3 RuCl3 Oxone NaHCO3 Dichloroethane/H2O 
4 RuCl3 NaIO4 No additive Dichloroethane/H2O 
 
Unfortunately, none of the procedures yielded in product formation. Using osmium tetroxide with 
either oxone or sodium periodate as oxidant resulted in an unidentifiable mixture. When ruthenium 
chloride was used as catalyst in combination with oxone only starting material could be obtained, 
whereas ruthenium chloride with sodium perioadate led to an complex mixture. Since the synthesis 
of diol 29 failed by this strategy we searched the literature for an alternative route. 
 
N
N
Ph
O3, CH2Cl2, -35 °C
then: NaBH4
rt, 17 h N
N
OH
OH
O3, CH2Cl2, -35 °C
then: SMe2
MeOH, rt, 17 h
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 2.2.3  Final synthesis of pyrazine diols 
 
An intensive search for routes to similar molecules revealed a three step synthesis for 
tetrahydronaphthalenediol starting from tetrahydronaphthalene[51] which we thought should be 
adaptable to our system (Scheme 17).  
 
Scheme 17: Synthesis of diols 29 and 40. 
 
First, we invesigated the synthesis of diol 29. Starting with a radical benzylic bromination of 
pyrazine 22 using N-bromosuccinimide gave the dibromide followed by conversion to the diacetate 
38 using silver acetate. The corresponding diacetate was obtained as a 2:1 mixture of the 
diastereomers in favor of the desired trans-diacetate. The mixture was used without separation of 
the diastereomers in the next step. Hydrolysis of the acetate using 2 M NaOH in methanol resulted 
in diol 29 in an overall yield of 51%. The diastereomers were separated by column chromatography 
to give trans-29 in an overall yield of 34% and cis-29 in 17%. The synthesis of phenyl substituted 
diol 40 started from the corresponding pyrazine 27 and was less efficient. The diol could be isolated 
in only 16% after the three steps. Again, it was obtained as a 2:1 mixture in favor of the trans-
isomer which was separated by column chromatography. 
 
 2.2.4  Ligand formation and complexation 
 
With the diols in hand we tried to synthesize the ligands by nucleophilic substitution with phosphine 
chlorides followed by in situ complexation with iridium and counterion exchange according to the 
standard procedure for the pyridine-phosphinite ligands (Scheme 18).[29a,45]  
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29: R = H, 51% over 3 steps
40: R = Ph, 16% over 3 steps
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Scheme 18: Synthesis of catalyst C1. 
 
The reaction progress was controlled by 31P-NMR analysis and measured chemical shifts were 
compared with the value for the corresponding pyridine-phosphinite ligand. After stirring overnight 
phosphinite formation could be observed together with some decomposition of the phosphorus 
reagent. A shift of the signal in 31P-NMR after addition of bis(1,5-cyclooctadiene)diiridium 
dichloride showed that the complexation worked but when NaBArF was added the reaction solution 
turned from red to green which normally indicates oxidation of the phosphorus atom. Nevertheless, 
the corresponding product was identified by 31P-NMR analysis of the crude mixture. After column 
chromatography, one fraction was obtained which showed several spots in TLC. In 31P-NMR, 
several peaks around 140 ppm could be observed (Figure 8), in the region where the signal for the 
catalyst is expected since the signal for the analogous pyridine-phosphinite complex comes at 135 
ppm. The signal at 30 ppm belongs to an oxidized phosphorus atom. However, the 1H-NMR 
revealed that the desired complex C1 was not present in the mixture. The two singlets in the 
aromatic range should belong to the BArF anion but the signal for the protons at the pyrazine ring at 
8.5 ppm was not observed. Furthermore, there were no signals for the olefinic protons of the 
cycloocatdiene. 
 
N
N
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1) tBu2PCl, NaH
THF:DMF 4:1
rt, 20 h
2) [Ir(COD)Cl]2
CH2Cl2, reflux, 3 h
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Figure 8: 1H- (top) and 31P-NMR spectrum (bottom) after column chromatography of attempted 
synthesis of C1. 
 
Since oxidation at the phosphorus atom was an issue and alkyl phosphines are more sensitive 
towards oxidation we decided to continue our investigations with aryl phosphines. They are easier 
to handle and we thought that the corresponding iridium complexes are more stable simplifying the 
isolation. Therefore, we attempted to synthesize ortho-tolyl substituted catalyst C3 and iridium 
complex C2 bearing two phenyl groups at the phosphinite residue (Scheme 19). 
 
Scheme 19: Attempted synthesis of aryl substituted iridium complexes. 
 
Unfortunately, the outcome was similar to the alkyl substituted phosphine. According to phosphorus 
NMR phosphinite formation and complexation worked fine but after addition of NaBArF the 
N
N
OH
OH
1) R2PCl, DMAP
THF, rt, 2 h
2) [Ir(COD)Cl]2
NaBArF
CH2Cl2, rt, 2 h
N
N
O
P
Ir
Ir
P
O
COD
COD
RR
RR 2 BArF
-
2+
29 C2: R = o-Tol
C3: R = Ph
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reaction mixture turned green in both cases. However, the NMR spectra of the crude products 
looked promising and did not show any oxidized species and after column chromatography a red 
foam was obtained. However, the 1H-NMR spectrum revealed that the desired complex C2 was not 
present. Although the signal for the pyrazine ring at 8.58 ppm could be observed for the ortho-tolyl 
substituted compound (Figure 9), the signals for the olefinic protons of the cyclooctadiene were 
missing. A broad signal at about 3.80 ppm could not be assigned. Furthermore, there were too many 
signals in the aliphatic region. The proton spectrum from the attempted synthesis of complex C3 
looked similar. 
 
Figure 9: 1H- (top) and 31P-NMR spectrum (bottom) of attempted synthesis of C2. 
 
Because the synthesis of the iridium catalysts was unsuccessful by this procedure we investigated 
other strategies. First, we wanted to know whether the formation of the phosphinite was the 
problem or the complexation. Therefore, we tried to isolate ligand L10 (Scheme 20). 
 
                                                                                                                                           CHAPTER 2 
23 
Scheme 20: Synthesis of ligand L10. 
 
We stopped the reaction after phosphinite formation was complete according to phosphorus NMR 
and after workup we checked the 1H-NMR spectrum of the crude product to see if the ligand was 
formed (Figure 10). We were delighted to see that the synthesis worked and ligand L10 was 
isolated. The 31P-NMR spectrum showed only one signal and also the 1H-NMR spectrum was clean 
showing that there was no starting material left and no side products were formed. 
 
Figure 10: 1H- (top) and 31P-NMR spectrum (bottom) of ligand L10. 
 
Since phospinite formation was not the problem we concentrated on further investigating the 
complexation with iridium. As the reaction mixture always turned green after addition of NaBArF 
we thought that the counterion exchange might be the critical step and we decided to try another 
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iridium source (Scheme 21). 
 
Scheme 21: Attempted complex formation with Ir(COD)2BArF. 
 
Instead of [Ir(COD)Cl]2, bis(cyclooctadiene)iridium(I) tetrakis[3,5-
bis(trifluoromethyl)phenyl]borate was used which would directly lead to catalyst C3 so that 
counterion exchange was not necessary anymore. However, the iridium complex was not isolated 
even though  31P-NMR analysis indicated product formation. The 1H-NMR spectrum showed 
mainly signals belonging to the iridium source together with some signals in the aliphatic range. 
Next, we tried to purify the crude product by column chromatography on AlOx because we thought 
that the complexes might decompose on silica gel but this procedure was not successful either. 
Another problem of column chromatography could be that a methanol/methylene chloride mixture 
was necessary as eluent due to the high polarity of the iridium complexes. Methanol might lead to a 
ligand exchange and could be the reason why not all the expected signals could be observed in 
proton NMR. Attempts to use less coordinating solvents such as THF were not successful. 
Since the isolation of the BArF complexes could not be achieved we tried to synthesize the 
corresponding iridium complex with a chloride as counterion (Scheme 22). 
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Scheme 22: Attempted synthesis of complex C4 with a chloride as counterion. 
 
We stopped the reaction after addition of the iridium source and purified the crude product by 
column chromatography. A red foam was obtained which showed a signal in the 31P-NMR spectrum 
at 92.7 ppm and new signals which had not been observed before at 42 and 42 ppm (Figure 11). 
The latter two signals were interpreted as doublets belonging to two different phosphorus atoms 
coupled to each other. The proton NMR again showed no signals for the olefinic protons of the 
cyclooctadiene ligands and was not clean. Therefore, no structural assignments could be made. 
Attempts to do a counterion exchange with the obtained product failed and only an oxidized 
phosphorus species could be observed. 
 
Figure 11: 31P-NMR after column chromatography of synthesis of complex C4. 
 
Although all the attempts to isolate a dinuclear iridium complex failed, the phosphorus NMR 
spectrum indicated that an iridium complex was formed. Therefore, we tested if the formed 
compound was capable to activate hydrogen and to catalyze hydrogenation. So, we performed the 
synthesis again and used the crude product directly for the hydrogenation of substrate 41 
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(Scheme 23). 
Scheme 23: Test hydrogenation with a crude iridium complex derived from diol 29. 
 
The reaction was performed with 10 mg of crude C2 which would correlate to 3.3 mol% if it was a 
pure catalyst. After four hours reaction time the 1H-NMR spectrum showed only reduced product 42 
and no starting material anymore. We were happy to see that the olefin could be reduced even 
though the structure of the catalytically active species was not clear. With the aim to prepare a 
structurally designed catalyst, we investigated the complexation of a ligand with a phenyl 
substituted pyrazine to see if the corresponding iridium complex is more stable (Scheme 24). 
 
Scheme 24: Attempted synthesis of phenyl substituted complex C5. 
 
Under the conditions previously used for catalyst preparation from the unsubstituted pyrazine 29 the 
same problems occurred. Phospinite formation and complexation worked fine according to 31P-
NMR but after addition of NaBArF the reaction mixture turned green. In the 
31P-NMR spectrum of 
the crude product was a signal belonging to a complexed phosphorus atom but after column 
chromatography this signal disappeared and there was only a peak assigned to an oxidized species. 
In view of these problems we decided not to do any further studies on the synthesis of these 
complexes. 
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 2.3  Synthesis of complexes with a five-membered carbocycle 
 
The strategy for the synthesis of complexes with a five-membered carbocycle was the same as for 
their six-membered analogues (Scheme 10). Since 1,2-diaminocyclopentane (41) was not 
commercially available we selected two literature procedures for its synthesis (Scheme 25).[52,53]  
 
Scheme 25: Synthesis of 1,2-diaminocyclopentane by Gilheany (top)[52] and Deniaud (bottom).[53] 
 
Both syntheses start from cyclopentene (41) and include the formation of diazide 42 which is 
reduced to diamine 43. Gilheany formed the diazide in one step using sodium azide and potassium 
permanganate while Deniaud followed a three step procedure to first form dimesylate 44 which is 
then transformed to diazide 42 and finally reduced. We first explored Gilheany's route since it 
included less steps. However, direct synthesis of diazide 42 failed and therefore, we tried Deniaud's 
protocol next. Epoxide formation of cyclopentene worked fine but ring opening with sodium 
hydroxide failed and the diol could not be obtained. Because of these problems at an early stage of 
the synthesis and since it included the formation of a diazide which is difficult to handle we chose 
another strategy. 
 
Scheme 26: New retrosynthetic plan for pyrazines with a five-membered carbocycle. 
 
As shown in Scheme 26, the pyrazine should be formed by a condensation reaction between a non-
cyclic diamine and cyclic 1,2-diketone 45 which can be obtained from commercially available 
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cyclopentanone (46). 
 
Scheme 27: Attempted synthesis of pyrazine 50 starting from cyclopentanone (46). 
 
In the first step, cyclopentanone is brominated to give α-bromoketone 47 which is then transformed 
into enol 48 with 21% yield over two steps.[54] Next, reaction of the enol with ethylenediamine 
should lead to imine 49 which we wanted to oxidize immediately to pyrazine 50 due to its 
instability.[55] However, the pyrazine could not be isolated and only an unidentifiable mixture was 
obtained. Formation of the imine worked according to GCMS but the heteroarene could not be 
detected. The same problem occurred already in the synthesis of methyl substituted pyrazines with a 
six-membered carbocycle (Scheme 12 and 13). Therefore, we changed our synthetic plan again and 
came up with a new route (Scheme 28). 
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Scheme 28: Changed retrosynthetic plan starting from cyclopentadiene (58). 
 
Diol 51 should be accessible from diolefin 52 by ozonolysis followed by reductive workup. The 
terminal alkene can be obtained from diol 53 by transformation of the hydroxy group into a leaving 
group and subsequent base induced elimination. The diol should be available from tricyclic olefin 
54 by another ozonolysis with reductive workup. This route had already been previously applied for 
the synthesis of a similar molecule where one of the primary alcohols of 53 was protected as a silyl 
ether.[56] Pyrazine 54 can be formed by condensation of diketone 55 with a 1,2-diamine followed by 
oxidation. The synthesis of diketone 55 is literature known and includes a Diels-Alder reaction and 
a Swern oxidation.[57] This strategy includes many steps which is a drawback but the first steps are 
literature known and the last reactions were reported for a similar molecule, so we tried to obtain 
diol 51 by this route (Scheme 29). 
 
N
N
HO
HO
N
N
N
N
OH
OH
N
N
R
R R
R R
R
R
R
R
R
H2N
H2NO
O
+
O
O
OO
O
+ O
555658 57
51 52 53 54
Development of pyrazine-phosphinite ligands                                                                                        
30 
Scheme 29: Synthesis of tricyclic pyrazine 54. 
 
The synthesis started by a Diels-Alder reaction between cyclopentadiene (58) and vinylene 
carbonate (57) to give cyclohexene 56 in 83% yield. Hydrolysis of the cyclic carbonate with sodium 
hydroxide led to almost quantitative formation of diol 59 which was subsequently oxidized under 
Swern conditions to give diketone 55. Treatment with ethylenediamine gave access to diimine 60 
which was finally oxidized to pyrazine 54 using nickel oxide with an overall yield of 6% over five 
steps. The drawback of this synthesis is the last step with a yield of only 16%. Moreover, the use of 
nickel oxide is problematic due to its environmental and health risks and its high costs. We also 
tried to perform the oxidation with DDQ but this did not lead to product formation. Instead, a 
unidentifiable mixture was obtained. 
We also studied the synthesis of pyrazine 64 with two phenyl groups at the aromatic ring, to see if it 
is accessible by oxidation of the corresponding diimine with DDQ as it was the case for the phenyl 
substituted tetrahydroquinoxaline 22 (Scheme 11). The required diphenylethylenediamine (63) was 
prepared according to Scheme 30. 
 
Scheme 30: Synthesis of diphenylethylenediamine. 
The formation of the diamine involved two steps following a procedure described by Hu.[58] In the 
O
O
+ O
toluene
180 °C, 20 h
O
O
O
aq. NaOH
40 °C, 18 h
OH
OH
TFAA, DMSO
NEt3, CH2Cl2
-78 °C to rt, 5 h
O
O
H2N
NH2
THF, reflux, 5 h
N
N
N
N
toluene
reflux, 18 h
56
83%
59
92%
55
72%
60
67%
58 57
54
16%
NiO2
O
NH4OAc
120 °C, 3 h
Ph Ph
N NH
Ph OPh
H2O, H2SO4
reflux, 24 h
PhH2N
H2N Ph
63
27% over 2 steps
61 62
                                                                                                                                           CHAPTER 2 
31 
first step, four equivalents of benzaldehyde (61) reacted with ammonium acetate to give amide 62. 
Hydrolysis of the amide under acidic conditions led to formation of the desired diamine 63 in 27% 
yield over both steps. With the diamine in hand we investigated the synthesis of the pyrazine 
(Scheme 31). 
 
Scheme 31: Synthesis of phenyl substituted pyrazine 64. 
 
We performed the transformation under the same conditions as before for the first step and used 
DDQ for the oxidation of the diimine. We were pleased to see that we could obtain pyrazine 64 by 
this procedure. As already observed in previous reactions, it seems that the phenyl substituents 
stabilize the diimine which allows the use of DDQ as oxidant instead of nickel oxide. However, the 
yield was unsatisfying with only 15% over two steps and only insignificantly higher than for 
unsubstituted pyrazine 54 (11% over the two steps). Because of the low yields obtained for the 
preparation of pyrazines which make the synthesis rather unattractive and the problems we 
encountered in the complexation of the ligands with a six-membered carbocycle, we discontinued 
this project at this stage. 
 
 2.4  Summary 
 
We synthesized two precursors of a new C2-symmetric ligand class, which can form dinuclear 
metal complexes, in three and/or five steps from commercially available starting materials. The 
procedure developed for related pyridine phosphinite ligands could no be applied so that a new 
strategy had to be found. One ligand was isolated and identified by 1H-NMR. However, iridium 
complexes of these ligands could not be isolated even though 31P-NMR indicated formation of 
them. Various methods were tested to obtain the complexes but it seemed that they were not stable 
and decomposed. In one case it could be shown that the crude product obtained by complexation 
can be used to reduce an alkene. However, the nature of the catalytically active species could not be 
determined.  
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For ligands with a five-membered carbocycle we developed a synthesis of potential precursors. 
However, these studies were discontinued because of the low yield for the pyrazine formation and 
the problems which occurred in the complexation of the ligands with a six-membered carbocycle. 
The remaining transformations to the desired ligands are literature known for similar substrates and 
should work but the synthesis would not be very efficient due to a high number of steps and low 
yield.
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 3  Chiral Diels-Alder products as substrates for iridium-catalyzed 
asymmetric hydrogenation 
 
 
 3.1  Introduction 
 
Cyclohexane rings are ubiquitous structural elements occurring I many important natural and 
synthetic compounds. Among the many possible routes to cyclohexanes,[59-61] ring formation via 
Diels-Alder reaction stands out because it gives access to a wide range of polysubstituted 
cyclohexenes from simple precursors in a regio-, diastereo- and also enantioselective manner. 
Moreover, by reaction at the C=C bond Diels-Alder products can be modified in a variety of ways. 
For instance, if the C=C bond bears one or two substituents, one or two additional stereogenic 
centers can be introduced by hydrogenation (Scheme 32). This strategy is most useful if C=C bond 
reduction can be carried out diastereoselectively. 
 
Scheme 32: Synthesis of cyclohexanes by chiral Diels-Alder reaction followed by iridium-catalyzed 
hydrogenation. 
 
Diastereoselectivity can be achieved by substrate or by catalyst control. The scope of substrate 
control is limited and strongly dependent on the specific substituents present in the cyclohexene 
ring. Furthermore, only one of two diastereomeric products is accessible by a susbtrate controlled 
transformation. 
A more widely applicable approach is an enantioselective Diels-Alder reaction followed by 
hydrogenation under catalyst control. By this way, both diastereomeric hydrogenation products are 
available depending on the absolute configuration of the catalyst. 
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 3.2  Objectives of this work 
 
Our goal was to synthesize different chiral cyclohexenes with a substituent at the double bond by 
enantioselective Diels-Alder reactions. In the second step, the products should be reduced 
diastereoselectively under catalyst control employing the chiral iridium catalysts developed in our 
group (Scheme 32). This Diels-Alder-hydrogenation sequence has been applied in the synthesis of 
several natural products.[62] Mulzer's synthesis of valerenic acid involved a hydroxy-directed 
asymmetric Diels-Alder reaction. A subsequent hydroxy-directed diastereoselective hydrogenation 
of the double bond using Crabtree's catalyst led to the product in 91% yield.[62a] To date, no 
examples have been reported, in which a chiral catalyst is used for the hydrogenation. 
Depending on the choice of the starting materials for the Diels-Alder reaction, the tandem Diels-
Alder-hydrogenation strategy allows the introduction of different substituents in various positions of 
the cyclohexane ring diastereoselectively. 
 
 3.3  Enantioselective Diels-Alder reaction 
 
The Diels-Alder reaction is a powerful tool for the synthesis of cyclohexene derivatives and was 
first reported by the German chemists Otto Paul Hermann Diels and Kurt Alder in 1928.[63] The 
reaction became a very efficient method for the formation of six-membered rings. In 1950, the two 
chemists obtained the Nobel Prize for “their discovery and development of the diene synthesis”. 
Due to its high regio- and stereoselectivity the method was applied in many transformations and is 
often used as a key step in natural product synthesis. For example, Woodward adopted it in the 
synthesis of cortisone and cholesterol.[64,65] 
The simplest example for a Diels-Alder reaction is the reaction of butadiene (65) with ethylene (66) 
(Scheme 33). 
 
Scheme 33: Diels-Alder reaction of 1,3-butadiene 65 with ethylene 66.[66] 
 
This reaction only proceeds at high temperature and pressure and in poor yield. However, by 
+
200 °C, 200-400 atm
65 66 67
18%
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introducing electron-withdrawing substituents at the dienophile the reaction is accelerated and can 
occur at room temperature due to lowering the LUMO energy of the dienophile.[67] The reactivity 
can be further increased by using a catalyst, either a Lewis acid[68] or an organocatalyst,[69] which 
interacts and/or reacts with a carbonyl group at the dienophile. By employing a chiral catalyst, the 
synthesis can be done in an enantioselective fashion. 
The first example for a catalytic system which allowed the synthesis of various cyclohexenes by an 
asymmetric Diels-Alder reaction was published by Evans in 1993.[68a] He used C2-symmetric 
bis(oxazoline)copper complexes to react cyclopentadiene with several imides and thiazolidine-2-
thione analogs and obtained the corresponding cyclohexenes with enantioselectivities higher than 
90% (Scheme 34). 
 
Scheme 34: Enantioselective Diels-Alder reaction by Evans.[68a] 
 
Corey used chiral oxazaborolidines as catalysts for the enantioselective Diels-Alder reaction of 
various dienes and furans with different dienophiles (Scheme 35).[68c] By treating oxazaborolidine 
68 with a strong Brønsted acid or aluminum tribromide very strong Lewis acids 69 and 70 are 
formed which give excellent results for the investigated reactions. High endo/exo-selectivities and 
enantioselectivities over 90% were reached in most cases at low temperatures. 
 
Scheme 35: Chiral oxazaborolidines as catalysts for asymmetric Diels-Alder reaction by Corey[68c]. 
 
MacMillan published a protocol for enantioselective Diels-Alder reactions using amine 71 as 
orgonacatalyst.[69a] The amine reacts with the carbonyl group of the dienophile and forms a chiral 
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iminium ion which then reacts with the diene. After hydrolysis the product is obtained and the 
catalyst released (Scheme 36). 
 
Scheme 36: Mechanism of the organocatalyzed Diels-Alder reaction by MacMillan.[69a] 
 
Another example for a method employing organocatalysts was developed by the group of Chen.[69f] 
They used the Jørgensen-Hayashi catalyst (72) in combination with o-fluorobenzoic (OFBA) acid 
as an additive to react several nitroalkenes with various 2,4-dienals to obtain multiply-substituted 
cyclohexenes with high diastereo- and enantioselectivities (Scheme 37). During the reaction, a 
trienamine is formed in the first step which attacks the nitroalkene to initiate the formation of the 
cyclohexene. Furthermore, they observed an unexpected exo-selectivity which they explain by an 
electrostatic repulsion between the nitro group and the π-electrons of the enamine. 
 
Scheme 37: Enantioselective Diels-Alder reaction by Chen.[69f] 
 
 
 3.4  Previous results 
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The project was started by Jaroslav Padevet who presented first results in his dissertation.[70] He 
began his investigations with an optimization of the hydrogenation of the (R)- and (S)-enantiomer of 
limonene derived ketone 73 (Table 4). The substrate was obtained in a three-step synthesis with 
30% yield starting from commercially available limonene. It was chosen because of the directing 
effect of coordinating groups, as described by Crabtree which induces reduction at the side of the 
keto group.[71] The goal was to find a catalytic system which enables reversal of the 
diastereoselectivity obtained by substrate control. 
 
Table 4: Catalyst screening for the diastereoselective hydrogenation of model substrate 73.[70] 
Catalyst 
Conv. of 
(R)-73 (%) 
74 
(cis/trans) 
Conv. of 
(S)-73 (%) 
74 
(cis/trans) 
C6 >99 0.5:99.5 97 0.6:99.4 
C7 95 1:9.7 94 1:4.6 
C8a) 76 1:23.4 14 1:3.8 
C9 5 1:4.7 68 4.9:1 
C10 51 1:16.2 >99 2.8:1 
C11 >99 7.5:1 >99 1:9.1 
C12a) >99 2.6:1 >99 1:4.5 
Standard conditions: 1 mol% catalyst, 0.4 M substrate conc., overnight reaction time. 
a) Reactions run with 3 mol% catalyst, 0.14 M substrate conc. 
 
The hydrogenation of both enantiomers of cyclohexene 73 was investigated to determine the degree 
of substrate versus catalyst control. Using Crabtree's catalyst with BArF as counterion (C6), perfect 
selectivity for the trans-product was observed in both cases (C6). The same major product was 
obtained with catalysts C7 and C8 but with lower selectivity. However, the diastereomeric ratios for 
the two enantiomers of the substrate differed between the reactions of the (R)- and (S)-substrate. 
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When using chiral iridium-PHOX catalysts C9 and C10, the cis/trans-selectivity was reversed 
though conversion and/or cis/trans-ratio were only moderate. The best results were obtained for 
iridium catalysts with pyridine-phosphinite ligands C11 and C12. For both catalysts full conversion 
was observed. Furthermore, the selectivity could be inverted from cis to trans depending on which 
enantiomer of the substrate was used which means that the outcome of the reaction is mainly 
catalyst-controlled. Catalyst C11 with a five-membered carbocycle and two tert-butyl groups at the 
phosphorus atom gave the best results and was therefore used as catalyst of choice for further 
studies.Next, Jaroslav Padevet tested the scope investigating the asymmetric reduction of different 
substrates with similar structure (Table 5). Trifluoroethylester 75 and aldehyde 77 were synthesized 
following Corey's procedure,[68c] as well as phenyl substituted cyclohexene 79 using MacMillan's 
protocol.[68a] To see whether the stereoselectivity can be controlled by the catalyst both enantiomers 
of C11 were tested in the asymmetric hydrogenation. 
 
Table 5: Hydrogenation results for Diels-Alder products.[70] 
Entry 
Hydrogenated 
product 
Cat. (R)-C11 Cat. (S)-C11 
Conversion (%) dr Conversion (%) dr 
1 76 full 49:1 full 1:49 
2 78 full 19:1 0 n. d. 
3 80 10 8:1 10 1:24 
Reaction conditions: 1 mol% catalyst, 50 bar H2, 0.2 M substrate conc. in CH2Cl2, 16 h reaction time. 
For ester 75 the reduced product 76 could be obtained with full conversion and excellent 
diastereoselectivity of 49:1 (entry 1). Furthermore, the selectivity was completely catalyst-
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controlled and could be reversed by using the other enantiomer of the catalyst. When aldehyde 77 
was tested, product formation was only observed for the (R)-enantiomer of the catalyst while the 
other enantiomer gave no reactivity at all (entry 2). Even at higher hydrogen pressure (90 bar) no 
reduction took place. The (R)-enantiomer led to complete conversion and a high diastereomeric 
ratio (19:1). Substrate 79 with a phenyl group at the double bond proved to be unreactive and only 
10% of the reduced cyclohexane 80 could be detected for both catalysts (entry 3). The 
diastereomeric ratio was good for both enantiomers (8:1 and 1:24) and the relative conformation of 
the major product was reversed again. 
One explanation for the bad results obtained for substrates 77 and 79 could be that the aldehyde 
group might interact with the iridium catalyst causing catalyst deactivation, e. g. by forming an 
iridium-acyl or -carbonyl complex. The goal of my studies was to confirm the results which were 
obtained by J. Padevet during his investigations and to further examine the influence of the 
aldehyde group on the asymmetric hydrogenation by transforming the aldehyde into other 
functional groups. 
 
 3.5  Confirmation of previous results 
 
The reproducibility of the reduction of substrate 75 was examined first. Cyclohexene 75 was 
synthesized usng a procedure described by Corey (Scheme 38).[68c]  
 
Scheme 38: Synthesis of substrate 75 using Corey's protocol. 
 
Using 20 mol% of oxazaborolidine 83 the ester could be obtained with moderate yield and excellent 
enantiomeric ratio by reacting isoprene (81) with the α,β-unsaturated ester 82 at 0 °C. 
Next, the asymmetric hydrogenation was studied to see if the results of Jaroslav Padevet could be 
confirmed (Scheme 39). 
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Scheme 39: Asymmetric hydrogenation of substrate 75. 
 
To compare the results the same conditions as before were used. The hydrogenation was performed 
at 50 bar hydrogen pressure in methylene chloride at room temperature and a catalyst loading of 
1 mol% was chosen. These conditions were used in all further hydrogenation studies if not 
otherwise mentioned. Full conversion and an excellent diastereomeric ratio could be obtained with 
both enantiomers of catalyst C11. The selectivity completely changed from one enantiomer to the 
other. The reactions were done by Romina Aliakbarkamrani during her Maturaarbeit in the group. 
The fact that Romina has no experience in synthetic chemistry shows that this method is very 
reliable and can be easily reproduced. 
Next, the hydrogenation of aldehyde 77 was investigated. Again, Corey's procedure[68c] was applied 
to synthesize the substrate (Scheme 40). 
 
Scheme 40: Synthesis of aldehyde 77 following Corey's procedure. 
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obtained which catalyzed the Diels-Alder reaction between isoprene (81) and methacrolein (84) 
effectively to get the desired product in excellent yield with high enantiomeric excess. To reach high 
yields for this reaction it is very important to be careful when removing solvents since the product is 
very volatile. With the substrate in hand we tested the reproducibility of the previously obtained 
result that only the (R)-enantiomer of the catalyst is active in the asymmetric reduction. 
Furthermore, Crabtree's catalyst (C12) was also tested to see which influence the chirality of the 
substrate has on the outcome of the reaction (Scheme 41). 
 
Scheme 41: Iridium-catalyzed hydrogenation of substarte 77. 
 
As observed before, the (S)-enantiomer of the catalyst showed no activity at all while the other 
enantiomer gave full conversion. The selectivity is 94:6 and almost identical with the previous 
report (95:5). Furthermore, achiral catalyst C12 showed also almost no activity and only led to 3% 
product formation. It was surprising that the activity of the catalyst varies so much by changing 
from one catalyst enantiomer to the other and since substrate 79 also gave only 10% conversion for 
both enantiomers (Table 5) we wondered if these problems were due to the aldehyde group. Hence, 
we decided to synthesize some derivatives of aldehyde 77 to see if these substrates are more easily 
reduced by our iridium catalysts. Furthermore, we also wanted to investigate the hydrogenation of 
other cyclohexenes with different substitution pattern. 
 
 3.6  Substrate synthesis 
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 3.6.1  Derivatisation of the aldehyde group 
 
Acetal (85) and alcohol 86 were considered as a potential substrates. Both derivatives can be 
obtained in one step from the aldehyde (Scheme 42). 
 
Scheme 42: Synthesis of acetal 85 and alchohol 86. 
 
The acetal was synthesized by reacting the aldehyde with an excess of ethylene glycol (2 eq.) under 
acidic conditions. The yield was only moderate (38%) but enough product was obtained so that no 
further investigations in the optimization of the reaction were done. Reduction of the aldehyde was 
first performed with sodium borohydride and full conversion was observed. However, after column 
chromatography the maximum yield obtained was around 50%. Since Williard reported the 
reduction of the same compound with lithium aluminum hydride with 94% yield[72] we also tested 
his protocol. Unfortunately, the yield was still only 64%. However, in further experiments the yield 
in the reduction with sodium borohydride could be improved to 87%. 
As a hydroxy group is also a strong coordinating group it was considered to protect the alcohol in 
different ways and to test these compounds in the asymmetric hydrogenation. Therefore, the 
corresponding acetate (87) and a silyl ether (88) were synthesized (Scheme 43). 
 
Scheme 43: Synthesis of acetate 87 and silyl ether 88. 
 
The acetate was formed using a protocol from Vollhardt[73] by treating the alcohol with acetic 
anhydride in pyridine to get the product in 86% yield. The TBDMS-ether 88 was synthesized 
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following a procedure described by Bartoszewicz.[74] The alcohol was treated with TBDMS-
chloride, iodine and 1-methylimidazole to give the silyl ether in 81% yield. The iodine accelerates 
the reaction and is believed to act as a scavenger for the chloride ion which is formed after reaction 
of TBDMS-chloride with imidazole. By removing the chloride ion from the equilibrium through 
formation of I2Cl
- it speeds up product formation. 
 
 3.6.2  Introduction of substituents on the phenyl ring 
 
Since the hydrogenation of aldehyde 79 did not give satisfying results (10% conv., see Table 2), π-
donor and -acceptor groups were introduced to study their influence on the reactivity. The substrates 
were synthesized in the same way as the parent compound (Scheme 44).[70] 
 
Scheme 44: Synthesis of substrate 79.[70] 
 
J. Padevet obtained 2-phenyl-1,4-butadiene (90a) following a synthesis of Marvel and Woolford.[75] 
Acetophenone (89a) was treated with vinylmagnesium bromide in a Grignard-reaction to form a 
tertiary alcohol which was dehydrated in a second step by slowly distilling it under acidic 
conditions affording the diene in moderate yield (31%). The Diels-Alder reaction was performed 
using MacMillan's imidazolidinone catalyst 91. After reacting the diene with an excess of trans-
crotonaldehyde (92), cyclohexene 79 was obtained in 73% yield as a 4:1 mixture of regioisomers. 
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Figure 12: Structure of acetophenones used for the synthesis of the corresponding dienes. 
 
From differently substituted acetophenones 89b-f the corresponding butadienes should be 
synthesized following the same procedure (Figure 12).  
 
Table 6: Synthesis of tertiary alcohols. 
Entry Product R Yield (%) 
1 93b p-OMe 92 
2 93c p-CN 63 
3 93d p-Cl 97 
4 93e m-OMe 82 
5 93f m-Cl 54 
 
All the desired alcohols could be isolated with moderate to excellent yields. With a π-acceptor 
group in para position the products were obtained in almost quantitative yield (entries 1 and 3). For 
the para-cyano derivative the yield was only 63% (entry 2). For the meta substituted acetophenones 
the yield was lower compared to the corresponding para substituted compounds (entries 4 and 5). 
 
 
Table 7: Synthesis of dienes by dehydration. 
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Entry Product R Temperature (°C) Yield (%) 
1 90b p-OMe 80 38 
2 90c p-CN 150 0 
3 90d p-Cl 120 13 
4 90e m-OMe 130 14 
5 90f m-Cl 140 0 
 
Next, the dehydration of alcohols 93b-f was investigated (Table 7). Elimination was induced by 
heating the alcohol with a catalytic amount of aniline hydrobromide and hydroquinone while 
continuously distilling the product. For the para-methoxy substituted alcohol 93b the yield was 
almost the same as for the unsubstituted substrate (entry 1). However, the reaction could be 
performed at 80 °C while 150 °C were necessary in the other case. In contrast, nitrile 93c did not 
react even at elevated temperatures (entry 2). Chloride 93d was converted to the diene in an 
unsatisfying yield of only 13% after heating to 120 °C (entry 3). A similar result was obtained for 
meta-substituted anisole derivative 93e (entry 4). Meta-substituted chloride 93f proved to be 
unreactive like the nitrile. Even at high temperature no product formation was observed (entry 5). In 
general, the same trend as for the Grignard reaction was observed. Electron-rich aryl groups gave 
better results than electron-poor aryl groups and para-substituted derivatives were more reactive 
than meta-substituted derivatives. The lack of reactivity of the para-cyano derivative is consistent 
with an E1-elimination via a carbocation, which is destabilized by an electron-withdrawing group at 
in the phenyl ring. 
Because only one diene could be obtained in satisfying yield, other methods to synthesize 2-
phenylbutadienes were sought. Among several protocols, a procedure by Oh[76] was chosen because 
the starting allene 94 can be coupled with various commercially available iodoarenes 95 giving 
access to several butadienes (Scheme 45). 
Scheme 45: Formation of butadienes by Pd-catalyzed coupling of allene 94 with iodoarenes by Oh. 
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In the first step, the palladium catalyst reacts with allene 94 to generate allylpalladium intermediate 
96. After reductive C-C bond cleavage, butadiene 90 and benzaldehyde (97) are formed. The 
synthesis of allene 94 is literature known[77] and can be performed in three steps starting from 
commercially available propargylic alcohol (98) (Scheme 46). 
 
Scheme 46: Three step synthesis of allene 94. 
 
In the first step, propargylic alcohol was protected as its corresponding THP-ether 99 under acidic 
conditions. The reaction worked nicely and the alkyne was isolated in 83% yield. Next, the alkyne 
was deprotonated to react with styrene oxide (100) at the sterically less hindered position to give 
alcohol 101 in only 16% yield. In the literature, 85% yield was reported, but even after several trials 
this could not be reached. In the last step, the alkyne was treated with lithium aluminum hydride to 
eliminate tetrahydropyranol in a SN2'-reaction and to form allene 94 in low yield (7%). Again, 
literature yield of about 50% could not be achieved. Because of synthetic difficulties it was decided 
to not further investigate the synthesis of 2-phenylbutadienes. 
Next, butadiene 90b, which was the only derivative that was isolated in a reasonable amount, was 
used for the Diels-Alder reaction (Scheme 47). 
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Scheme 47: Synthesis of cyclohexene 102 by imidazolidinone-catalyzed Diels-Alder reaction. 
 
Cyclohexene 102 was synthesized using MacMillan's imidazolidinone 26 as chiral catalyst for the 
reaction between butadiene 90b and trans-crotonaldehyde (92). The product was obtained in 
moderate yield (56%) and good enantiomeric excess (89%). 
 
 3.6.3  Synthesis of other substrates 
 
After a literature search three additiona potentially interesting substrates were considered for 
hydrogenation studies (Figure 13). 
 
Figure 13: Structure of other substrates for the diastereoselective hydrogenation. 
 
Substrates 103 and 104 contain a trisubstituted C=C bond, while compound 105 has two methyl 
groups at the double bond which should make it a challenging substrate for the hydrogenation, as a 
tetrasubstituted double bonds are not very reactive and hard to reduce. 
Diethylester 103 was synthesized following Corey's protocol (Scheme 48).[68c] 
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Scheme 48: Synthesis of substrate 103. 
 
An excess of isoprene (81) was used and reacted with dienophile 106 without any solvent over three 
days to form the desired product in moderate yield and excellent enantioselectivity. Activated 
oxazaborolidine 70 was used to catalyze the reaction in an enantioselective fashion. 
The synthesis of cyclohexenes 104 and 105 was performed following Hayashi's procedure[69c] using 
an organocatalyst (Scheme 49). 
 
Scheme 49: Synthesis of Diels-Alder products 104 and 105. 
 
The products were obtained after the reaction of enal 108 with three equivalents of either isoprene 
(81) or 2,3-dimethylbutadiene (107) in water at 0 °C. The catalyst for this reaction was the 
ammonium perchlorate salt of Jørgensen catalyst 109. Trisubstituted alkene 104 could be isolated 
with moderate yield (56%) and high enantiomeric excess of 93%. For the tetrasubstituted alkene 
105, both the yield (50%) and enantioselectivity (85%) were a bit lower. While the yields for 
cyclohexenes 104 and 105 were lower than the literature values (93% and 89%, respectively) the 
selectivities matched the reported data. 
Since the aldehyde group was considered to be responsible that reduction was observed only for one 
of the catalyst enantiomers in the asymmetric hydrogenation of compound 77 (see Scheme 41), we 
decided to synthesize and test the alcohol and acetate derivatives of substrates 104 and 105 to see if 
the same trend can be observed (Scheme 50). 
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Scheme 50: Derivatisation of cyclohexenes. 
 
The reduction of the aldehyde was achieved using sodium borohydride. For both substrates, full 
reduction could be observed but the alcohols could only be isolated in 64% yield in case of the 
trisubstituted alkene 110 and in 69% yield in case of the tetrasubstituted alkene 111. The same 
problem was encountered previously in the reduction of aldehyde 77. The acetate was prepared by 
treating the alcohol with acetic anhydride in pyridine. Cyclohexene 112 with only one methyl group 
was thereby obtained in 43% yield. The acetate of the tetrasubstituted alkene was not synthesized. 
Another interesting class of substrates are cyclohexenes with a substituent next to the double bond, 
such as compound 115 synthesized by MacMillan using his enantioselective Diels-Alder approach 
(Scheme 51).[69a] 
 
Scheme 51: Synthesis of substrate 115 by MacMillan.[69a] 
 
The Diels-Alder reaction between 2-methyl-1,3-pentadiene (113) and acrolein (114) led to the 
formation of cyclohexene 115 with a methyl group next to the double bond. MacMillan reported the 
product 115 in 75% yield and 90% ee and an endo/exo ratio of 5:1 in favor of the endo-product. The 
diene 113 is not commercially available and reported syntheses were not promising.[78-82] Either 
they use relatively complicated starting materials or they produce mixtures of isomers or 
polymerize. We decided to try a method described by Bacon and Farmer[79] which consists of the 
dehydration of hexylene glycol (116) under acidic conditions (Scheme 52).
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Scheme 52: Synthesis of the diene by double dehydration of hexylene glycol. 
 
The glycol was mixed with 1% vol. of hydrobromic acid and the mixture was continuously distilled 
under heating. Heating to 80 °C was necessary until a reaction took place which could be seen by 
the fact that the product started to boil. To distill off the formed product the temperature had to be 
increased to 120 °C. Unfortunately, the desired product could not be isolated but only a mixture of 
unidentified products was obtained. It probably contained polymers of the diene and therefore, the 
same reaction was tried again under vacuum to perform the distillation at lower temperature which 
should reduce the formation of polymers. But even when the temperature was kept below 85 °C 
pentadiene 113 could not be isolated as a pure compound but only as a minor isomer together with 
other olefins. Since the purification by distillation did not work and a separation by column 
chromatography was not possible, an alternative synthesis of diene 113 was sought. We thought that 
it might be easier to start with an alcohol where one double bond is already formed and only one 
hydroxy group has to be eliminated. This alcohol should be accessible from commercially available 
ketone 117 reacting with methyl lithium. The elimination of this hydroxy group could further be 
simplified by transforming it to a better leaving group like a mesylate for example (Scheme 53). 
 
Scheme 53: Proposed alternative synthesis of pentadiene 113. 
 
In the first step, allylic alcohol 118 should be formed by treating 3-penten-2-one (117) with methyl 
lithium. However, the reaction did not work and the alcohol could not be isolated. Therefore, we 
followed a procedure from the literature[83] where they reacted methyl ester 119 with two 
equivalents of methyl lithium (Scheme 54). 
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Scheme 54: Synthesis of allylic alcohol 118. 
 
We were pleased to see that we were able to obtain the alcohol in 60% yield. Next, we wanted to 
transform the alcohol into its corresponding mesylate 120 to ease the elimination to give pentadiene 
113 (Scheme 55). 
 
Scheme 55: Transformation of the alcohol to the mesylate. 
 
A one pot procedure consisting of mesylation followed by immediate elimination of the mesylate to 
form the diene was tried but only an unidentifiable mixture was obtained. Hence, it was attempted 
to isolate mesylate 120 first by treating the alcohol with methanesulfonyl chloride under basic 
conditions but no product formation was observed. Since the synthesis of the diene was not 
successful by this method another strategy based on a Wittig reaction or a Horner-Wadsworth-
Emmons (HWE) reaction was explored (Scheme 56). 
 
Scheme 56: Attempted synthesis of the diene by a Wittig or a HWE-reaction. 
 
Since there are two double bonds in the pentadiene there are also two possibilities where the new 
double bond may be formed. First, we tried to form the terminal C=C bond by a Wittig reaction 
because E/Z-selectivity is not an issue there. Unfortunately, the reaction between ketone 117 and 
phosphonium bromide 121 did not lead to any product formation. Next, a method used for the 
synthesis of several terminal 1,3-dienes (but not 113) by a reaction between phosphonate 123 and 
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different aldehydes reported by Wang and West was tried.[84] In the publication they reported 
slightly better yields with HMPA as additive instead of DMPU but for reasons of health the less 
toxic DMPU was used. When we performed the reaction between acetaldehyde (122) and 
phosphonate 123 applying West's conditions we were disappointed to see that again no product 
formation could be observed. 
Because the racemic Diels-Alder product 115 is commercially available as mixture of the 
diastereomers we tried to separate the components by semi preparative HPLC on a chiral stationary 
phase. Unfortunately, a chromatographic separation was not possible with any of our chiral 
columns. Because it is often difficult to separate aldehydes by HPLC and we were also interested in 
the corresponding alcohol and acetate as substrates, we decided to synthesize these derivatives to 
see if we could achieve separation (Scheme 57). 
 
Scheme 57: Derivatisation of cyclohexene 115. 
 
Aldehyde 115 was reduced with sodium borohydride to form alcohol 124 in good yield of 87% 
followed by acetylation with acetic anhydride and pyridine to afford acetate 125 with 71% yield. 
Next, it was tried to separate the isomers by semi preparative HPLC. Unfortunately, for both 
derivatives only a partial separation could be achieved which was not sufficient for our 
hydrogenation experiments. 
Because we were not able to obtain one of the isomers of cyclohexenes 124 or 125 in 
enantiomerically pure form we decided to prepare other Diels-Alder products for our studies. As 
previously mentioned, Chen described the synthesis of various nitrocyclohexenes using Jørgensen-
Hayashi catalyst with an acetaldehyde moiety next to the double bond (Scheme 36). Because of this 
substitution pattern and the nitro group which is also a synthetically valuable functional group we 
chose olefin 126 and 127 as substrates for the diastereoselective hydrogenation (Figure 14). 
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Figure 14: Structure of nitrocyclohexenes synthesized by Chen's procedure. 
 
Cyclic olefin 126 with a methyl group at the double bond was synthesized in a four step procedure 
starting from 3-methylcrotonaldehyde 128 (Scheme 58) following Chen's protocol.[69f] 
 
Scheme 58: Synthesis of nitrocyclohexene 126. 
 
In the first step, the aldehyde reacted with phosphonium ylide 129 to give α,β,γ,δ-unsaturated ester 
130 as a 6:1 mixture of the E,E- and E,Z-product with the E,E-isomer as the main product. The 
isomers were not separated and used together in the next step. The ester was reduced to its 
corresponding alcohol using DIBAL and then oxidized with Dess-Martin periodinane to give dienal 
131 in 57% yield over three steps. Interestingly, after the oxidation the E,Z-isomer was not observed 
anymore and only the all trans-product was formed which means that the double bond isomerized 
during the reaction. The dienal is quite unstable and decomposes if not stored in the freezer. In the 
freezer it is stable for several weeks. In the next step cyclohexene 126 is formed in a Diels-Alder 
reaction between an excess of the dienal (2 eq.) and trans-β-nitrostyrene. Organocatalyst 71 and o-
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flurobenzoic acid (OFBA) as an additive deliver the desired product in 76% yield with excellent 
enantio- and diastereoselectivity. 
The second nitrocyclohexene 127 was obtained following the same strategy starting from (E)-2-
phenylpent-2-enal (133) (Scheme 59). 
 
Scheme 59: Synthesis of nitrocyclohexene 127. 
 
Unsaturated ester 134 is formed in a Wittig reaction between the phosphonium ylide 129 and enal 
133. This time no formation of the Z-isomer was observed and only the all trans-product was 
obtained. Next, ester 134 was reduced to the alcohol and oxidized to the aldehyde under the same 
conditions as before to give dienal 135 in 35% yield over three steps. In the last step, the diene 
reacted with nitroolefin 132 applying the same conditions as before to give the desired product in a 
good yield of 63% and excellent selectivity of 93% ee and over 19:1 diastereomeric ratio. 
To see if the observations made in the hydrogenation of aldehyde 77 and its derivatives also apply 
to this substrate class, we synthesized the corresponding alcohol and acetate derivatives of 
nitrocyclohexenes 126 and 127 as well (Scheme 60). 
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Scheme 60: Synthesis of derivatives of nitrocyclohexene. 
 
Both aldehydes 126 and 127 could be reduced with excellent yield using sodium borohydride to the 
corresponding alcohols 136 and 137, respectively. After treating these alcohols with acetic 
anhydride in pyridine overnight the acetates were formed. While cyclohexene 138 with a methyl 
group at the double bond could only be isolated with a moderate yield of 43%, cyclohexene 139 
with a phenyl group was obtained in good yield (79%). 
 
 3.7  Diastereoselective hydrogenation of chiral cyclohexenes 
 
 3.7.1  Hydrogenation of derivatives of previous substrates 
 
With the chiral Diels-Alder products in hand we started to investigate the diastereoselective 
reduction of these cyclohexenes. All hydrogenations were performed under the same conditions as 
for the substrates mentioned above. For each substrate, both enantiomers of catalyst C11 were 
tested as well as an achiral catalyst. First, the asymmetric reduction of derivatives 65-68 of 
aldehyde 77 was investigated (Table 8). 
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Table 8: Diastereoselective reductions of derivatives of aldehyde 77. 
Entry R Product 
(R)-C11 (S)-C11 C12 
Conv. (%)a) dra) Conv. (%)a) dra) Conv. (%)a) dra) 
1 
 
140 >99 60:40 >99 27:73 38 15:85 
2 CH2OH 141 >99 64:36 >99 3:97 75 3:97 
3 CH2OAc 142 >99 92:8 >99 11:89 9 36:64 
4 CH2OTBDMS 143 58 75:25 60 7:93 6 12:88 
a) Determined by GCMS. 
 
In contrast to aldehyde 77, all its derivatives could be reduced with both the (R)- and (S)-enantiomer 
of catalyst C11 with the same conversion. While the acetal, the alcohol and the acetate gave full 
conversions (entries 1-3), the silyl ether only gave 60% conversion. Achiral catalyst C12 showed 
generally lower activity. Furthermore, the diastereomeric ratio was reversed by changing from one 
catalyst enantiomer to the other. For acetal 140 the best diastereomeric ratio was obtained with 
Crabtree's catalyst but conversion was only 38%. (S)-C11 showed a selectivity of 1:3 while (R)-C11 
gave a 3:2 mixture (entry 1). These results imply that the diastereoselective outcome of the reaction 
is mainly substrate-controlled and that for (R)-C11 there is a mismatched case. For alcohol 141, 
only low selectivity could be obtained with the (R)-C11 (2:1). On the other hand, with (S)-C11 and 
catalyst C12 an excellent diastereomeric ratio of 3:97 was observed. However, Crabtree's catalyst 
led only to 75% product formation. From these experimental results, it can be concluded that the 
reduction is mainly substrate-controlled, this time even stronger than in case of the acetal. 
We were pleased to see that in the hydrogenation of acetate 142 the results for both enantiomers of 
C11 were almost identical. With both catalysts we obtained full conversion and a selectivity of 
about 9:1. With the achiral catalyst we observed only 9% product formation and a diastereomeric 
ratio of 36:64. This implies that this time the diastereoselectivity is mainly catalyst-controlled and, 
O
O
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consequently, almost no selectivity is obtained with the achiral catalyst C12. Silyl ether 88 was 
harder to reduce and the corresponding cyclohexane 143 could only be hydrogenated with about 
60% conversion using the (R)- or (S)-enantiomer of C11 and 6% conversion with catalyst C12. The 
lowest selectivity was observed with the (R)-catalyst (3:1). The other two catalysts gave excellent 
diastereomeric ratios with the best result for the (S)-catalyst (7:93). Notably, all products have a 
mirror plane and therefore are achiral. 
The best results were obtained for the alcohol and for the acetate (entry 2 and 3). The selectivities in 
the hydrogenation of the acetal and the silyl ether derivatives were not very promising and, 
therefore, only the alcohol and acetate derivatives were tested in further investigations of other 
substrates. 
Next, the hydrogenation of aryl-substituted compound 102 was investigated. Unfortunately, no 
reduction to cyclohexane 144 could be observed for all catalysts under these conditions 
(Scheme 61). 
 
Scheme 61: Unsuccessful reduction of olefin 102 to cyclohexane 144. 
 
The reduction of cyclohexene 79 with no substituent on the phenyl ring was already very sluggish 
(only 10% conversion, see Table 5) and it seems that an electron-donating group makes the double 
bond even less reactive. 
 
 3.7.2  Hydrogenation of ethyl esters 
 
Another substrate class we synthesized for the asymmetric reduction were cyclohexenes with 
carboxylic ester substituents. 
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Scheme 62: Iridium-catalyzed hydrogenation of diester 103. 
 
We were disappointed to see that both enantiomers of chiral iridium catalyst C11 did not lead to any 
product formation. Only Crabtree's catalyst gave cyclohexane 145 in 16% conversion but with 
perfect diastereomeric ratio of over 99:1. An explanation for this low reactivity might be steric 
reasons since an ester group is tolerated as will be shown below. 
Next, we investigated the reduction of mono ethyl ester 104 and its derivatives (Table 9). This time 
we used palladium on charcoal as achiral catalyst. 
 
Table 9: Asymmetric reduction of mono ethyl ester 104. 
Entry R Product bar H2 
(R)-C11 (S)-C11 Pd/C 
Conv. (%)a) dra) Conv. (%)a) dra) Conv. (%)a) dra) 
1 CHO 146 50 0 n.d. 0 n.d. >99 75:25 
2 CHO 146 100 0 n.d. 0 n.d. not tested 
3 CH2OH 147 50 92 85:15 75 33:67 >99 90:10 
4 CH2OAc 148 50 94 79:21 94 15:85 92 66:34 
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a) Determined by GCMS. 
No formation of cyclohexane 146 was observed when trisubstituted olefin 104 was hydrogenated 
using chiral catalyst C11 (entry 1). None of the two enantiomers showed any activity while we got 
full conversion with palladium on charcoal. However, the diastereoselectivity was low with 3:1. At 
100 bar hydrogen pressure as well no reaction was observed (entry 2). Since we had already 
obtained bad results in the hydrogenation of aldehyde 77 and assumed that the lack of reactivity is 
due to the aldehyde group, we decided to test the reduction of alcohol 110 and acetate 112. When 
we examined the asymmetric hydrogenation of the alcohol we were pleased to see that product 147 
was formed with 92% conversion using catalyst (R)-C11 and 75% using (S)-C11 (entry 3). The 
diastereomeric ratio was relatively high with (R)-C11 (85:15) but (S)-C11 only showed a selectivity 
of 1:2. The best result was again obtained with palladium on charcoal. This catalyst led to full 
conversion and a selectivity of 9:1. The best results of all substrates were determined for acetate 
148 (entry 4). For all three catalysts conversion to cyclohexane 148 was over 90% with slightly 
better values for the chiral catalysts. This time the achiral catalyst showed the lowest selectivity 
(2:1). The diastereomeric ratio for the two enantiomers of catalyst C11 was similar with 79:21 for 
(R)-C11 and 15:85 for (S)-C11. This indicates that the outcome is mainly catalyst-controlled for the 
acetate-susbtituted cyclohexene.  
In general, the values for this substrate class are comparable to those obtained for aldehyde 77 and 
its derivatives. Moderate to good results were obtained for the alcohol and the acetate. Aldehyde 
104 could not be reduced neither with the (R)- nor the (S)-catalyst while for aldehyde 77 the (S)-
catalyst showed activity at least. 
After this, tetrasubstituted olefin 109 and the corresponding alcohol 111 were investigated 
(Table 10). 
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Table 10: Hydrogenation of tetrasubstituted olefins. 
Entry R Product 
(R)-C11 (S)-C11 Pd/C 
Conv. (%)a) dra) Conv. (%)a) dra) Conv. (%)a) dra) 
1 CHO 149 0 n.d. 0 n.d. >99 75:25 
2 CH2OH 150 0 n.d. 0 n.d. 0 n.d. 
a) Determined by GCMS. 
 
Aldehyde 149 could only be obtained using palladium on charcoal as catalyst with full conversion 
and a selectivity of 3:1 (entry 1). For the two enantiomers of catalyst C11 no product formation 
could be detected. This was expected since no reaction had been observed for the trisubstituted 
substrate 108 and the tetrasubstituted C=C bond should be even harder to hydrogenate. We hoped to 
see improved reactivity with the corresponding alcohol 111 as before, but when we investigated the 
hydrogenation of alcohol 111 we observed no formation of the saturated alcohol 150 with all three 
catalysts (entry 2). Even palladium on charcoal proved to be inactive which was surprising because 
this catalyst was able to reduce aldehyde 109. Since all three catalysts did not lead to any product 
formation we decided not to test the corresponding acetate. 
 
 3.7.3  Hydrogenation of nitrocyclohexenes 
 
Next, we examined the hydrogenation of nitro-substituted cyclohexenes. First, we tested the 
reduction the substrates 136 and 138 with a methyl group at the double bond (Table 11). Aldehyde 
127 was not tested due to the poor reactivity generally obtained for substrates with an aldehyde 
group. 
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Table 11: Hydrogenation of nitrocyclohexenes with a methyl group at the double bond. 
Entry R Product 
(R)-C11 (S)-C11 Pd/C 
Conv. (%)a) dra) Conv. (%)a) dra) Conv. (%)a) dra) 
1 H 151 0 n.d. 80 >99:1 >99 83:17 
2 Ac 152 0 n.d. 0 n.d. 23 58:42 
a) Determined by 1H-NMR. 
 
When applying the (R)-enantiomer of catalyst C11 no product formation could be observed while 
the use of the other enantiomer led to 80% conversion to cyclohexane 151 and perfect 
diastereoselectivity (>99:1). Palladium on charcoal gave full conversion but a lower diastereomeric 
ratio of 83:17. We were surprised to see that only one catalyst enantiomer gave good results while 
the other was not active at all. On the other hand the substrate has three stereogenic centerswith one 
close to the C=C bond which means that the outcome is strongly influenced by the substrate itself. 
This might explain the pronounced difference in reactivity. For acetate 138 the saturated compound 
152 could not be obtained for any of the enantiomers of the catalyst (entry 2). Only the achiral 
catalyst led to low conversion, with almost no selectivity (58:42). This time the alcohol gave better 
results than the acetate. This is different from the previously investigated cases in which the acetate 
gave the best results. 
Finally, we investigated the hydrogenation of phenyl substituted nitrocyclohexenes (Table 12). We 
expected this substrate class to be difficult to reduce since we had encountered already problems 
with aryl substituted double bonds earlier. Furthermore, the fact that there are four stereogenic 
centers makes these cyclohexenes demanding substrates. 
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Table 12: Asymmetric hydrogenation of phenyl substituted nitrocyclohexenes. 
Entry R Product 
(R)-C11 (S)-C11 Pd/C 
Conv. (%)a) dra) Conv. (%)a) dra) Conv. (%)a) dra) 
1 CHO 153 0 n.d. 0 n.d. 0 n.d. 
2 CH2OH 154 0 n.d. 0 n.d. 0 n.d. 
3 CH2OAc 155 0 n.d. 0 n.d. 57 90:10 
a) Determined by 1H-NMR. 
 
Unfortunately, neither the saturated aldehyde 153 nor the alcohol 154 could be obtained by using 
any of the three catalysts (entry 1 and 2). Only acetate 139 could be reduced to the corresponding 
cyclohexane 155 but only when employing palladium on charcoal (entry 3). The chiral iridium 
catalysts proved to be inactive. With the achiral catalyst the product was formed with moderate 
conversion (57%) and good selectivity (9:1). 
 
 3.8  Summary 
 
Several chiral cyclohexenes were synthesized by asymmetric Diels-Alder reactions following 
different literature known procedures. Furthermore, products bearing an aldehyde group were 
modified to give access to further substrates for the diastereoselective iridium-catalyzed 
hydrogenation. All cyclohexene derivatives were tested in the asymmetric reduction using an 
achiral catalyst and the two enantiomers of a chiral iridium catalyst with a pyridine phosphinite 
ligand. 
Previously obtained results could be confirmed and it seems that the chiral catalyst is rather inactive 
for cyclohexene substrates with an aldehyde substituent. When investigating the corresponding 
alcohols and acetates conversion was usually high and good to excellent diastereomeric ratios could 
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be obtained (Figure 15). In general the acetates gave better results than the alcohols. 
 
Figure 15: Best results obtained in the diastereoselective hydrogenation of chiral cyclohexenes. 
 
For more challenging substrates like cyclohexenes with a tetrasubstituted C=C bond and highly 
substituted cyclohexenes the chiral catalyst proved to be inactive and only with palladium on 
charcoal reduction of the olefins was observed in some cases. We showed one example where a 
cyclohexene with already four stereogenic centers could be hydrogenated. This means that we were 
able to synthesize a cyclohexane with five stereogenic centers in two steps.
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 4  Investigations of NeoPHOX ligands in asymmetric hydrogenation 
and allylic substitution reactions 
 
 
 4.1  Introduction 
 
Since their first application in enantioselective palladiun catalyzed allylic substitution in 1993,[85] 
PHOX ligands have become a widely used ligand class, especially in iridium catalyzed asymmetric 
hydrogenation (see Chapter 1.2.2). However, the substrate scope was limited at first and, therefore, 
many different ligand classes have been developed to find catalytic systems which can reduce 
different substrate classes efficiently. Initially developed ThrePHOX and SimplePHOX ligands 
showed high selectivity and could be prepared in only a few steps[25-28]. However, the ligands 
proved to be very sensitive towards air and moisture which resulted in low yields in the formation 
of the corresponding iridium complexes. By replacing the P-O bond by a P-C bond the stability of 
the ligands could be increased which facilitated the synthesis of the iridium complexes. Due to their 
neopentyl backbone these ligands are called NeoPHOX ligands. 
 
Figure 16: Structure of selected PHOX ligands. 
 
The first generation of NeoPHOX ligands was synthesized in three steps starting from 3-
chloropivaloyl chloride (156) and an aminoalcohol (Scheme 63).[85] Due to the higher stability of 
the  ligands, the efficiency of the synthesis could be much improved compared to ThrePHOX and 
SimplePHOX ligands. The most efficient ligand in asymmetric hydrogenation bears a tert-butyl 
group at the oxazoline ring. The drawback of its synthesis is the high cost of tert-leucinol as starting 
material which makes it unattractive for large scale application. 
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Scheme 63: Synthesis of 1st generation NeoPHOX ligands. 
 
One possibility to avoid this problem is to use L-valine as starting material which is much less 
expensive. The lower steric hindrance of the isopropyl group may be compensated by the 
introduction of two substituents at C5 (Figure 16). However, ligands of this type gave distinctly 
lower selectivities than the tert-butyl substituted ligand.[86] 
 
Figure 17: Structure of L-valine derived NeoPHOX ligand with two phenyl groups at C5. 
 
Another approach which had been previously applied in the synthesis of PHOX ligands uses 
threonine or serine as starting material.[87] A synthesis which gives access to this 2nd generation of 
NeoPHOX ligands was developed in our group by Jaroslav Padevet (Scheme 64).[70] 
 
Scheme 64: Retrosynthetic analysis for 2nd generation of NeoPHOX ligands. 
 
The synthesis resembles that of the 1st generation. The tertiary alcohol which mimics the tert-butyl 
group of tert-leucine was formed by double addition of a Grignard reagent to the methyl ester. 
Protection of the alcohol as a silyl ether or acetate allowed further optimization of the steric 
properties. Additionally, a second stereogenic center at C5 could be introduced by starting from 
threonine. 
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Jaroslav Padevet synthesized several iridium complexes of these ligands and successfully applied 
them in the asymmetric hydrogenation of some test substrates. Within the frame of this thesis, 
additional hydrogenation studies were carried out in order to obtain a more complete picture of the 
scope of this ligands. Furthermore, we applied these ligands in enantioselective palladium catalyzed 
allylic substitution reactions since PHOX ligands were initially developed for this type of 
transformation.[35,88] 
 
 4.2  Synthesis of iridium complexes 
 
Several NeoPHOX derivatives and two of the corresponding iridium complexes were synthesized 
following the procedure reported by J. Padevet (Scheme 65).[70]  
 
Scheme 65: Synthesis of serine derived NeoPHOX ligands. 
 
In the first step, amide 158 was formed by SN2 reaction between serine methylester hydrochloride 
(157) and acid chloride 156 under basic conditions. Next, oxazoline 159 was prepared using 
diethylaminosulfur trifluoride (DAST) in quantitative yield. Addition of two equivalents of 
methylmagnesium chloride led two the formation tertiary alcohol 160 which was converted to 
ligand L12 by treatment with potassium diphenylphosphide with moderate yield for both steps. 
Finally, the hydroxy group was protected as silyl ether to obtain sterically more demanding ligand 
L13 in good yield. 
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Starting from threonine methylester hydrochloride (161) we synthesized three more ligands and two 
of their corresponding iridium complexes (Scheme 66). 
 
Scheme 66: Synthesis of threonine derived NeoPHOX ligands and their iridium complexes. 
 
Amide formation and ring closure to build oxazoline 162 worked nicely with 79% yield over two 
steps. Next, addition of the Grignard reagent had to be performed this time at 78 °C to give 
alcohol 163 in satisfying yield. Transformation of the chloride to the phosphine resulted in isolation 
of ligand L14 in moderate yield. The hydroxy group was again protected as TBDMS ether to give 
ligand L16. Additionally, TES protected silyl ether L15 was also synthesized. Finally, the iridium 
complexes of the protected alcohols were prepared to give catalyst C13 and C14 in 84% and 73% 
respectively. With the two iridium catalysts in hand we tested them in the asymmetric 
hydrogenation of an imine and an allylic alcohol. 
 
 4.3  Hydrogenation of test substrates 
 
J. Padevet investigated the enantioselective reduction of several alkenes and imine 164 using 
various iridium catalysts with NeoPHOX ligands of the 2nd generation. In this work we tested 
catalysts C13 and C14 for these two substrates to determine the influence of the silyl group. The 
results are presented in Table 13. 
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N OH
164 165
Table 13: Hydrogenation of imine 164 and allylic alcohol 165 using various 2nd generation 
NeoPHOX catalysts. 
 
Catalyst 
164 
conversion (%)a) 
ee (%)b) 
165 
conversion (%)a) 
ee (%)b) 
C13 
8/32c) 
68/62c) (S) 
60/>99c) 
89/88c) () 
C14 
79 
49 (S) 
>99 
91 () 
C15[70] 
4 
7 (S) 
10 
41 () 
C16[70] 
73 
16 (S) 
92 
90 () 
C17[70] 
5 
67 (S) 
82 
88 () 
C18[70] 
79 
77 (S) 
>99 
84 () 
Reaction conditions: 50 bar H2, rt, 2 h, 1 mol% catalyst, 0.1 mmol substrate, 0.5 mL CH2Cl2. 
a) Determined by 1H-NMR; b) Determined by chiral HPLC; c) reaction time 16 h. 
 
None of the tested catalysts induced high enantioselectivities in the hydrogenation of imine 164 and 
also the conversion was low in most cases. Catalyst C13 with a TES group showed only 8% 
conversion and a moderate enantiomeric excess. Even prolonged reaction time increased conversion 
only slightly. Iridium complex C14 gave the highest conversion (79%) but only 49% ee. The best 
results for this substrate were obtained with serine derived catalyst C18 with 79% conversion and 
77% enantiomeric excess. With iridium complexes C15-C17 either low conversion or low ee was 
observed. 
The asymmetric reduction of olefin 165 with NeoPHOX catalysts was more efficient. Catalyst C13 
showed good enantioselectivity but only 60% conversion under standard conditions. However, 
longer reaction time led to full conversion. The best results were obtained for the TBMDS protected 
catalyst C14 with full conversion and an ee of 91%. Iridium complex C18 gave full conversion as 
Ph2P
Ir
N
O
R
OR'
BArF
-
C13: R = Me, R' = TES
C14: R = Me, R' = TBDMS
C15: R = Me, R' = H
C16: R = Me, R' = OAc
C17: R = Me, R' = TMS
C18: R = H, R' = TBDMS
+
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well but the enantiomeric excess was lower. Good performance was also observed for catalysts C16 
and C17 while C15 turned out to be inefficient for this substrate. 
 
 4.4  Application in allylic substitution reactions 
 
Next, we tested NeoPHOX ligands in asymmetric palladium-catalyzed allylic substitution. Due to 
their good performance in asymmetric hydrogenation we chose 2nd generation ligands L14 and L15 
as well as 1st generation ligand L16 which also had given excellent results.[70] For a test reaction we 
chose the standard substrate 166 which had already been used by J. Padevet in a preliminary study 
(Scheme 67). 
 
Scheme 67: Palladium-catalyzed allylic substitution with rac-(E)-1,3-diphenylallyl acetate (166). 
 
Both catalysts derived from 2nd generation NeoPHOX ligands with a free hydroxy group and the 
corresponding TES-protected derivative performed well, yielding enantioselectivities of 90% and 
98% ee, respectively. Ligand L15 gave the best result and was even more selective than tert-leucine 
derived NeoPHOX ligand L16 (97% ee). However, the best yield was obtained for least selective 
ligand L14 (84%). Next, we investigated the palladium-catalyzed allylic substitution of (E)-1,3-
dimethylallyl acetate (Scheme 68). 
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Scheme 68: Palladium-catalyzed allylic substitution with rac-(E)-1,3-dimethylallyl acetate (168). 
 
All three tested ligands gave disappointing results. The yield was low in all cases and the 
enantiomeric excess reached only 41% for the best ligand L14. Interestingly, the sterically more 
demanding ligand L15 did not lead to higher selectivity as for 1,3-diphenylallyl acetate. Last, we 
also tested the ligands on more demanding cyclic substrate 170 (Scheme 69). 
 
Scheme 69: Asymmetric palladium-catalyzed allylic substitution with cyclic substrate 170. 
 
In allylic substitution with substrate 170 a notable enantiomeric excess of 70% together with 90% 
yield was achieved using TES-protected ligand L15. In contrast, standard PHOX ligands have been 
found to give extremely low enantioselectivities with cyclic substrates of this type. With ligand L14 
with a free hydroxy group the result was less satisfying. Not only the yield dropped to 53% but also 
an ee of only 23% was observed. For 1st generation NeoPHOX ligand L16 the enantiomeric excess 
was even lower. These results demonstrate the potential that 2nd generation NeoPHOX ligands 
possess for palladium-catalyzed allylic substitution reactions. 
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 4.5  Summary 
 
We prepared five 2nd generation NeoPHOX ligands and two of their corresponding iridium 
complexes following a previously developed synthesis. The iridium complexes were tested in the 
asymmetric hydrogenation of an imine and an allylic alcohol giving similar results as other 
NeoPHOX catalysts. For the allylic alcohol catalyst C14 showed the best performance of all iridium 
complexes. Furthermore, we investigated the palladium-catalyzed allylic substitution of three 
substrates with two NeoPHOX ligands of the 2nd generation and one ligand of the 1st generation. 
While excellent results were obtained for all three ligands with (E)-1,3-diphenylallyl acetate, none 
of them performed well with (E)-1,3-dimethylallyl acetate. In the reaction with cyclohex-2-en-1-yl 
benzoate ligand L15 gave promising results showing the potential of this ligand class.
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 5  Experimental Part 
 
 
 5.1  Analytical Methods 
 
NMR-Spectroscopy 
1H- and 13C-spectra were recorded on a Bruker Advance 400 MHz instrument. All measurements 
were performed at 25 °C. Chemical shifts (δ) were referred to the signal of the solvent (1H-NMR: 
CHCl3, s, δ = 7.26 ppm, 13C-NMR: CHCl3, t, δ = 77.16 ppm). 13C-, 19F- and 31P-spectra were 
recorded in a broadband decoupled mode. For splitted signals, the chemical shift is characterised by 
the arithmetic mean of the signal lines. Coupling constants (J) are given in hertz (Hz). The signals 
were assigned as s (singlet), d (doublet), t (triplet), q (quartet), quint (quintet), m (multiplet) and br 
(broad). 
 
Infrared Spectroscopy (IR) 
Infrared spectra were measured on a Shimadzu FTIR-8400S. Compounds were measured as pure 
substances via ATR-technique. Absorption bonds are given in wave numbers (ṽ = cm-1, s: strong, m: 
medium, w: weak). 
 
Gas Chromatography-Mass Spectrometry (GC-MS) 
Measurements were carried out on a Shimadzu GCMS-QP2010SE, AOC-20i (auto injector). As 
column a Rtx-5MS was used, 30 m (length), 0.25 μm (thickness), 0.25 mm (diameter). Either 
method A (EI, 70 eV, Me2Si, 60 kPa, 60/3/3-140/0/40-250/5), method B (EI, 70 eV, Me2Si, 60 kPa, 
100/2/7-250/10) method C (EI, 70 eV, Me2Si, 100 kPa, 50/2/30-250/5) or method D (EI, 70 eV, 
Me2Si, 100 kPa, 120/3/20-250/25) was the method of choice. 
 
Gas Chromatography(GC) 
Gas chromatograms were recorded on a Carlo Erba HRGC Mega2 Series 800 instrument. 
Separations on chiral phases were performed on a γ-cyclodextrin column 
(30 m × 0.25 mm × 0.25 µm). 
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High-Performance Liquid Chromatography (HPLC) 
HPLC measurements were carried out on a Shimadzu Class-VP version 5.0, SCL-10A (system), 
CTO-10AC (column oven), LC-10AD (pump system), DGU-14A (degaser), SPD-M10A (diode 
array detector) or on a Shimadzu SIL-20A (auto sampler), CTO-10AS (column oven), LC-20AD 
(pump system), DGU-20A3 (degaser), SPD-M20A (diode array detector). Separations were done on 
an OD-H or AD-H column (25 cm × 0.46 cm) from Daicel Chemical Industries. 
 
Thin Layer Chromatography (TLC) 
All thin layer chromatograms were carried out on Macherey-Nagel plates (Polygram®-SIL G/UV254  
with fluorescence indicator, 40×80 mm, 0.2 mm silica). For visualization UV-light (254 nm) or 
basic permanganate solution was used. 
 
Optical Rotation (α) 
Angles of rotation were measured on a Perkin-Elmer polarimeter 341 in a cuvette (l = 1 dm) at 
20 °C and 589 nm in CHCl3. 
 
Melting Point (m.p.) 
The melting points were measured on a Büchi 535 instrument. The values are not corrected. 
 
 5.2  Reagents and Techniques 
 
Chemicals and Solvents 
Commercially available chemicals and absolute solvents were purchased from Acros Organics, 
Aldrich, Alfa Aesar or Fluka and were used without further purification. 
 
Syntheses 
Air- and moisture-sensitive syntheses were carried out under argon atmosphere in pre-dried 
glassware using standard Schlenk techniques.  
 
Column Chromatography 
All chromatographic separations were carried out under increased nitrogen pressure using Merck 
silica gel 60 (0.040-0.063 mm). Column dimension (diameter × height) and mixture of the eluent 
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(ν/ν) are given in parentheses. Solvents were technical grade and were purified by distillation prior 
to use. 
 
Autoclaves 
For hydrogenations autoclaves from PREMEX Reactor AG of the type HPM-005 with a capacity of 
50 mL were used . 
Experimental part                                                                                                                                    
76 
 5.3  Synthesis of pyrazine phosphinite ligands and precursors 
 
5,6,7,8-Tetrahydroquinoxaline 1,4-dioxide (28) 
In a round bottom flask 5,6,7,8-tetrahydroquinoxaline 27 (2.00 g, 14.9 mmol, 1.0 eq.) and sodium 
hydrogen carbonate (6.26 g, 74.5 mmol, 5.0 eq.) were dissolved in methanol (100 mL). Oxone 
(27.5 g, 44.7 mmol, 3.0 eq.) was added followed by water (40 mL) and the reaction mixture was 
stirred at 50 °C for 20 hours. The suspension was filtrated, methanol was removed by rotatory 
evaporator and the remaining reaction mixture was extracted with methylene chloride (3 x 40 mL), 
washed with water (40 mL), dried over sodium sulfate and concentrated. The product was obtained 
as a colorless solid (2.05 g, 83%). 
 
C8H10N2O2 (166.18 g/mol) 
m.p.: 195-198 °C 
TLC: Rf  = 0.50 (methylene chloride:methanol = 9:1, UV). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 7.98 (s, 2H), 2.90-2.87 (m, 4H), 1.88-1.85 (m, 4H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 147.0, 133.3, 24.2, 20.5 
GC-MS (Method D, tR = 9.1 min): m/z (%) 167 ([M
++1], 36), 150 (11), 149 (100), 113 (11), 71 
(21), 70 (17), 57 (23), 43 (14), 41 (10). 
IR: ṽ = 3079 (w), 2934 (w), 2868 (w), 1397 (s), 1338 (m), 1252 (m), 1170 (m), 1070 (m), 971 (m), 
815 (m), 780 (s), 698 (m). 
 
 
5,8-Dibromo-5,6,7,8-tetrahydroquinoxaline 
A solution of 5,6,7,8-tetrahydroquinoxaline 27 (1.91 g, 13.5 mmol, 1.0 eq.), N-bromosuccinimide 
(6.07 g, 33.8 mmol, 2.5 eq.) and AIBN (0.11 g, 0.68 mmol, 0.05 eq.) in carbon tetrachloride 
N
N
O
O
N
N
Br
Br
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(60 mL) was heated to reflux for two hours in a round bottom flask. After cooling to room 
temperature the reaction mixture was filtrated and the filtrate was concentrated to obtain the crude 
product as a brown oil which was purified by column chromatography (silica gel, 3 cm × 17 cm, 
cyclohexane:EtOAc = 9:1) to obtain the product as a yellow liquid (3.70 g, 94%). 
 
C8H8Br2N2 (291.97 g/mol) 
TLC: Rf  = 0.25 (cyclohexane:EtOAc = 9:1, UV). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 8.45 (s, 2H), 5.52-5.50 (m, 2H), 2.78-2.75 (m, 2H), 2.38-
2.34 (m, 2H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 150.2, 144.9, 48.9, 28.3. 
GC-MS (Method B, tR = 16.5 min): m/z (%) 292 (M, 2), 211 (10), 132 (21), 131 (100), 104 (12), 
77 (13), 52 (10). 
IR: ṽ = 3050 (w), 2968 (w), 2912 (w), 2842 (w), 1407 (m), 1194 (s), 1048 (m), 929 (s), 699 (s), 579 
(s), 530 (m), 426 (s). 
 
 
5,6,7,8-Tetrahydroquinoxaline-5,8-diyl diacetate (38) 
In a round bottom flask 5,8-dibromo-5,6,7,8-tetrahydroquinoxaline (3.70 g, 12.7 mmol, 1.0 eq.) was 
dissolved in absolute DMF (15 mL) and acetic acid (45 mL). At 0 °C silver acetate (5.30 g, 
31.8 mmol, 2.5eq) was added and the mixture was stirred for 22 hours at room temperature. The 
reaction mixture was filtrated and the filtrate was concentrated under high vacuum. Water (20 mL) 
and saturated NaHCO3-solution (20 mL) were added and the aqueous phase was extracted with 
MTBE (3 x 60 mL). The combined organic layers were washed with brine (50 mL), dried over 
sodium sulfate and concentrated to get a brown liquid (2.26 g, 71%) which was used without further 
purification in the next step. The product was a 2:1 mixture of the cis- and trans-isomer with the 
trans-product as the main product. 
 
 
 
N
N
OAc
OAc
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C12H14N2O4 (250.25 g/mol) 
TLC: Rf  = 0.26 (cyclohexane:EtOAc = 1:1, UV).1H-NMR (400 MHz, CDCl3): δ (ppm) = 8.57 (s, 
2H), 6.10-6.08 (m, 2H), 2.38-2.33 (m, 2H), 2.26-2.16 (m, 2H), 2.10 (s, 6H) all trans, 8.56 (s, 2H), 
6.04-6.02 (m. 2H), 2.13 (s, 6H), 2.12-2.05 (m, 4H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 170.2, 150.2, 144.8, 69.6, 24.7, 21.3 all trans, 170.4, 
150.5, 144.6, 69.6, 24.7, 21.3 all cis. 
GC-MS (Method B, tR = 17.6 min (trans), 17.8 min (cis)): m/z (%) 208 ([M
+42], 24), 149 (10), 
148 (100), 147 (79), 131 (31), 120 (18), 119 (28), 43 (48) all trans. 
IR: ṽ = 3050 (w), 2968 (w), 2912 (w), 2842 (w), 1407 (m), 1194 (s), 1048 (m), 929 (s), 699 (s), 579 
(s), 530 (m), 426 (s). 
 
 
5,6,7,8-Tetrahydroquinoxaline-5,8-diol (29) 
In a round bottom flask, 1 M NaOH-solution (40 mL) was given to a solution of 5,6,7,8-
tetrahydroquinoxaline-5,8-diyl diacetate 38 (1.97 g, 7.87 mmol, 1.0 eq.) in methanol (80 mL) and 
the mixture was stirred at room temperature for 72 hours. The reaction mixture was acidified with 
1 M HCl-solution (pH 5) and concentrated. The residue was dissolved in a 1:1 mixture of ethanol 
and chloroform (50 mL), filtrated and concentrated. The crude product was separated by column 
chromatography (silica gel, 3 cm × 15 cm, 3% methanol in methylene chloride) to obtain the trans-
product (0.66 g, 52%) and the cis-product (0.34 g, 25%) as a brown solid. 
 
C8H10N2O2 (166.18 g/mol) 
Analytical data for the trans-isomer: 
m.p.: 96-97 °C 
TLC: Rf  = 0.27 (methylene chloride:methanol = 19:1, UV). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 8.51 (s, 2H), 4.87-4.81 (m, 2H), 3.45 (brs, 2H), 2.51-2.45 
(m, 2H), 1.90-1.81 (m, 2H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 153.4, 143.3, 68.8, 28.1. 
N
N
OH
OH
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GC-MS (Method B, tR = 11.7 min): m/z (%) 166 (M
+, 7), 149 (10), 148 (100), 147 (44), 138 (18), 
120 (20), 119 (41), 110 (52), 109 (15), 107 (27), 81 (23), 80 (15), 54 (11), 53 (11), 52 (15). 
IR: ṽ = 3195 (w), 2956 (w), 2927 (w), 2864 (w), 2832 (w), 1329 (m), 1156 (w), 1062 (s), 1025 (m), 
914 (w), 858 (w), 494 (w). 
 
Analytical data for the cis-isomer: 
m.p.: 97-98 °C 
TLC: Rf  = 0.24 (methylene chloride:methanol = 19:1, UV). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 8.46 (s, 2H), 4.78 (s, 2H), 4.58 (brs, 2H), 2.20-2.05 (m, 
4H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 153.1, 143.5, 68.1, 26.2. 
GC-MS (Method B, tR = 12.1 min): m/z (%) 166 (M
+, 36), 148 (49), 147 (56), 138 (36), 137 (10), 
120 (26), 119 (46), 110 (100), 109 (25), 107 (98), 94 (13), 92 (11), 81 (33), 80 (23), 79 (11), 78 
(12), 65 (11), 55 (11), 54 (17), 53 (18), 52 (22), 41 (15). 
IR: ṽ = 3233 (m), 2951 (w), 2938 (w), 2869 (w), 2829 (w), 1403 (m), 1337 (m), 1069 (s), 968 (s), 
880 (m), 567 (m), 528 (m). 
 
 
5,8-Di((E)-benzylidene)-5,6,7,8-tetrahydroquinoxaline (33) 
Under inert atmosphere 5,6,7,8-tetrahydroquinoxaline 27 (200 mg, 1.49 mmol, 1.0 eq.) and 
benzaldehyde (791 mg, 7.45 mmol, 5.0 eq.) were dissolved in acetic acid anhydride (4 mL) in a 
Schlenk flask and heated to 180 °C for five days. The reaction mixture was concentrated under high 
vacuum, 2 M NaOH-solution (30 mL) was added and the aqueous phase was extracted with 
methylene chloride (3 x 30 mL). The combined organic layers were dried over sodium sulfate and 
concentrated. The crude product was purified by column chromatography (silica gel, 2 cm × 18 cm, 
cyclohexane:EtOAc = 19:1, then 9:1) to obtain the product 33 (292 mg, 63%) as a brown solid and 
125 mg of the mono olefin 35. 
 
N
N
Ph
Ph
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C22H18N2 (310.40 g/mol) 
TLC: Rf  = 0.22 (cyclohexane:EtOAc = 9:1, UV). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 8.46 (s, 2H), 7.95 (s, 2H), 7.43-7.37 (m, 8H), 7.31-7.27 
(m, 2H), 2.93 (s, 4H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 147.9, 142.9, 137.3, 134.3, 129.7, 129.1, 128.4, 127.5, 
26.4. 
GC-MS (Method D, tR = 32.7 min): m/z (%) 310 (M
+, 34), 309 (100), 308 (14), 154 (29), 153 (12), 
147 (15). 
 
 
2,3-Diphenyl-4a,5,6,7,8,8a-hexahydroquinoxaline 
In a round bottom flask, benzil 21 (4.99 g, 43.3 mmol, 1.0 eq.) and 1,2-diaminocyclohexane 20 
(9.10 g, 43.3 mmol, 1.0 eq.) were dissolved in THF (100 mL). Then, a catalytic amount of acetic 
acid and the reaction mixture was heated to reflux for three hours. The solvent was removed and the 
crude product was recrystallized from hot ethanol to give the product (10.0 g, 80%) as a brown 
solid. 
 
C20H20N2 (288.39 g/mol) 
m.p.: 155-157 °C. 
TLC: Rf  = 0.35 (cyclohexane:EtOAc = 9:1, UV). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 7.41-7.38 (m, 4H), 7.30-7.27 (m, 2H), 7.25-7.21 (m, 4H), 
2.86-2.82 (m, 2H), 2.52-2.49 (m, 2H), 1.92-1.87 (m, 2H), 1.66-1.59 (m, 2H), 1.46-1.40 (m, 2H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 159.8, 137.9, 129.6, 128.2, 128.1, 59.7, 33.6, 25.6. 
GC-MS (Method C, tR = 13.1 min): m/z (%) 288 (M
+, 44), 287 (10), 104 (100), 82 (19), 67 (29), 54 
(10). 
IR: ṽ = 2935 (w), 2855 (w), 1552 (w), 1443 (w), 1261 (w), 1022 (w), 765 (m), 694 (s), 547 (w). 
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2,3-Diphenyl-5,6,7,8-tetrahydroquinoxaline (22) 
In a round bottom flask, a solution of DDQ (10.0 g, 43.3 mmol, 1.0 eq.) in absolute toluene (80 mL) 
was added to a solution of 2,3-diphenyl-4a,5,6,7,8,8a-hexahydroquinoxaline (12.5 g, 43.3 mmol, 
1.0 eq.) in absolute toluene (80 mL) and the reaction mixture was heated under reflux for 60 hours. 
The reaction mixture was cooled down to room temperature, filtrated, the solvent removed and the 
residue was recrystallized from hot ethanol to obtain the product as a yellow solid (10.4 g, 84% 
over two steps). 
 
C20H18N2 (286.38 g/mol) 
m.p.: 77-80 °C. 
TLC: Rf  = 0.42 (cyclohexane:EtOAc = 9:1, UV). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 7.40-7.38 (m, 4H), 7.28-7.24 (m, 6H), 3.08-3.04 (m, 4H), 
2.01-1.97 (m, 4H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 150.7, 149.7, 139.2, 129.8, 128.3, 128.3, 32.0, 23.0. 
GC-MS (Method B, tR = 28.3 min): m/z (%) 287 (14), 286 (M
+, 77), 285 (100), 52 (11). 
IR: ṽ = 2942 (w), 2862 (w), 2231 (w), 1937 (m), 1220 (m), 1142 (m), 1083 (m), 990 (w), 901 (w), 
767 8m), 697 (s). 
 
 
5,8-Dibromo-2,3-diphenyl-5,6,7,8-tetrahydroquinoxaline 
A solution of 2,3-diphenyl-5,6,7,8-tetrahydroquinoxaline 22 (1.69 g, 5.90 mmol, 1.0 eq.), N-
bromosuccinimide (3.18 g, 17.7 mmol, 3.0 eq.) and AIBN (0.05 g, 0.30 mmol, 0.05 eq.) in carbon 
tetrachloride (25 mL) was heated to reflux for 2.5 hours in a round bottom flask. After cooling to 
room temperature the reaction mixture was filtrated and the filtrate was concentrated. The residue 
was purified by column chromatography (silica gel, 3 cm × 12 cm, cyclohexane:EtOAc = 49:1) to 
obtain the product as a yellow solid (1.12 g, 43%). 
C20H16Br2N2 (444.17 g/mol) 
N
N Ph
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m.p.: 154-155 °C. 
TLC: Rf  = 0.23 (cyclohexane:EtOAc = 49:1, UV). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 7.49-7.46 (m, 4H), 7.37-7.28 (m, 6H), 5.70-5.68 (m, 2H), 
2.98-2.92 (m, 2H), 2.53-2.46 (m, 2H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 152.6, 146.7, 137.8, 129.9, 129.3, 128.5, 49.4, 28.7. 
IR: ṽ = 2942 (w), 1388 (m), 1216 (m), 948 (m), 775 (m), 731 (m), 699 (s), 673 (m), 588 (m), 555 
(m), 433 (w). 
 
 
2,3-Diphenyl-5,6,7,8-tetrahydroquinoxaline-5,8-diol (40) 
In a round bottom flask 5,8-dibromo-2,3-diphenyl-5,6,7,8-tetrahydroquinoxaline (200 mg, 
0.45 mmol, 1.0 eq.) was dissolved in absolute DMF (1 mL) and acetic acid (3 mL). At room 
temperature silver acetate (188 mg, 1.13 mmol, 2.5 eq) was added and the mixture was stirred for 
4.5 hours at room temperature. The reaction mixture was filtrated and the filtrate was concentrated. 
Saturated NaHCO3-solution (30 mL) was added and the aqueous phase was extracted with MTBE 
(3 x 40 mL). The combined organic layers were washed with brine (30 mL), dried over sodium 
sulfate and concentrated to obtain a brown liquid. 
The residue was dissolved in methanol (4 mL) and 1 M NaOH-solution (2 mL) was added. The 
mixure was stirred at room temperature for 60 hours. The reaction mixture was acidified with 
1 M HCl-solution (pH 4) and concentrated. The residue was dissolved in a 1:1 mixture of ethanol 
and chloroform, filtrated and concentrated. The crude product was purified by column 
chromatography (silica gel, 2 cm × 15 cm, methylene chloride, then methylene      
chloride:methanol = 49:1) to obtain the trans-diol (37.2 mg, 26%) and the cis-diol (17.2 mg, 12%) 
as brown solids. 
 
C20H18N2O2 (318.38 g/mol) 
Analytical data for the trans-isomer: 
m.p.: 185-190 °C. 
TLC: Rf  = 0.35 (methylene chloride:methanol = 49:1, UV). 
N
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1H-NMR (400 MHz, CDCl3): δ (ppm) = 7.43-7.28 (m, 10H), 4.93-4.85 (m, 2H), 3.71 (brs, 2H), 
2.55-2.48 (m, 2H), 1.95-1.84 (m, 2H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 151.3, 150.2, 138.0, 129.8, 129.0, 128.4, 68.7, 28.2. 
GC-MS (Method D, tR = 9.2 min): m/z (%) 279 ([M
+39], 13), 167 (37), 150 (11), 149 (100), 113 
(11), 71 (22), 70 (18), 57 (25), 55 (10), 43 (20), 41 (16). 
IR: ṽ = 3254 (w), 3060 (w), 3032 (w), 2945 (w), 2870 (w), 1388 (m), 1025 (m), 977 (w), 767 (m), 
695 (s). 
 
Analytical data for the cis-isomer: 
m.p.: 188-192 °C 
TLC: Rf  = 0.27 (methylene chloride:methanol = 49:1, UV). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 7.42-7.28 (m, 10H), 4.87 (s, 2H), 3.52 (brs, 2H), 2.26-2.13 
(m, 4H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 151.7, 150.1, 138.0, 129.8, 129.0, 128.4, 68.1, 26.4. 
GC-MS (Method D, tR = 9.2 min): m/z (%) 279 ([M
+39], 18), 167 (46), 150 (10), 149 (100), 113 
(13), 71 (14), 70 (18), 57 (30), 55 (12), 43 (17), 41 (16). 
 
 
General working procedure for the formation of pyrazine-bisphosphinite ligands 
 
A 25 mL Schlenk tube was charged with the diol (0.09 mmol, 1.0 eq) and DMAP (22.2 mg, 0.18 
mmol, 2.0 eq), evacuated and filled with argon. The mixture was dissolved in absolute methylene 
chloride (3 mL), the chlorophosphine (0.22 mmol, 2.4 eq) was added and the solution was stirred at 
room temperature for 2.5 hours. The reaction mixture was filtrated through a pipette with silica gel 
(0.5 cm × 2 cm) under inert atmosphere and washed with absolute THF(2 x 2 mL). The solvent was 
removed under high vacuum to give the ligand which was directly used for the formation of the 
iridium complex. 
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trans-5,8-Bis((diphenylphosphanyl)oxy)-5,6,7,8-tetrahydroquinoxaline (L10) 
 
C32H28N2O2P2 (534.16 g/mol) 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 8.34 (s, 2H), 7.44-7.39 (m, 4), 7.29-7.22 (m, 10H), 7.19-
7.14 (m, 6), 5.12-5.09 (m, 2H), 2.36-2.34 (m, 2H), 2.08-2.05 (m, 2H). 
31P{1H}-NMR (162 MHz, CDCl3): δ (ppm) = 114.4. 
 
 
trans-5,8-Bis((di-o-tolylphosphanyl)oxy)-5,6,7,8-tetrahydroquinoxaline 
C36H36N2O2P2 (590.64 g/mol) 
31P{1H}-NMR (162 MHz, CDCl3): δ (ppm) = 95.5. 
 
 
trans-5,8-Bis((di-o-tolylphosphanyl)oxy)-2,3-diphenyl-5,6,7,8-tetrahydroquinoxaline 
C48H44N2O2P2 (742.84 g/mol) 
31P{1H}-NMR (162 MHz, CDCl3): δ (ppm) = 102.7. 
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General working procedure for the formation of the iridium complexes 
 
The ligand (0.09 mmol, 1.0 eq) was dissolved in absolute methylene chloride (2 mL) and 
[Ir(COD)Cl]2 (40.3 mg, 0.09 mmol 1.0 eq) was added and the reaction mixture stirred for 1.5 hours 
at room temperature. NaBArF (159 mg, 0.18 mmol, 2.0 eq) was added and stirring continued under 
reflux for 1 hour. The solvent was removed and the crude product was separated by column 
chromatography (silica gel, 3 cm × 15 cm, methylene chloride, then methylene 
chloride:methanol = 90:10) to obtain a red or foam. In all cases, the 1H-NMR-spectra revealed that 
an unidentifiable mixture was obtained and the desired iridium complexes could not be isolated (see 
Figure 9 as a typical example). 
 
 
Working procedure for the formation of iridium complexes with Ir(COD)2BArF 
 
The ligand (0.09 mmol, 1.0 eq) and [Ir(COD)2BArF (230 mg, 0.18 mmol, 2.0 eq) were dissolved in 
absolute methylene chloride (3 mL) and the mixture was stirred overnight at room temperature. The 
solvent was removed and the crude product was dissolved in DCM (5 mL), layered with heptane 
(5 mL) and stored in the freezer overnight. The precipitate was filtered off and dried under high 
vacuum to get a red solid. The 1H-NMR spectra revealed that an unidentifiable mixture was 
obtained. 
 
3a,4,7,7a-Tetrahydro-4,7-methanobenzo[d][1,3]dioxol-2-one (56)[57] 
In a round bottom flask under inert atmosphere, freshly prepared cyclopentadiene 58 (4.93 g, 
74.6 mmol, 1.0 eq.) and vinylene carbonate 57 (19.3 g, 224 mmol, 3.0 eq) were dissolved in 
absolute toluene (3 mL) and stirred at 180 °C for 20 hours. The reaction mixture was concentrated 
and the crude product was distilled under high vacuum (120 °C oil bath temperature) to obtain the 
product as a colorless wax (9.43 g, 83%). 
 
C8H8O3 (152.15 g/mol) 
m.p.: 98-99 °C. 
O
O
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TLC: Rf  = 0.67 (cyclohexane:EtOAc = 1:1, KMnO4). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 6.23 (t, 3JHH = 1.8 Hz, 2H), 4.99 (dd, 3JHH = 2.3 Hz, 
3JHH = 1.8 Hz, 2H), 3.29 (t, 
3JHH = 1.8 Hz, 2H), 1.77 (dt, 
2JHH = 10.4 Hz, 
3JHH = 1.9 Hz, 1H), 1.28 (d, 
2JHH = 10.4 Hz, 1H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 155.6, 134.4, 79.0, 45.7, 42.6. 
GC-MS (Method B, tR = 10.5 min): m/z (%) 107 ([M
+45], 2), 79 (40), 77 (23), 66 (100). 
IR: ṽ = 2995 (w), 1778 (s), 1368 (s), 1159 (s), 1079 (s), 1048 (s), 947 (m), 822 (m), 757 (s), 705 (s). 
 
 
Bicyclo[2.2.1]hept-5-ene-2,3-diol (59) [57] 
3a,4,7,7a-tetrahydro-4,7-methanobenzo[d][1,3]dioxol-2-one 56 (3.03 g, 19.9 mmol, 1.0 eq.) was 
dissolved in 1 M NaOH-solution (25 mL) and stirred at 40 °C for 18 hours. The reaction mixture 
was neutralized with 1 M HCl-solution and extracted with MTBE (3 x 30 mL), dried over sodium 
sulfate and concentrated to obtain the product (2.32 g, 92%) as a colorless solid. 
 
C7H10O2 (126.16 g/mol) 
m.p.: 166-168 °C. 
TLC: Rf  = 0.36 (cyclohexane:EtOAc = 1:1, KMnO4). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 6.23 (t, 3JHH = 1.8 Hz, 2H), 4.17 (dd, 3JHH = 2.4 Hz, 
3JHH = 1.5 Hz, 2H), 3.03-3.00 (m, 2H), 1.50 (dt, 
2JHH = 9.6 Hz, 
3JHH = 1.8 Hz, 1H), 1.20 (d, 
2JHH = 9.7 Hz, 1H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 135.3, 71.2, 47.8, 42.0 
GC-MS (Method B, tR = 15.3 min): m/z (%) 79 ([M
+47], 13), 77 (10), 67 (100), 66 (85), 65 (13), 
60 (55), 41 (12). 
IR: ṽ = 3444 (w), 3392 (m), 3206 (w), 2982 (w), 2920 (w), 1385 (w), 1252 (w), 1112 (s), 1098 (s), 
1041 (s), 923 (w), 778 (w), 733 (s), 709 (s), 589 (m), 454 (w). 
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Bicyclo[2.2.1]hept-5-ene-2,3-dione (55) [57] 
In a round bottom flask with dropping funnel, trifluoroacetic anhydride (21.0 mL, 151 mmol, 
2.8 eq.) was added within 30 minutes to a solution of DMSO (11.9 mL, 167 mmol, 3.1 eq.) in 
methylene chloride (90 mL) at 78 °C, followed by a solution of bicyclo[2.2.1]hept-5-ene-2,3-diol 
59 (6.80 g, 53.9 mmol, 1.0 eq.) in methylene chloride (30 mL) within 10 minutes. The solution was 
stirred for two hours at 78 °C. Then, triethylamine (37.9 mL, 270 mmol, 5.0 eq.) was added and  
the reaction mixture was stirred for another three hours while slowly warming to room temperature. 
1 M HCl-solution (20 mL) was added and the reaction mixture was extracted with methylene 
chloride (5 x 50 mL). The combined organic phases were dried over sodium sulfate and 
concentrated. The crude product was purified by vacuum distillation (0.1 mbar, 70 °C oil bath 
temperature) to obtain the product as a yellow solid (4.75 g, 72%). 
 
C7H6O2 (122.12 g/mol) 
b.p.: 29 °C, 0.1 mbar. 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 6.50 (s, 2H), 3.32-3.31 (m, 2H), 2.95 (dt, 2JHH = 10.9 Hz, 
3JHH = 2.1 Hz, 1H), 2.49 (d, 
2JHH = 10.9 Hz, 1H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 195.8, 137.9 51.7, 43.8. 
GC-MS (Method C, tR = 5.9 min): m/z (%) 122 (M
+, 17), 66 (100), 65 (17), 40 (19). 
 
 
2,3,5,8-Tetrahydro-5,8-methanoquinoxaline (60) 
In a round bottom flask with Dean-Stark apparatus bicyclo[2.2.1]hept-5-ene-2,3-dione 55 (117 mg, 
0.96 mmol, 1.0 eq.), ethylene diamine (69.1 mg, 1.15 mmol, 1.2 eq.) and p-toluene sulfonic acid 
(15.6 mg, 0.33 mmol, 0.1 eq.) were dissolved in absolute toluene (5 mL) and heated to reflux for 
four hours. The reaction mixture was washed with NaHCO3-solution (5 mL) and brine (5 mL), 
dried over sodium sulfate and concentrated to obtain the product as a yellow liquid (80 mg, 67%) 
which was used without further purification. 
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C9H10N2 (146.19 g/mol) 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 6.35 (t, 3JHH = 1.6 Hz, 2H), 3.58-3.48 (m, 2H), 3.45-3.56 
(m, 2H), 3.34-3.32 (m, 2H), 2.30 (dt, 2JHH = 9.3 Hz, 
3JHH = 1.7 Hz, 1H), 1.20 (d, 
2JHH = 9.3 Hz, 1H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 163.7, 137.0, 49.8, 48.3, 45.7. 
GC-MS (Method B, tR = 7.9 min): m/z (%) 146 (M
+, 64), 145 (29), 119 (27), 118 (11), 92 (34), 91 
(15), 80 (12), 66 (100), 65 (17). 
 
 
5,8-Dihydro-5,8-methanoquinoxaline (54) 
In a round bottom flusk, a solution of nickel dioxide (645 mg, 7.11 mmol, 13.0 eq) and 2,3,5,8-
tetrahydro-5,8-methanoquinoxaline 60 (80.0 mg, 0.55 mmol, 1.0 eq) in absolute toluene (2 mL) was 
heated under reflux over night. The mixture was filtrated and the solvent removed. The crude 
product was purified by column chromatography (silica gel, 2 cm × 15 cm, 
cyclohexane:EtOAc = 19:1) to obtain the product as a yellow liquid (0.35 g, 15%). 
 
C9H8N2 (144.18 g/mol) 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 7.86 (s, 2H), 6.90 (t, 3JHH = 1.7 Hz, 2H), 3.89-3.87 (m, 
2H), 2.66 (dt, 2JHH = 8.2 Hz, 
3JHH = 1.7 Hz, 1H), 2.54 (d, 
2JHH = 8.2 Hz, 1H). 
 
 
1,2-Diphenylethane-1,2-diamine (63) 
In a round bottom flask benzaldehyde 61 (10.0 g, 94.2 mmol, 1.0 eq.) and ammonium acetate 
(22.2 g, 282 mmol, 3.0 eq.) were stirred at 120 °C for 3.5 hours. The reaction mixture was cooled to 
room temperature and washed with water. The remaining yellow sticky solid was recrystallized 
from hot ethanol (20 mL) to obtain a white solid (3.7 g). The solid was dissolved in water (40 mL) 
and concentrated sulfuric acid (13 mL) and was refluxed over the weekend. After cooling to room 
temperature the mixture was filtrated and 6 M NaOH-solution (20 mL) was given to the filtrate. 
NH2
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Solid NaOH was added until pH 14 was reached. The precipitate was filtrated off and recrystallized 
from hot cyclohexane (10 mL) to obtain the product as pale brown crystals (1.96 g, 39%). 
 
C14H16N2 (212.30 g/mol) 
m.p.: 113-114 °C. 
TLC: Rf  = 0.37 (methylene chloride:methanol = 19:1, UV). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 7.40-7.34 (m, 8H), 7.31-7.28 (m, 2H), 4.03 (s, 2H), 1.47 
(brs, 4H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 143.1, 128.6, 127.8, 127.7, 63.0. 
GC-MS (Method B, tR = 18.3 min): m/z (%) 106 ([M
+106], 100), 79 (20), 77 (11). 
IR: ṽ = 3342 (w), 3272 (w), 3027 (w), 1773 (m), 1452 (m), 1160 (s), 1081 (s), 756 (s), 696 (s), 614 
(s). 
 
 
2,3-Diphenyl-5,8-dihydro-5,8-methanoquinoxaline (64) 
In a round bottom flask, 1,2-diphenylethane-1,2-diamine 63 (1.68 g, 7.91 mmol, 1.0 eq.) and 
bicyclo[2.2.1]hept-5-ene-2,3-dione (0.97 g, 7.91 mmol, 1.0 eq.) 55 were dissolved in THF (50 mL), 
followed by a catalytic amount of p-toluene sulfonic acid and the reaction mixture was heated to 
reflux for three hours. The solvent was removed and the residue was dissolved in absolute toluene 
(30 mL). A solution of DDQ (1.83 g, 7.91 mmol, 1.0 eq.) in absolute toluene (30 mL) was added 
and the reaction mixture was heated under reflux for five hours. The mixture was filtrated and the 
solvent removed under reduced pressure. The crude product was purified by column 
chromatography (silica gel, 3 cm × 15 cm, cyclohexane:EtOAc = 9:1) to obtain the product as a 
brown solid (0.35 g, 15%). 
 
C21H16N2 (296.37 g/mol) 
TLC: Rf  = 0.37 (methylene chloride:methanol = 9:1, UV). 
N
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1H-NMR (400 MHz, CDCl3): δ (ppm) = 7.40-7.35 (m, 4H), 7.27-7.24 (m, 6H), 6.96 (t, 
3JHH = 1.9 Hz, 2H), 4.02-4.00 (m, 2H), 2.74 (dt, 
2JHH = 8.2 Hz, 
3JHH = 1.7 Hz, 1H), 2.64 (d, 
2JHH = 8.2 Hz, 1H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 166.2, 145.6, 143.0, 139.6, 130.0, 128.3, 128.0, 67.1, 
50.0. 
GC-MS (Method B, tR = 28.7 min): m/z (%) 296 (M
+, 100), 295 (95), 193 (12), 165 (10), 90 (18), 
89 (22). 
IR: ṽ = 3061 (w), 3006 (w), 2976 (w), 2937 (w), 1660 (m), 1364 (m), 1210 (m), 828 (m), 763 (m), 
693 (s), 523 (m). 
 
 
 5.4  Synthesis of Diels-Alder products and derivatives 
 
2,2,2-Trifluoroethyl (R)-4-methylcyclohex-3-ene-1-carboxylate (75) [68c] 
Under inert atmosphere, bis(trifluoromethanesulfonyl)imide (0.65 g, 2.70 mmol, 0.2 eq.) was 
dissolved in absolute toluene (12 mL) and cooled to 25 °C. A solution of oxazaborolidine 68 
(0.5 M in toluene, 6.40 mL, 3.20 mmol, 0.05 eq.) was added and the mixture was stirred for 10 
minutes. A solution of 2,2,2-trifluoroethyl acrylate 82 (2.03 g, 13.2 mmol, 1.0 eq.) in absolute 
toluene (12 mL) and isoprene 81 (0.99 g, 14.5 mmol, 1.10 eq) were added and the reaction mixture 
was stirred at 0 °C for eight hours. The reaction was quenched with triethylamine (0.4 mL), warmed 
to room temperature and the solvent was removed. The crude product was purified by column 
chromatography (silica gel, 3 cm × 15 cm, pentane:ether = 49:1) to obtain the product as a colorless 
liquid (0.89 g, 30%). 
 
C10H13F3O2 (222,21 g/mol) 
TLC: Rf  = 0.61 (pentane:ether = 49:1, KMnO4). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 5.39-5.36 (m, 1H), 4.55-4.41 (m, 2H), 2.65-2.57 (m, 1H), 
2.27-2.23 (m, 2H), 2.08-1.96 (m, 3H), 1.80-1.69 (m, 1H), 1.65 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 174.5, 134.0, 123.2 (q, 1JCF = 277 Hz), 118.9, 60.3 (q, 
2JCF = 36 Hz), 39.0, 29.2, 27.6, 25.4, 23.6. 
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19F-NMR (376 MHz, CDCl3): δ (ppm) = 73.9. 
GC-MS (Method A, tR = 12.7 min): m/z (%) 222 (M
+, 14), 123 (13), 122 (31), 95 (59), 94 (100), 93 
(16), 79 (68), 77 (17), 68 (19), 67 (29), 55 (19), 53 (10), 41 (13). 
GC (γ-TA, 65 °C): tr(major) = 31.8 min, tr(minor) = 31.1 min, 97% ee. 
IR: ṽ (cm-1) = 2968 (w), 2932 (w), 1753 (s), 1443 (w), 1410 (w), 1277 (s), 1224 (w), 1140 (s), 1075 
(w), 1053 (w), 978 (m), 650 (w). 
[α]20D =  (c = 0.98, CHCl3). 
 
 
(S)-1,4-Dimethylcyclohex-3-enecarbaldehyde (77) [68c] 
In the glove box, a solution of oxazaborolidine 68 (0.5 M in toluene, 1.50 mL, 0.75 mmol, 0.05 eq.) 
was diluted with absolute DCM (10 mL). Outside the box, the solution was cooled to 40 °C and 
AlBr3 (0.16 g, 0.60 mmol, 0.04 eq.) was added (weighed in the glove box). After stirring for 30 min 
the temperature was further decreased to 78 °C, isoprene 81 (7.56 mL, 75.0 mmol, 5.0 eq.) and 
methacroleine 84 (1.38 mL, 15.0 mmol, 1.0 eq.) were added and the reaction mixture was stirred at 
this temperature over night. The reaction was quenched with triethylamine (2.4 mL), warmed to 
room temperature and the solvent was removed. The crude product was purified by column 
chromatography (silica gel, 4 cm × 15 cm, pentane:ether = 49:1) to obtain the product as a colorless 
liquid (2.01 g, 97%). 
 
C9H14O (138.21 g/mol) 
TLC: Rf  = 0.38 (pentane:ether = 49:1, KMnO4). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 9.46 (s, 1H), 5.38-5.35 (m, 1H), 2.34-2.28 (m, 1H), 1.95-
1.94 (m, 2H), 1.88-1.78 (m, 2H), 1.63 (s, 3H), 1.95-1.63 (m, 1H), 1.03 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 206.3, 133.9, 118.5, 44.5, 31.9, 29.1, 27.0, 23.5, 20.8. 
GC-MS (Method A, tR = 9.8 min): m/z (%) 138 (M
+, 61), 123 (45), 120 (13), 110 (18), 109 (31), 
107 (13), 105 (26), 95 (82), 94 (17), 93 (19), 91 (26), 81 (40), 80 (14), 79 (35), 77 (25), 69 (11), 68 
(51), 67 (100), 65 (12), 55 (30), 53 (19), 43 (38), 41 (41). 
O
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HPLC (ODH, nheptane:iPrOH 99:1, 1.0 mL/min, 25 °C): tr(major) = 3.5 min, tr(minor) = 4.3 min, 
98% ee. 
IR: ṽ (cm-1) = 2963 (w), 2913 (m), 2838 (w), 2691 (w), 1724 (s), 1438 (w), 1376 (w), 1156 (w), 
1061 (w), 910 (w), 803 (w), 765 (w). 
[α]20D =  (c = 0.98, CHCl3). 
 
 
(S)-2-(1,4-Dimethylcyclohex-3-en-1-yl)-1,3-dioxolane (85) 
To a solution of (S)-1,4-dimethylcyclohex-3-enecarbaldehyde 77 (200 mg, 1.45 mmol, 1.0 eq.) in 
absolute toluene (5 mL) in a round bottom flask with Dean-Stark apparatus was added p-toluene 
sulfonic acid (27.6 mg, 0.15 mmol, 0.1 eq.) followed by ethylene glycol (180 mg, 2.90 mmol 2.0 
eq.) and the reaction mixture was heated to reflux for 2 hours. Saturated NaHCO3-solution (15 mL) 
was added and the phases were separated. The aqueous phase was extracted with ether (2 x 20 mL) 
and the combined organic phases were dried over sodium sulfate and concentrated. The crude 
product was purified by column chromatography (silica gel, 2 cm × 14 cm, pentane:ether = 49:1, 
KMnO4) to obtain the pure product as a colorless liquid (100 mg, 38%). 
 
C11H18O2 (182.26 g/mol) 
TLC: Rf  = 0.17 (pentane:ether = 49:1, KMnO4). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 5.31-5.29 (m, 1H), 4.58 (s, 1H) 3.93-3.85 (m, 4H), 2.10-
2.03 (m, 1H), 2.02-1.88 (m, 2H), 1.74-1.67 (m, 1H), 1.64 (s, 3H), 1.58-1.51 (m, 1H), 1.48-1.41 (m, 
1H), 0.88 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 132.9, 119.1, 109.8, 65.4, 65.4, 35.6, 32.6, 29.2, 26.8, 
23.5, 18.0. 
GC-MS (Method B, tR = 8.8 min): m/z (%) 182 (M
+, 4), 120 (15), 113 (15), 73 (100), 45 (18). 
IR: ṽ (cm-1) = 2962 (w), 2910 (m), 2876 (m), 2837 (m), 1438 (w), 1392 (w), 1145 (m), 1116 (s), 
1061 (m), 1038 (m), 994 (m), 806 (w). 
[α]20D =  (c = 1.19, CHCl3). 
 
(S)-(1,4-Dimethylcyclohex-3-en-1-yl)methanol (86) 
O
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Sodium borohydride (0.41 g, 10.9 mmol, 1.5 eq.) was added slowly to a solution of (S)-1,4-
dimethylcyclohex-3-enecarbaldehyde 77 (1.00 g, 7.24 mmol, 1.0 eq.) in methanol (50 mL) at 0 °C. 
After addition, the reaction mixture was stirred at room temperature for 60 minutes. Then, 2 M HCl-
solution (20 mL) was added and stirred for a few minutes. The aqueous phase was extracted with 
ether (4 x 40 mL). The combined organic phases were washed with saturated NaHCO3-solution 
(40 mL) and water (40 mL), dried over sodium sulfate and concentrated. The crude product was 
purified by column chromatography (silica gel, 3 cm × 13 cm, pentane:ether = 4:1, KMnO4) to 
obtain the alcohol as a yellow liquid (0.88 g, 87%). 
 
C9H16O (140.23 g/mol) 
TLC: Rf  = 0.34 (cyclohexane:EtOAc = 4:1, KMnO4). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 5.31-5.29 (m, 1H), 3.38 (d, 2JHH = 20.0 Hz, 1H), 3.36 
(d, 2JHH = 20.0 Hz, 1H), 1.94-1.87 (m, 3H), 1.72-1.66 (m, 1H), 1.65 (s, 3H), 1.54-1.47 (m, 1H), 
1.42-1.37 (m, 1H), 1.31 (brs, 1H), 0.91 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 133.1, 119.4, 71.6, 34.3, 33.5, 30.7, 27.3, 23.5, 22.4. 
GC-MS (Method B, tR = 5.4 min): m/z (%) 140 (M
+, 30), 122 (27), 109 (86), 107 (55), 94 (34), 93 
(100), 91 (31), 81 (22), 79 (41), 77 (22), 68 (38), 67 (84), 55 (19), 53 (15), 43 (21), 41 (31). 
IR: ṽ (cm-1) = 3319 (w), 2960 (m), 2909 (s), 2871 (m), 2835 (w), 1437 (m), 1376 (m), 1155 (w), 
1031 (s), 803 (w). 
[α]20D =  (c = 0.92, CHCl3). 
 
 
(S)-(1,4-Dimethylcyclohex-3-en-1-yl)methyl acetate (87) 
Acetic anhydride (68.8 mg, 0.67 mmol, 1.05 eq.) was added to a solution of (S)-(1,4-
dimethylcyclohex-3-en-1-yl)methanol 86 (90 mg, 0.64 mmol 1.0 eq.) in pyridine (0.5 mL) in a 
round bottom flask at 0 °C. After addition the mixture was stirred for 72 hours at room temperature. 
The reaction mixture was concentrated and the crude product was purified by column 
OH
OAc
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chromatography (silica gel, 2 cm × 15 cm, n-hexane:EtOAc = 9:1) to obtain the product as a 
colorless liquid (95.0 mg, 81%). 
 
C11H18O2 (182.26 g/mol) 
TLC: Rf  = 0.61 (cyclohexane:EtOAc = 9:1, KMnO4). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 5.29-5.27 (m, 1H), 3.85 (d, 2JHH = 19.4 Hz, 1H), 3.82 
(d, 2JHH = 19.4 Hz, 1H), 2.06 (s, 3H), 1.94-1.89 (m, 3H), 1.75-1.70 (m, 1H), 1.64 (s, 3H), 1.56-1.49 
(m, 1H), 1.43-1.36 (m, 1H), 0.92 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 171.6, 133.0, 119.0, 72.1, 34.5, 32.0, 31.0, 27.1, 23.5, 
22.8, 21.1. 
GC-MS (Method B, tR = 7.6 min): m/z (%) 123 ([M
+59], 6), 122 (53), 109 (16), 107 (71), 94 (66), 
93 (100), 91 (24), 81 (14), 79 (36), 77 (14), 68 (17), 67 (33), 55 (10), 43 (58), 41 (17). 
IR: ṽ = 2961 (w), 2912 (w), 2882 (w), 2838 (w), 1739 (s), 1438 (w), 1373 (m), 1240 (s), 1036 (m). 
[α]20D =  (c = 0.61, CHCl3). 
 
 
(S)-tert-Butyl((1,4-dimethylcyclohex-3-en-1-yl)methoxy)dimethylsilane (88) 
In a round bottom flask (S)-(1,4-dimethylcyclohex-3-en-1-yl)methanol 86 (120 mg, 0.86 mmol, 
1.0 eq.), N-methylimidazole (211 mg, 2.57 mmol, 3.0 eq.) and iodine (217 mg, 0.86 mmol, 1.0 eq.) 
were dissolved in absolute THF (3 mL). tert-Butyldimethylsilyl chloride (141 mg, 0.94 mmol, 
1.1 eq.) was added and the reaction mixture was stirred for 30 minutes at room temperature. The 
reaction mixture was concentrated and the residue redissolved in EtOAc (10 mL) and washed with 
concentrated sodium thiosulfate-solution (10 mL). The aqueous phase was extracted with EtOAc 
(2 x 10 mL) and the combined organic phases were dried over sodium sulfate and concentrated 
under reduced pressure. The crude product was purified by column chromatography (silica gel, 
2 cm × 16 cm, cyclohexane:EtOAc = 4:1, KMnO4) to obtain the product as a colorless liquid 
(187 mg, 86%).
OTBDMS
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C15H30OSi (254.49 g/mol) 
TLC: Rf  = 0.82 (cyclohexane, KMnO4). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 5.30-5.29 (m, 1H), 3.28 (d, 2JHH = 26.8 Hz, 1H), 3.26 
(d, 2JHH = 26.8 Hz, 1H), 1.91-1.87 (m, 3H), 1.64 (s, 3H), 1.65-1.59 (m, 1H), 1.53-1.47 (m, 1H), 
1.34-1.26 (m, 1H), 0.89 (s, 9H), 0.85 (s, 3H), 0.02 (s, 6H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 132.9, 119.8, 71.3, 34.4, 33.7, 30.7, 27.4, 26.1, 23.6, 22.5, 
18.5, 5.3. 
GC-MS (Method B, tR = 10.6 min): m/z (%) 239 ([M
+15], 2), 198 (10), 197 (59), 122 (65), 121 
(94), 107 (27), 94 (42), 93 (62), 91 (10), 89 (30), 81 (12), 79 (12), 77 (10), 75 (100), 73 (28),  
IR: ṽ = 2953 (m), 2927 (m), 2883 (m), 2855 (m), 1471 (w), 1448 (w), 1252 (m), 1093 (s), 1006 (w), 
837 (s), 775 (m), 666 (w). 
[α]20D = 9.0 (c = 1.02, CHCl3). 
 
 
2-(4-Methoxyphenyl)but-3-en-2-ol (93b) 
Under inert atmosphere a solution of 4-methoxyacetophenone 89b (1.00 g, 6.68 mmol, 1.0 eq.) in 
absolute THF (2 mL) was added to a solution of vinylmagnesium bromide in THF (1 M, 8.0 mL, 
8.00 mmol, 1.2 eq.) via a dropping funnel and the mixture was stirred for one hour under reflux. 
Saturated ammonium chloride-solution (5 mL) was added and the aqueous phase was extracted with 
THF (2 x 15 mL). The combined organic layers were dried over sodium sulfate and concentrated. 
The crude product was obtained as a yellow liquid (1.09 g, 92%) and was used without further 
purification. 
 
C11H14O2 (178.23 g/mol) 
TLC: Rf  = 0.24 (cyclohexane:EtOAc = 9:1, KMnO4). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 7.41-7.37 (m, 2H), 6.89-6.86 (m, 2H), 6.16 
(dd, 2JHH = 17.6 Hz, 
3JHH = 10.6 Hz, 1H), 5.29 (dd, 
2JHH = 17.6 Hz, 
3JHH = 1.1 Hz, 1H), 5.13 
(dd, 3JHH = 10.6 Hz, 
3JHH = 1.1 Hz, 1H), 3.80 (s, 3H), 1.85 (brs, 1H), 1.64 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 158.7, 145.2, 138.7, 126.6, 113.7, 112.2, 74.6, 55.4, 29.4.
OH
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GC-MS (Method B, tR = 10.7 min): m/z (%) 178 (M
+, 33), 163 (47), 151 (10), 145 (13), 135 (22), 
121 (100), 108 (22), 91 (12), 77 (15), 55 (50), 43 (55). 
IR: ṽ = 3381 (w), 2976 (w), 2932 (w), 2835 (w), 1609 (m), 1510 (s), 1463 (w), 1413 (w), 1367 (w), 
1300 (m), 1248 (s), 1177 (s), 1103 (w), 1032 (s), 921 (m), 832 (s). 
 
 
1-(Buta-1,3-dien-2-yl)-4-methoxybenzene (90b) 
In a round bottom flask, 2-(4-methoxyphenyl)but-3-en-2-ol 93b (551 mg, 3.09 mmol, 1.0 eq.), 
aniline hydrobromide (48.0 mg, 0.28 mmol, 0.09 eq.) and hydroquinone (6.90 mg, 0.06 mmol, 
0.02 eq.) were dissolved in THF (5 mL) and stirred under reflux for two hours.  
The reaction mixture was concentrated and purified by column chromatography (silica gel, 
2 cm × 13 cm, cyclohexane) to obtain the product as a colorless liquid (190 mg, 38%). 
 
C11H12O (160,22 g/mol) 
TLC: Rf  = 0.41 (cyclohexane, UV). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 7.28 (d, 3JHH = 8.6 Hz, 2H), 6.90 (d, 3JHH = 8.6 Hz, 2H), 
6.63 (dd, 2JHH = 10.9 Hz, 
3JHH = 7.1 Hz, 1H), 5.25-5.18 (m, 4H), 3.83 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 159.2, 147.8, 138.5, 132.3, 129.5, 117.1, 116.1, 113.7, 
55.4. 
GC-MS (Method B, tR = 8.1 min): m/z (%) 161, (11), 160 (M
+, 100), 159 (43), 145 (41), 144 (30), 
132 (12), 129 (47), 128 (25), 127 (15), 121 (13), 177 (44), 116 (16), 115 (52), 91 (24), 89 (16), 77 
(10), 65 (10), 63 (13), 51 (10). 
IR: ṽ = 3089 (w), 3003 (w), 2955 (w), 2835 (w), 1609 (m), 1509 (s), 1285 (m), 1242 (s), 1176 (m), 
1032 (m), 892 (m), 833 (s), 802 (m). 
 
 
 
 
 
O
                                                                                                                                           CHAPTER 5 
97 
(3S,4S)-4'-Methoxy-3-methyl-2,3,4,5-tetrahydro-[1,1'-biphenyl]-4-carbaldehyde (102) 
To a solution of 1-(buta-1,3-dien-2-yl)-4-methoxybenzene 90b (150 mg, 0.94 mmol, 1.0 eq.) in 
1.0 mL acetonitrile/water (95/5 v/v) was added (S)-5-benzyl-2,2,3-trimethylimidazolidin-4-one 
hydrochloride 91 (47.7 mg, 0.187 mmol, 0.2 eq.) at 0 °C followed by the addition of trans-
crotonaldehyde 92 (203 mg, 2.90 mmol, 3.1 eq.). The reaction mixture was stirred at 0 °C for 24 
hours and then placed directly onto a silica gel column (2 cm × 15 cm, pentane:EtOAc = 19:1). The 
product was obtained as a yellow liquid (120 mg, 56%).  
 
C15H18O2 (230.31 mg/mol) 
TLC: Rf  = 0.22 (pentane:EtOAc = 19:1, UV). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 9.70 (d, 3JHH = 3.1 Hz, 1H), 7.32-7.29 (m, 2H), 6.87-6.84 
(m, 2H), 6.02-5.99 (m, 1H), 3.81 (s, 3H), 2.62-2.09 (m, 6H), 1.13 (d, 3JHH = 6.3 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 205.2, 158.9, 135.6, 134.3, 126.2, 119.6, 113.8, 55.5, 
52.4, 34.7, 28.9, 24.9, 19.9. 
GC-MS (Method B, tR = 20.4 min): m/z (%) 230 (M
+, 94), 202 (100), 199 (73), 187 (37), 185 (50), 
184 (22), 173 (88), 160 (31), 159 (48), 148 (29), 145 (33), 144 (20), 129 (34), 128 (32), 121 (67), 
117 (20), 115 (46), 91 (34), 77 (31). 
HPLC (ODH, nheptane:iPrOH 94:6, 1.0 mL/min, 25 °C): tr(major) = 17.3 min, tr(minor) = 20.2 min, 
89% ee, determined for the corresponding alcohol. 
IR: ṽ = 2955 (w), 2905 (w), 2834 (w), 1720 (s), 1607 (m), 1512 (s), 1461 (w), 1372 (w), 1249 (s), 
1180 (m), 1035 (m), 831 (w). 
[α]20D = .2 (c = 1.00, CHCl3). 
 
 
 
 
 
 
4-(2-Hydroxybut-3-en-2-yl)benzonitrile (93c) 
O
O
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Under inert atmosphere a solution of 4-cyanoacetophenone 89c (1.94 g, 13.3 mmol, 1.0 eq.) in 
absolute THF (4 mL) was added to a solution of vinylmagnesiumbromide in THF (1 M, 16.0 mL, 
16.0 mmol, 1.2 eq.) via a dropping funnel and the mixture was stirred for one hour under reflux. 
Saturated ammonium chloride-solution (10 mL) was added and the aqueous phase was extracted 
with THF (2 x 30 mL). The combined organic layers were dried over sodium sulfate and 
concentrated. The crude product was purified by column chromatography (silica gel, 4 cm × 15 cm, 
cyclohexane:EtOAc = 9:1) to obtain the product as a yellow liquid (1.45 g, 63%). 
 
C11H11NO (173.21 g/mol) 
TLC: Rf  = 0.35 (cyclohexane:EtOAc = 4:1, UV). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 7.64-7.61 (m, 2H), 7.59-7.57 (m, 2H), 6.12 
(dd, 2JHH = 17.3 Hz, 
3JHH = 10.6 Hz, 1H), 5.31 (dd, 
2JHH = 17.3 Hz, 
3JHH = 0.7 Hz, 1H), 5.21 
(dd, 3JHH = 10.6 Hz, 
3JHH = 0.7 Hz, 1H), 1.98 (brs, 1H), 1.65 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 152.1, 144.1, 132.5, 126.5, 119.3, 114.1, 111.2, 75.1, 29.8 
GC-MS (Method B, tR = 12.2 min): m/z (%) 173 (M
+, 8), 158 (51), 146 (13), 140 (14), 131 (46), 
130 (45), 116 (10), 103 (14), 102 (15), 55 (22), 43 (100). 
IR: ṽ = 3425 (w), 2980 (w), 2931 (w), 2229 (s), 1687 (w), 1606 (m), 1501 (w), 1402 (m), 1362 (w), 
1262 (w), 1067 (m), 927 (s), 840 (s), 570 (m). 
 
 
2-(4-Chlorophenyl)but-3-en-2-ol (93d) 
Under inert atmosphere a solution of 4-chloroacetophenone 89d (2.01 g, 13.0 mmol, 1.0 eq.) in 
absolute THF (10 mL) was added to a solution of vinylmagnesiumbromide in THF (1 M, 15.6 mL, 
15.6 mmol, 1.2 eq.) via a dropping funnel. The mixture was stirred for one hour under reflux. 
Saturated ammonium chloride-solution (10 mL) was added and the aqueous phase was extracted 
with THF (2 x 25 mL). The combined organic layers were dried over sodium sulfate and 
OH
NC
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concentrated. The crude product was purified by column chromatography (silica gel, 4 cm × 14 cm, 
cyclohexane:EtOAc = 19:1) to obtain the product as a yellow liquid (2.30 g, 97%). 
 
C10H11ClO (182.65 g/mol) 
TLC: Rf  = 0.53 (cyclohexane:EtOAc = 9:1, UV). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 7.42-7.38 (m, 2H), 7.32-7.28 (m, 2H), 6.13 
(dd, 2JHH = 17.3 Hz, 
3JHH = 10.6 Hz, 1H), 5.29 (dd, 
2JHH = 17.3 Hz, 
3JHH = 0.9 Hz, 1H), 5.16 
(dd, 3JHH = 10.6 Hz, 
3JHH = 0.9 Hz, 1H), 1.94 (brs, 1H), 1.63 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 145.1, 144.6, 132.9, 128.4, 126.9, 113.0, 74.6, 29.5. 
GC-MS (Method B, tR = 9.5 min): m/z (%) 182 (M
+, 17), 169 (13), 147 (41), 147 (34), 139 (24), 
132 (12), 129 (11), 127 (11), 125 (23), 103 (19), 77 (14), 75 (13), 55 (38), 51 (10), 43 (100). 
IR: ṽ = 3362 (w), 2977 (w), 2930 (w), 1590 (w), 1489 (m), 1400 (m), 1368 (m), 1217 (w), 1176 
(w), 1094 (s), 1013 (s), 924 (m), 829 (m). 
 
 
1-(Buta-1,3-dien-2-yl)-4-chlorobenzene (90d) 
In a round bottom flask, 2-(4-chlorophenyl)but-3-en-2-ol 93d (1.40 g, 7.66 mmol, 1.0 eq.), aniline 
hydrobromide (0.12 g, 0.69 mmol, 0.09 eq.) and hydroquinone (0.02 g, 0.15 mmol, 0.02 eq.) were 
heated at 100 to 150 °C for 3 hours while continuously distilling. The distillate was purified by 
column chromatography (silica gel, 2 cm × 14 cm, cyclohexane) to obtain the product as a colorless 
liquid (0.15 g, 12%). 
 
C10H9Cl (164.63 g/mol) 
TLC: Rf  = 0.67 (cyclohexane, UV). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 7.32-7.28 (m, 2H), 7.24-7.21 (m, 2H), 6.58 
(ddd, 2JHH = 17.4 Hz, 
3JHH = 10.7 Hz, 
3JHH = 0.7 Hz, 1H), 5.29-5.28 (m, 1H), 5.22-5.19 (m, 1H) 
5.17-5.16 (m, 1H), 5.15-5.11 (m, 1H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 147.3, 138.3, 138.0, 133.5, 129.8, 128.5, 117.5, 117.4.
Cl
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GC-MS (Method B, tR = 6.7 min): m/z (%) 164 (M
+, 14), 130 (10), 129 (100), 128 (52), 127 (26), 
51 (11). 
IR: ṽ = 2914 (w), 2878 (w), 1638 (w), 1490 (m), 1090 (m), 1012 (m), 916 (m), 829 (s), 806 (s), 528 
(m). 
 
 
2-(3-Methoxyphenyl)but-3-en-2-ol (93e) 
Under inert atmosphere a solution of 3-methoxyacetophenone 89e (1.03 g, 6.66 mmol, 1.0 eq.) in 
absolute THF (4 mL) was added to a solution of vinylmagnesiumbromide in absolute THF (1 M, 
8.0 mL, 8.0 mmol, 1.2 eq.) via a dropping funnel. The mixture was stirred for two hours under 
reflux. After cooling to room temperature, saturated ammonium chloride-solution (5 mL) was added 
and the aqueous phase was extracted with THF (2 x 15 mL). The combined organic layers were 
dried over sodium sulfate and concentrated. The crude product was purified by column 
chromatography (silica gel, 3 cm × 14 cm, cyclohexane:EtOAc = 9:1) to obtain the product as a 
yellow liquid (0.97 g, 82%). 
 
C11H14O2 (178.23 g/mol) 
TLC: Rf  = 0.24 (cyclohexane:EtOAc = 9:1, UV). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 7.26 (dd,  3JHH = 8.0 Hz, 3JHH = 7.7 Hz, 1H), 7.06-6.87 (m, 
2H), 6.20-6.13 (m, 1H), 6.17 (dd, 2JHH = 17.3 Hz, 
3JHH = 10.6 Hz, 1H), 5.31 (dd, 
2JHH = 17.3 Hz, 
3JHH = 1.0 Hz, 1H), 5.15 (dd, 
3JHH = 10.6 Hz, 
3JHH = 1.0 Hz, 1H), 3.82 (s, 3H), 1.86 (brs, 1H), 1.65 
(s, 3H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 159.7, 148.4, 144.8, 129.4, 117.7, 112.5, 112.4, 111.3, 
74.9, 55.4, 29.5. 
GC-MS (Method B, tR = 10.3 min): m/z (%) 178 (M
+, 26), 163 (20), 136 (10), 135 (100), 105 (12), 
91 (10), 77 (13), 55 (55), 43 (57). 
IR: ṽ = 3396 (w), 3083 (w), 2976 (w), 2936 (w), 2834 (w), 1599 (m), 1485 (m), 1431 (m), 1318 
(m), 1287 (s), 1045 (s), 924 (m), 784 (m), 699 (m). 
 
OH
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1-(Buta-1,3-dien-2-yl)-3-methoxybenzene (90e) 
In a round bottom flask 2-(3-methoxyphenyl)but-3-en-2-ol 93e (970 mg, 5.33 mmol, 1.0 eq.), 
aniline hydrobromide (82.5 mg, 0.48 mmol, 0.09 eq.) and hydroquinone (11.9 mg, 0.11 mmol, 
0.02 eq.) were dissolved in THF (10 mL) and stirred at 130 °C for 15 hours. The reaction mixture 
was concentrated and purified by column chromatography (silica gel, 2 cm × 13 cm, cyclohexane) 
to obtain the product as a colorless liquid (120 mg, 14%). 
 
C11H12O (160.22 g/mol) 
TLC: Rf  = 0.30 (cyclohexane, UV). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 7.29-7.24 (m, 1H), 6.93-6.91 (m, 1H), 6.88-6.85 (m, 2H), 
6.64-6.57 (m, 1H), 5.30-5.29 (m, 1H), 5.25-5.23 (m, 1H), 5.22-5.21 (m, 2H), 3.82 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 159.5, 148.2, 141.3, 138.1, 129.2, 120.9, 117.4, 117.0, 
114.1, 113.1, 55.4. 
GC-MS (Method B, tR = 7.7 min): m/z (%) 161 (12), 160 (M
+, 100), 159 (53), 145 (30), 144 (33), 
130 (10), 129 (78), 128 (37), 127 (22), 117 (25), 116 (17), 115 (54), 102 (12), 91 (22), 89 (11), 77 
(10). 
IR: ṽ = 3086 (w), 3000 (w), 2935 (w), 2833 (w), 1575 (s), 1485 (m), 1429 (m), 1321 (m), 1283 (m), 
1228 (s), 1049 (s), 901 (m), 784 (m), 715 (m). 
 
 
2-(3-Chlorophenyl)but-3-en-2-ol (93f) 
Under inert atmosphere a solution of 3-chloroacetophenone 89f (515 mg, 3.33 mmol, 1.0 eq.) in 
absolute THF (2 mL) was added to a solution of vinylmagnesiumbromide in THF (1 M, 4.0 mL, 
4.00 mmol, 1.2 eq.) via a dropping funnel and the mixture was stirred for two hours under reflux. 
Saturated ammonium chloride-solution (5 mL) was added and the aqueous phase was extracted with 
THF (2 x 15 mL). The combined organic layers were dried over sodium sulfate and concentrated. 
O
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The crude product was separated by column chromatography (silica gel, 3 cm × 13 cm, 
cyclohexane:EtOAc = 19:1) to obtain the product as a pale yellow liquid (330 mg, 54%). 
 
C10H11ClO (182.65 g/mol) 
TLC: Rf  = 0.53 (cyclohexane:EtOAc = 9:1, UV). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 7.47-7.46 (m, 1H), 7.34-7.31 (m, 1H), 7.28-7.24 (m, 1H), 
7.23-7.20 (m, 1H), 6.13 (dd, 2JHH = 17.3 Hz, 
3JHH = 10.6 Hz, 1H), 5.30 (dd, 
2JHH = 17.3 Hz, 
3JHH = 0.9 Hz, 1H), 5.17 (dd, 
3JHH = 10.6 Hz, 
3JHH = 0.9 Hz, 1H), 1.91 (brs, 1H), 1.63 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 148.7, 144.3, 134.3, 129.6, 127.2, 125.7, 123.6, 113.2, 
74.6, 29.5. 
GC-MS (Method B, tR = 9.4 min): m/z (%) 182 (M
+, 18), 167 (31), 147 (23), 141 (13), 139 (38), 
132 (10), 103 (19), 77 (14), 75 (11), 55 (38), 51 (12), 43 (100). 
IR: ṽ = 3357 (w), 3068 (w), 2980 (w), 2930 (w), 1595 (m), 1474 (m), 1416 (s), 1368 (m), 1214 (m), 
1122 (m), 1068 (m), 996 (m), 926 (s), 893 (m), 787 (s), 766 (s), 708 (m). 
 
 
2-(Prop-2-yn-1-yloxy)tetrahydro-2H-pyran (99) 
In round bottom flask, a solution of propargyl alcohol 98 (2.10 g, 37.8 mmol, 1.0 eq.), 
dihydropyrane (5.01 g, 60.0 mmol, 1.6 eq.) and p-toluenesulfonic acid (0.95 g, 5.00 mmol, 0.13 eq.) 
were dissolved in ether (75 mL) and stirred for three hours at room temperature. The reaction 
mixture was washed with saturated NaHCO3-solution (50 mL) and the phases were separated. The 
aqueous phase was extracted with ether (2 x 50 mL) and the combined organic phases were washed 
with brine (50 mL), dried over sodium sulfate and concentrated. The crude product was separated 
by column chromatography (silica gel, 4 cm × 15 cm, cyclohexane: EtOAc = 49:1) to obtain the 
product as a colorless liquid (4.37 g, 83%). 
 
C8H12O2 (140.18 g/mol) 
TLC: Rf  = 0.46 (cyclohexane:EtOAc = 19:1, KMnO4). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 4.82 (t, 3JHH = 3.3 Hz, 1H), 4.32-4.21 (m, 2H), 3.86-3.81 
(m, 1H), 3.55-3.52 (m, 1H), 2.41 (t, 4JHH = 2.4 Hz, 1H), 1.84-1.71 (m, 2H), 1.66-1.52 (m, 4H).
OO
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13C-NMR (100 MHz, CDCl3): δ (ppm) = 97.0, 79.9, 74.1, 62.1, 54.1, 30.4, 25.5, 19.1. 
GC-MS (Method C, tR = 5.1 min): m/z (%) 139 ([M
+1], 8), 85 (100), 83 (10), 82 (12), 67 (10), 57 
(24), 56 (46), 55 (29), 53 (11), 43 (15), 41 (50). 
IR: ṽ = 3288 (w), 2942 (m), 2869 (w), 1441 (w), 1345 (w), 1323 (w), 1264 (m), 1119 (s), 1026 (s), 
901 (m), 663 (w). 
 
 
1-Phenyl-5-((tetrahydro-2H-pyran-2-yl)oxy)pent-3-yn-1-ol (101) [77] 
In a 100 mL round bottom flask at 78 °C, n-butyllithium (1.6 mol/L in hexanes, 11.0 mL, 
17.6 mmol, 1.5 eq.) was slowly added to a solution of 2-(prop-2-yn-1-yloxy)tetrahydro-2H-pyran 
99 (2.46 g, 17.6 mmol, 1.5 eq.) in absolute THF (50 mL) and the reaction mixture was stirred for 
30 min. A solution of styrene oxide 100 (1.41 g, 11.7 mmol, 1.0 eq.) in absolute THF (10 mL) was 
slowly added followed by boron trifluoride diethyl etherate (2.49 g, 17.6 mmol, 1.5 eq.) and the 
mixture was stirred for 18 hours at room temperature. The reaction was quenched with saturated 
ammonium chloride-solution (50 mL). The phases were separated and the aqueous phase extracted 
with ether (3 x 50 mL). The combined organic phases were washed with brine (50 mL), dried over 
sodium sulfate and concentrated. The crude product was purified by column chromatography (silica 
gel, 3 cm × 15 cm, cyclohexane:EtOAc = 6:1) to obtain the product as a colorless liquid (0.48 g, 
16%). 
 
C16H20O3 (260.33 g/mol) 
TLC: Rf  = 0.23 (petroleum ether:EtOAc = 4:1, KMnO4). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 7.40-7.26 (m, 5H), 4.89-4.85 (m, 1H), 4.75 (t, 
3JHH = 3.5 Hz, 1H), 4.32-4.19 (m, 2H), 3.87-3.80 (m, 1H), 3.54-3.49 (m, 1H), 2.69-2.67 (m, 2H), 
2.50 (dd, 3JHH = 3.5 Hz, 
3JHH = 11.0 Hz, 1H), 1.86-1.78 (m, 1H), 1.75-1.68 (m, 1H), 1.64-1.49 (m, 
4H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 142.8, 128.6, 128.0, 125.9, 97.1, 82.8, 79.0, 72.6, 62.2, 
54.8, 30.5, 30.2, 25.5, 19.3. 
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IR: ṽ = 3359 (w), 2939 (w), 2868 (w), 1453 (w), 1345 (w), 1201 (w), 1116 (m), 1021 (s), 902 (w), 
753 (w), 701 (m). 
 
 
1-Phenylpenta-3,4-dien-1-ol (94) [77] 
Under inert atmosphere a solution of 1-phenyl-5-((tetrahydro-2H-pyran-2-yl)oxy)pent-3-yn-1-ol 
101 (1.10 g, 4.23 mmol, 1.0 eq.) in absolute ether (2 mL) was added to a slurry of lithium 
aluminium hydride (0.18 g, 4.65 mmol, 1.1 eq.) in absolute ether (10 mL) a round bottom flask and 
stirred under reflux for 4.5 hours. The reaction mixture was quenched with a small amount of water 
and filtrated. The solid was washed with ether (3 x 10 mL) and the filtrate was dried over sodium 
sulfate and concentrated. The crude product was purified by column chromatography (silica gel, 
2 cm × 15 cm, cyclohexane:EtOAc = 9:1) to obtain the product as a colorless liquid (0.05 g, 7%). 
 
C11H12O (160.22 g/mol) 
TLC: Rf  = 0.24 (cyclohexane:EtOAc = 9:1, KMnO4). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 7.38-7.33 (m, 4H), 7.32-7.27 (m, 1H), 5.15-5.08 (m, 1H), 
4.78-4.75 (m, 1H), 4.73-4.70 (m, 2H), 2.49-2.44 (m, 2H), 2.24 (d, 3JHH = 44.1 Hz, 1H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 209.6, 143.8, 128.6, 127.7, 126.0, 86.3, 75.2, 73.8, 38.6. 
GC-MS (Method B, tR = 10.0 min): m/z (%) 142 ([M
+18], 6), 118 (10), 107 (100), 105 (18), 79 
(93), 77 (49), 54 (11), 51 (16). 
IR: ṽ = 3351 (w), 3061 (w), 2917 (w), 2871 (w), 1955 (m), 1453 (m), 1054 (m), 1026 (m), 844 (m), 
758 (m), 700 (s). 
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Diethyl (1R,2R)-4-methylcyclohex-4-ene-1,2-dicarboxylate (103) [68c] 
In the glove box a solution of oxazaborolidine 68 (0.5 M in toluene, 0.38 mL, 0.19 mmol, 0.05 eq.) 
was weighed in a Schlenk tube. Outside the glove box, aluminium bromide (40.0 mg, 0.15 mmol, 
0.04 eq.) was added to the solution at 40 °C and stirred for 30 min. Then, the temperature was 
increased to 20 °C and isoprene 81 (1.13 mL, 11.3 mmol, 3.0 eq.) and diethyl fumarate 106 
(0.62 mL, 3.75 mmol, 1.0 eq.) were added and the reaction mixture was stirred at this temperature 
for 72 hours, then 48 hours at room temperature. 
The reaction was quenched with triethylamine (0.6 mL) and the solvent was removed. The crude 
product was purified by column chromatography (silica gel, 3 cm × 15 cm, cyclohexane:EtOAc = 
99:1) to obtain the product as a colorless liquid (480 mg, 53%). 
 
C13H20O4 (240.30 g/mol) 
TLC: Rf  = 0.18 (cyclohexane:EtOAc = 19:1, KMnO4). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 5.38-5.37 (m, 1H), 4.21-4.08 (m, 4H), 2.90-2.83 (m, 1H), 
2.80-2.73 (m, 1H), 2.42-2.36 (m, 1H), 2.30-2.24 (m, 1H), 2.18-2.08 (m, 2H), 1.67 (s, 3H), 1.27-1.22 
(m, 6H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 175.2, 175.0, 132.4, 119.2, 60.7, 60.7, 42.0, 41.4, 32.8, 
28.3, 23.2, 14.3. 
GC-MS (Method B, tR = 13.5 min): m/z (%) 195 ([M
+45], 17), 194 (14), 166 (32), 94 (11), 93 
(100), 92 (32), 91 (13), 79 (11), 77 (14). 
HPLC (OJ, nheptane:iPrOH 99:1, 1.0 mL/min, 25 °C): tr(major) = 8.4 min, tr(minor) = 9.2 min, 96% ee. 
IR: ṽ = 2979 (w), 2933 (w), 2846 (w), 1731 (s), 1445 (w), 1372 (w), 1308 (m), 1253 (m), 1180 (m), 
1158 (m), 1035 (m). 
[α]20D =  (c = 1.03, CHCl3). 
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Ethyl (1S,6S)-6-formyl-3-methylcyclohex-3-ene-1-carboxylate (104) [69c] 
At 0 °C isoprene 81 (1.61 g, 23.4 mmol, 3.0 eq.) was added to a mixture of (S)-2-(bis(3,5-
bis(trifluoromethyl)phenyl)((trimethylsilyl)oxy)methyl)pyrrolidinium perchlorate 109 (0.27 g, 
0.39 mmol, 0.05 eq.) and ethyl (Z)-4-oxobut-2-enoate 108 (1.00 g, 7.80 mmol, 1.0 eq.) in water 
(4 mL) and was stirred at 0 °C for 18 hours. Saturated NaHCO3-solution (10 mL) and EtOAc 
(15 mL) were added. The aqueous phase was extracted with EtOAc (2 x 15 mL), the combined 
organic phases were dried over sodium sulfate and concentrated. The crude product was purified by 
column chromatography (silica gel, 3 cm × 19 cm, cyclohexane:EtOAc = 19:1) to obtain the 
product as a colorless liquid (0.86 g, 56%). 
 
C11H16O3 (196.25 g/mol) 
TLC: Rf  = 0.42 (cyclohexane:EtOAc = 19:1, KMnO4). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 9.71 (d, 3JHH = 1.1 Hz, 1H), 5.42-5.39 (m, 1H), 4.16 (q, 
3JHH = 7.2 Hz, 2H), 2.95-2.75 (m, 2H), 2.36-2.06 (m, 4H), 1.67 (s, 3H), 1.26 (t, 
3JHH = 7.2 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 202.9, 174.6, 133.1, 118.4, 61.0, 47.4, 39.9, 31.6, 24.3, 
23.3, 14.3. 
GC-MS (Method B, tR = 10.6 min): m/z (%) 196 (M
+, 2), 151 (18), 150 (30), 122 (20), 107 (25), 
106 (15), 105 (64), 95 (23), 94 (20), 93 (100), 91 (29), 79 (24), 77 (28), 67 (12), 55 (10), 41 (11). 
HPLC (ADH, nheptane:iPrOH 99:1, 1.0 mL/min, 25 °C): tr(major) = 19.5 min, tr(minor) = 22.6 min, 
93% ee. 
IR: ṽ = 2966 (w), 2915 (w), 2847 (w), 2720 (w), 1725 (s), 1444 (w), 1376 (w), 1280 (m), 1179 (m), 
1032 (m). 
[α]20D = 24.5 (c = 0.95, CHCl3). 
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Ethyl (1S,6S)-6-formyl-3,4-dimethylcyclohex-3-ene-1-carboxylate (105) [69c] 
At 4 °C 2,3-dimethyl-1,3-butadiene 107 (0.94 g, 11.5 mmol, 2.3 eq.) was added to a mixture of 
bis(trifluoromethyl)phenyl)((trimethylsilyl)oxy)methyl)pyrrolidinium perchlorate 109 (0.17 g, 
0.25 mmol, 0.05 eq.) and ethyl (Z)-4-oxobut-2-enoate 108 (0.64 g, 5.00 mmol, 1.0 eq.) in water 
(2.5 mL) and was stirred at this temperature for 20 hours. Saturated NaHCO3-solution (10 mL) and 
EtOAc (15 mL) were added. The aqueous phase was extracted with EtOAc (2 x 15 mL) and the 
combined organic phases were dried over sodium sulfate and concentrated. The crude product was 
purified by column chromatography (silica gel, 3 cm × 22 cm, cyclohexane:EtOAc = 19:1) to obtain 
the product as a yellow liquid (0.53 g, 50%).  
 
C12H18O3 (210.27 g/mol) 
TLC: Rf  = 0.45 (cyclohexane:EtOAc = 19:1, KMnO4). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 9.70 (d, 3JHH = 1.4 Hz, 1H), 4.16 (q, 3JHH = 7.2 Hz, 2H), 
2.91-2.84 (m, 1H), 2.84-2.78 (m, 1H), 2.25-2.18 (m, 3H), 2.10-2.03 (m, 1H), 1.65 (s, 3H), 1.63 (s, 
3H), 1.26 (t, 3JHH = 7.2 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 202.8, 174.7, 124.7, 123.4, 60.9, 48.4, 40.2, 33.3, 30.4, 
19.0, 18.9, 14.3. 
GC-MS (Method B, tR = 12.4 min): m/z (%) 210 (M
+, 5), 165 (11), 164 (22), 136 (26), 121 (24), 
120 (11), 119 (59), 109 (11), 108 (20), 107 (100), 105 (14), 93 (23), 91 (34), 79 (13), 77 (13), 67 
(10), 41 (14). 
HPLC (ADH, nheptane:iPrOH 99:1, 1.0 mL/min, 25 °C): tr(major) = 17.5 min, tr(minor) = 20.8 min, 
85% ee. 
IR: ṽ = 2981 (w), 2910 (w), 2838 (w), 2719 (w), 1725 (s), 1442 (w), 1374 (w), 1309 (w), 1217 (m), 
1180 (m), 1032 (m). 
[α]20D =  (c = 1.06, CHCl3). 
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Ethyl (1S,6S)-6-(hydroxymethyl)-3-methylcyclohex-3-ene-1-carboxylate (110) 
Sodium borohydride (38.5 mg, 1.02 mmol, 1.0 eq.) was added slowly to a solution of ethyl (1S,6S)-
6-formyl-3-methylcyclohex-3-ene-1-carboxylate 104 (200 mg, 1.02 mmol, 1.0 eq.) in methanol 
(8 mL) at 0 °C. After addition, the reaction mixture was stirred at room temperature for 2.5 hours. 
Then, 2 M HCl-solution (10 mL) was added and stirred for a few minutes. It was extracted with 
ether (4 x 10 mL). The combined organic phases were washed with saturated NaHCO3-solution 
(10 mL) and water (10 mL), dried over sodium sulfate and concentrated. The crude product was 
purified by column chromatography (silica gel, 2 cm × 16 cm, cyclohexane:EtOAc = 4:1) to obtain 
the alcohol as a colorless liquid (130 mg, 64%). 
 
C11H18O3 (198.26 g/mol) 
TLC: Rf  = 0.21 (cyclohexane:EtOAc = 4:1, KMnO4). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 5.38-5.37 (m, 1H), 4.17 (qd, 3JHH = 7.2 Hz, 5JHH = 0.9 Hz, 
2H), 3.61-3.58 (m, 2H), 2.55-2.49 (m, 1H), 2.34-2.26 (m, 1H), 2.14-2.08 (m, 2H), 2.02-1.90 (m, 
2H), 1.70 (t, 3JHH = 6.2 Hz, 1H) 1.67 (s, 3H), 1.28 (t, 
3JHH = 7.2 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 176.2, 132.0, 119.9, 65.7, 60.7, 42.8, 38.3, 32.8, 27.9, 
23.3, 14.4. 
GC-MS (Method B, tR = 12.0 min): m/z (%) 180 (M
+18, 14), 152 (10), 107 (100), 106 (47), 105 
(13), 93 (34), 91 (40), 80 (10), 79 (34), 77 (18), 41 (11). 
IR: ṽ = 3408 (w), 2963 (w), 2925 (m), 2846 (w), 1729 (s), 1440 (m), 1377 (m), 1299 (m), 1253 (m), 
1177 (s), 1035 (s). 
[α]20D =  (c = 1.02, CHCl3). 
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Ethyl (1S,6S)-6-(hydroxymethyl)-3,4-dimethylcyclohex-3-ene-1-carboxylate (111) 
Sodium borohydride (48 mg, 1.27 mmol, 1.0 eq.) was added slowly to a solution of ethyl (1S,6S)-6-
formyl-3,4-dimethylcyclohex-3-ene-1-carboxylate 105 (266 mg, 1.27 mmol, 1.0 eq.) in methanol 
(8 mL) at 0 °C. After addition, the reaction mixture was stirred at room temperature for one hour. 
2 M HCl-solution (10 mL) was added to the reaction mixture, stirred for a few minutes and then 
extracted with ether (4 x 10 mL). The combined organic phases were washed with saturated 
NaHCO3-solution (10 mL) and water (10 mL), dried over sodium sulfate and concentrated. The 
crude product was purified by column chromatography (silica gel, 2 cm × 16 cm, 
cyclohexane:EtOAc = 4:1) to obtain the alcohol as a colorless liquid (185 mg, 69%). 
 
C12H20O3 (212.29 g/mol) 
TLC: Rf  = 0.24 (cyclohexane:EtOAc = 4:1, KMnO4). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 4.16 (qd, 3JHH = 7.1 Hz, 5JHH = 1.0 Hz, 2H), 3.62-3.52 (m, 
2H), 2.49-2.42 (m, 1H), 2.35-2.28 (m, 1H), 2.14-2.09 (m, 1H), 2.05-1.93 (m, 3H), 1.76 (t, 
3JHH = 6.1 Hz, 1H) 1.61 (s, 2x3H), 1.27 (t, 
3JHH = 7.1 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 176.3, 124.6, 123.7, 65.8, 60.6, 43.3, 39.2, 34.7, 34.4, 
18.9, 18.7, 14.4. 
GC-MS (Method B, tR = 13.7 min): m/z (%) 212 (M
+, 2), 194 (10), 122 (10), 121 (100), 120 (25), 
107 (43), 105 (26), 93 (22), 81 (22), 79 (16), 77 (11), 41 (12). 
IR: ṽ = 3343 (w), 2980 (w), 2903 (w), 2881 (w), 2837 (w), 1716 (s), 1374 (m), 1307 (m), 1257 (m), 
1177 (s), 1050 (s), 994 (m), 664 (w). 
[α]20D =  (c = 1.02, CHCl3). 
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Ethyl (1S,6S)-6-(acetoxymethyl)-3-methylcyclohex-3-ene-1-carboxylate (112) 
Acetic anhydride (505 mg, 4.95 mmol, 1.05 eq.) was added to a solution of ethyl (1S,6S)-6-
(hydroxymethyl)-3-methylcyclohex-3-ene-1-carboxylate 110 (933 mg, 4.71 mmol 1.0 eq.) in 
pyridine (3.5 mL) at 0 °C. After addition, the mixture was stirred for seven hours at room 
temperature. The reaction mixture was concentrated and the crude product was purified by column 
chromatography (silica gel, 3 cm × 18 cm, cyclohexane:EtOAc = 9:1) to obtain the product as a 
colorless liquid (490 mg, 43%). 
 
C13H20O4 (240.30 g/mol) 
TLC: Rf  = 0.57 (cyclohexane:EtOAc = 4:1, KMnO4). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 5.36-5.34 (m, 1H), 4.15 (q, 3JHH = 7.1 Hz, 2H), 4.07 (dd, 
2JHH = 11.1 Hz, 
3JHH = 5.7 Hz, 1H), 3.98 (dd, 
2JHH = 11.1 Hz, 
3JHH = 5.3 Hz, 1H), 2.54-2.48 (m, 1H), 
2.32-2.08 (m, 4H), 2.03 (s, 3H), 1.91-1.82 (m, 1H), 1.66 (s, 3H), 1.28 (t, 3JHH = 7.1 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 175.3, 171.1, 132.1, 119.3, 66.7, 60.6, 42.5, 34.6, 32.5, 
27.6, 23.3, 21.0, 14.4. 
GC-MS (Method B, tR = 14.0 min): m/z (%) 195 (M
+45, 1), 180 (19), 153 (19), 152 (10), 107 
(100), 106 (54), 105 (12), 93 (13), 91 (32), 79 (20), 77 (10), 43 (35). 
IR: ṽ = 2964 (w), 2906 (w), 2846 (w), 1731 (s), 1442 (w), 1366 (m), 1232 (s), 1176 (m), 1035 (m). 
[α]20D =  (c = 1.04, CHCl3). 
 
 
(E)-2-Methylpent-3-en-2-ol (118) [83] 
A solution of (E)-methyl-crotonate 119 (1.00 g, 10.0 mmol, 1.0 eq.) in absolute ether (7 mL) was 
added dropwise to a solution of methyllithium in ether (1.6 M, 13.8 mL, 22.0 mmol, 2.2 eq.) at 
78 °C over 5 minutes. The mixture was warmed to room temperature during one hour and was 
stirred for another 20 hours at this temperature. The reaction mixture was quenched with saturated 
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ammonium chloride-solution (60 mL). The aqueous phase was extracted with ether (3 x 70 mL) and 
the combined organic phases were washed with brine (50 mL), dried over sodium sulfate and 
concentrated. The crude product was purified by column chromatography (silica gel, 3 cm × 14 cm, 
pentane:ether = 4:1) to obtain the product as a pale yellow liquid (0.60 g, 60%). 
 
C6H12O (100.16 g/mol) 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 5.68-5.58 (m, 2H), 1.68-1.67 (m, 3H), 1.44 (brs, 1H), 1.29 
(s, 2x3H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 139.2, 122.1, 70.8, 29.9, 17.8. 
IR: ṽ = 3352 (w), 2970 (m), 2920 (w), 2859 (w), 1450 (w), 1375 (m), 1146 (m), 967 (s), 895 (m). 
 
 
(2,4-Dimethylcyclohex-3-en-1-yl)methanol (124) 
Sodium borohydride (0.41 g, 10.9 mmol, 1.5 eq.) was added slowly to a solution of 2,4-
dimethylcyclohex-3-ene-1-carbaldehyde 115 (1.00 g, 7.24 mmol, 1.0 eq.) in methanol (50 mL) at 
0 °C. After addition, the reaction mixture was stirred at room temperature for one hour. Then, 2 M 
HCl-solution (20 mL) was added and stirred for a few minutes. The reaction mixture was extracted 
with ether (4 x 40 mL). The combined organic phases were washed with saturated NaHCO3-
solution (40 mL) and water (40 mL), dried over sodium sulfate and concentrated. The crude product 
was purified by column chromatography (silica gel, 3 cm × 13 cm, pentane:ether = 4:1) to obtain 
the alcohol as a yellow liquid (0.88 g, 87%). The product was obtained as a mixture of the cis- and 
trans-product (3:1 in favour of the trans). 
 
C9H16O (140.23 g/mol) 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 5.36-5.33 (m, 1H), 3.61 (dd, 2JHH = 10.5 Hz, 3JHH = 7.4 Hz, 
1H), 3.54-3.49 (m, 1H), 2.35-2.30 (m, 1H), 2.02-1.92 (m, 2H), 1.90-1.78 (m, 1H), 1.64 (s, 3H), 
1.60-1.53 (m, 1H), 1.46-1.35 (m, 1H), 1.34-1.25 (m, 1H), 0.85 (d, 3JHH = 7.1 Hz, 3H), all trans. 
5.18-5.17 (m, 1H), 3.74 (dd, 2JHH = 10.6 Hz, 
3JHH = 4.2 Hz), 3.54-3.49 (m, 1H), 2.35-2.30 (m, 1H), 
2.02-1.92 (m, 2H), 1.90-1.78 (m, 1H), 1.64 (s, 3H), 1.60-1.53 (m, 1H), 1.46-1.35 (m, 1H), 1.34-1.25 
(m, 1H), 1.00 (d, 3JHH = 6.9 Hz, 3H), all cis. 
OH
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13C-NMR (100 MHz, CDCl3): δ (ppm) = 133.3, 127.3, 65.2, 39.7, 30.6, 30.0, 23.7, 21.2, 15.5, all 
trans. 
133.3, 127.2, 65.9, 43.2, 31.9, 29.3, 24.9, 20.8, 15.5, all cis. 
GC-MS (Method B, tR = 5.7 min (cis), 6.1 min (trans)): m/z (%) 140 (M
+, 11), 122 (39), 109 (37), 
108 (10), 107 (100), 94 (15), 93 (22), 91 (24), 82 (28), 81 (22), 79 (30), 77 (14), 67 (70), 55 (17), 43 
(14), 41 (25), all trans. 
IR: ṽ = 3307 (w), 2959 (m), 2923 (s), 2870 (m), 2833 (m), 1450 (m), 1377 (m), 1077 (m), 1034 
(m), 1013 (m), 842 (w). 
 
 
(2,4-Dimethylcyclohex-3-en-1-yl)methyl acetate (125) 
Acetic anhydride (0.15 g, 1.50 mmol, 1.05 eq.) was added to a solution of (2,4-dimethylcyclohex-3-
en-1-yl)methanol 124 (0.20 g, 1.43 mmol, 1.0 eq.) in pyridine (1 mL) at 0 °C. After addition, the 
mixture was stirred for seven hours at room temperature. The reaction mixture was concentrated 
and purified by column chromatography (silica gel, 2 cm × 15 cm, cyclohexane:EtOAc = 49:1) to 
obtain the product as a colorless liquid (0.19 g, 71%). The product was obtained as a mixture of the 
cis- and trans-product (3:1 in favour of the trans). 
 
C11H18O2 (182.26 g/mol) 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 5.33-5.30 (m, 1H), 3.98 (d, 3JHH = 7.6 Hz, 2H), 2.33-2.28 
(m, 1H), 2.05 (s, 3H), 2.01-1.90 (m, 3H), 1.64 (s, 3H), 1.58-1.52 (m, 1H), 1.49-1.39 (m, 1H), 0.85 
(d, 3JHH = 7.1 Hz, 3H) all trans. 
5.17-5.16 (m, 1H), 4.14 (dd, 2JHH = 10.8 Hz, 
3JHH = 4.3 Hz, 1H), 3.97-3.93 (m, 1H), 2.33-2.28 (m, 
1H), 2.05 (s, 3H), 2.01-1.90 (m, 3H), 1.64 (s, 3H), 1.58-1.52 (m, 1H), 1.49-1.39 (m, 1H), 1.00 (d, 
3JHH = 6.9 Hz, 3H) all cis. 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 171.5, 133.1, 126.9, 66.5, 36.1, 30.8, 29.6, 23.6, 21.4, 
21.2, 15.7 trans. 
171.5, 133.2, 126.8, 67.4, 39.9, 32.2, 29.0, 25.1, 23.6, 21.2, 20.7 all cis. 
GC-MS (Method B, tR = 8.0 min (cis), 8.5 min (trans)): m/z (%) 122 ([M
+60], 44), 107 (100), 94 
(19), 93 (31), 91 (17), 82 (14), 79 (22), 67 (26), 43 (43), 41 (13) all trans. 
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IR: ṽ = 2958 (w), 2913 (w), 2873 (w), 2834 (w), 1740 (s), 1451 (w), 1366 (m), 1232 (s), 1034 (m). 
 
 
Ethyl (E)-5-methylhexa-2,4-dienoate (130) 
Under inert atmosphere (carbethoxymethylene)triphenylphosphorane 129 (2.43 g, 6.99 mmol, 
1.0 eq.) was added to a solution 3-methyl-2-butenal 128 (0.58 g, 6.85 mmol, 1.0 eq.) in absolute 
toluene (16 mL) and the solution was stirred under reflux for five hours. Water (20 mL) was added 
to the reaction mixture and the phases were separated. The aqueous phase was extracted with ether 
(3 x 20 mL) and the combined organic phases were dried over sodium sulfate and concentrated. The 
crude product was obtained as a 6:1 mixture of the E- and the Z-isomer with the desired E-isomer as 
the major product. The isomers could be purified by column chromatography (silica gel, 
3 cm × 15 cm, cyclohexane:EtOAc=49:1) to obtain the E-isomer as a colorless liquid (0.78 g, 75%). 
 
C9H14O2 (154.21 g/mol) 
Analytical data for the E-isomer: 
TLC: Rf  = 0.34 (cyclohexane:EtOAc = 19:1, UV). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 7.56 (dd, 3JHH = 15.1 Hz, 3JHH = 11.6 Hz, 1H), 5.99-5.96 
(m, 1H), 5.75 (d, 3JHH = 15.1 Hz, 1H), 4.20 (q, 
3JHH = 7.1 Hz, 2H), 1.89 (s, 3H), 1.87 (s, 3H), 1.29 (t, 
3JHH = 7.1 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 167.9, 146.4, 141.1, 123.8, 118.7, 60.2, 26.7, 19.1, 14.5. 
GC-MS (Method B, tR = 6.6 min): m/z (%) 154 (M
+, 32), 139 (22), 111 (50), 109 (36), 81 (100), 80 
(29), 79 (38), 53 (15), 41 (22). 
IR: ṽ = 2978 (w), 2908 (w), 1709 (s), 1637 (s), 1444 (w), 1366 (m), 1275 (s), 1212 (m), 1138 (s), 
991 (m), 968 (m), 880 (w). 
 
Analytical data for the Z-isomer: 
TLC: Rf  = 0.43 (cyclohexane:EtOAc = 19:1, UV). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 7.21-7.16 (m, 1H), 6.85 (t, 3JHH = 11.7 Hz, 1H), 5.55 (d, 
3JHH = 11.7 Hz, 1H), 4.18 (q, 
3JHH = 7.1 Hz, 2H), 1.91 (s, 3H), 1.85 (s, 3H), 1.29 (t, 
3JHH = 7.1 Hz, 
3H).
O
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13C-NMR (100 MHz, CDCl3): δ (ppm) = 167.0, 146.8, 140.7, 122.1, 114.8, 59.9, 27.0, 18.4, 14.5. 
GC-MS (Method B, tR = 6.2 min): m/z (%) 154 (M
+, 32), 139 (23), 111 (54), 109 (36), 81 (100), 80 
(29), 79 (40), 53 (15), 41 (23). 
IR: ṽ = 2979 (w), 2908 (w), 1710 (s), 1634 (s), 1595 (m), 1419 (m), 1203 (s), 1163 (s), 1043 (m), 
820 (m). 
 
 
(E)-5-Methylhexa-2,4-dien-1-ol 
Under inert atmosphere, DIBALH (1 M in toluene, 8.6 mL, 8.60 mmol, 2.2 eq.) was added to a 
solution of ethyl (E)-5-methylhexa-2,4-dienoate 130 (0.60 g, 3.89 mmol, 1.0 eq.) in absolute 
toluene (40 mL) at 78 °C and stirred for one hour at room temperature. Saturated ammonium 
chloride-solution (20 mL) was added and the reaction mixture was filtrated over celite. The aqueous 
phase was separated and extracted with methylene chloride (3 x 20 mL). The combined organic 
phases were washed with brine (30 mL), dried over sodium sulfate and the solvent was removed to 
obtain the product as a colorless liquid (0.38 g, 87%). 
 
C7H12O (112.17 g/mol) 
TLC: Rf  = 0.24 (cyclohexane:EtOAc = 4:1, UV). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 6.46 (ddt, 3JHH = 15.1 Hz, 3JHH = 10.9 Hz, 4JHH = 1.3 Hz, 
1H), 5.84 (d, 3JHH = 10.9 Hz, 1H), 5.71 (dt, 
3JHH = 15.1 Hz, 
3JHH = 6.1 Hz, 1H), 4.18 (d, 
3JHH = 5.5 
Hz, 2H), 1.78 (s, 3H), 1.76 (s, 3H), 1.35 (brs, 1H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 136.5, 129.1, 128.6, 124.3, 64.0, 26.2, 18.4 
 
 
(E)-5-Methylhexa-2,4-dienal (131) [69f] 
Dess-Martin-periodinane (11.2 g, 25.7 mmol, 1.3 eq.) was added to a solution of (E)-5-methylhexa-
2,4-dien-1-ol (2.20 g, 19.6 mmol, 1.0 eq.) in DMSO (50 mL) and the reaction mixture was stirred 
overnight at room temperature. Saturated ammonium chloride-solution (150 mL) was added and the 
reaction mixture was filtrated over celite. The aqueous phase was separated and extracted with 
O
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methylene chloride (3 x 120 mL). The combined organic phases were washed with brine (150 mL), 
dried over sodium sulfate and the solvent was removed. The crude product was purified by column 
chromatography (silica gel, 4 cm × 15 cm, pentane:ether = 9:1) to obtain the product as a yellow 
liquid (1.46 g, 68%). 
 
C7H10O (110.16 g/mol) 
TLC: Rf  = 0.49 (cyclohexane:EtOAc = 4:1, UV). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 9.56 (d, 3JHH = 8.0 Hz, 1H), 7.38 (dd, 3JHH = 15.0 Hz, 
3JHH = 11.5 Hz, 1H), 6.16-6.12 (m, 1H), 6.06 (dd, 
3JHH = 15.0 Hz, 
3JHH = 8.0 Hz, 1H), 1.94 (s, 3H), 
1.93 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 194.3, 149.6, 148.8, 129.8, 124.4, 27.0, 19.3. 
GC-MS (Method A, tR = 9.2 min): m/z (%) 110 (M
+, 21), 95 (100), 79 (16), 77 (10), 67 (30), 53 
(12), 41 (33). 
IR: ṽ = 2975 (w), 2911 (w), 2810 (w), 2714 (w), 1675 (s), 1626 (s), 1441 (m), 1378 (m), 1250 (m), 
1179 (m), 1126 (s), 982 (m), 877 (m), 623 (m). 
 
 
2-((1S,2R,3S)-5-Methyl-2-nitro-1,2,3,6-tetrahydro-[1,1'-biphenyl]-3-yl)acetaldehyde (126) [69f] 
trans-β-Nitrostyrene 132 (257 mg, 1.72 mmol, 1.0 eq.), ortho-fluorobenzoic acid (48.2 mg, 
0.34 mmol, 0.2 eq.) and (S)-()-α,α-diphenyl-2-pyrrolidinemethanol trimethylsilyl ether 71 
(112 mg, 0.34 mmol, 0.2 eq.) were added to a solution of (E)-5-methylhexa-2,4-dienal 131 (380 mg, 
3.45 mmol, 2.0 eq.) in chloroform (10 mL) and stirred for three hours at 55 °C under inert 
atmosphere. The reaction mixture was concentrated and purified by column chromatography (silica 
gel, 2 cm × 17 cm, cyclohexane:EtOAc = 9:1) to obtain the product as a yellow liquid (340 mg, 
76%). 
 
C15H17NO3 (259.31 g/mol) 
TLC: Rf  = 0.37 (cyclohexane:EtOAc = 4:1, UV). 
Ph
NO2
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1H-NMR (400 MHz, CDCl3): δ (ppm) = 9.77 (s, 1H), 7.34-7.20 (m, 5H), 5.26 (s, 1H), 4.74 (dd, 
3JHH = 11.6 Hz, 
3JHH = 10.1 Hz, 1H), 3.53-3.45 (m, 2H), 2.67 (ddd, 
2JHH = 17.8 Hz, 
3JHH = 8.8 Hz, 
4JHH = 1.7 Hz, 1H), 2.54 (ddd, 
2JHH = 17.8 Hz, 
3JHH = 3.6 Hz, 
4JHH = 0.9 Hz, 1H), 2.38-2.35 (m, 2H), 
1.72 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 199.4, 139.5, 135.0, 129.0, 127.9, 127.5, 120.7, 92.4, 
46.3, 45.4, 38.4, 36.8, 22.8. 
GC-MS (Method B, tR = 21.2 min): m/z (%) 212 ([M
+47], 45), 194 (47), 183 (10), 181 (10), 179 
(16), 170 (14), 169 (80), 168 (34), 167 (13), 155 (15), 154 (18), 153 (14), 141 (19), 129 (14), 128 
(19), 115 (19), 105 (10), 91 (100), 77 (21), 65 (12), 41 (11). 
HPLC (IC, nheptane:iPrOH 80:20, 1.0 mL/min, 25 °C): tr(major) = 25.3 min, tr(minor) = 24.0 min, 
93% ee, determined for the corresponding alcohol. 
IR: ṽ = 3031 (w), 2924 (w), 2851 (w), 1720 (w), 1547 (s), 1376 (m), 763 (m), 699 (s), 533 (w). 
[α]20D =  (c = 0.98, CHCl3). 
 
 
2-((1S,2R,3S)-5-Methyl-2-nitro-1,2,3,6-tetrahydro-[1,1'-biphenyl]-3-yl)ethan-1-ol (136) 
Sodium borohydride (53.5 mg, 1.41 mmol, 1.1 eq.) was added slowly to a solution of 2-((1S,2R,3S)-
5-methyl-2-nitro-1,2,3,6-tetrahydro-[1,1'-biphenyl]-3-yl)acetaldehyde 126 (340 mg, 1.31 mmol, 
1.0 eq.) in methanol (10 mL) at 0 °C. After addition, the reaction mixture was stirred at room 
temperature for three hours. Then, 2 M HCl-solution (10 mL) was added and stirred for a few 
minutes. The reaction mixture was extracted with ether (4 x 15 mL). The combined organic phases 
were washed with saturated NaHCO3-solution (15 mL) and water (15 mL), dried over sodium 
sulfate and concentrated. The crude product was purified by column chromatography (silica gel, 
3 cm × 15 cm, cyclohexane:EtOAc = 4:1) to obtain the product as a yellow solid (300 mg, 88%). 
 
C15H19NO3 (261.32 g/mol) 
TLC: Rf  = 0.33 (cyclohexane:EtOAc = 4:1, UV). 
Ph
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1H-NMR (400 MHz, CDCl3): δ (ppm) = 7.33-7.29 (m, 2H), 7.26-7.20 (m, 3H), 5.38 (s, 1H), 4.77 
(dd, 3JHH = 11.6 Hz, 
3JHH = 10.1 Hz, 1H), 3.82-3.71 (m, 2H), 3.44 (dt, 
3JHH = 11.6 Hz, 
3JHH = 8.7 Hz, 
1H), 3.11 (brs, 1H), 2.35 (d, 3JHH = 8.7 Hz, 2H), 1.81-1.75 (m, 1H), 1.74 (s, 3H), 1.68-1.61 (m, 1H), 
1.35 (brs, 1H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 139.8, 134.3, 129.0, 127.8, 127.5, 121.5, 93.4, 59.8, 45.8, 
39.2, 38.5, 35.2, 22.9. 
IR: ṽ = 3359 (w), 3035 (w), 2918 (w), 2864 (w), 1542 (s), 1455 (w), 1370 (m), 1049 (m), 760 (m), 
696 (m), 545 (m). 
[α]20D =  (c = 0.91, CHCl3). 
 
 
2-((1S,2R,3S)-5-Methyl-2-nitro-1,2,3,6-tetrahydro-[1,1'-biphenyl]-3-yl)ethyl acetate (138) 
Acetic anhydride (123 mg, 1.21 mmol, 1.05 eq.) was added to a solution of 2-((1S,2R,3S)-5-methyl-
2-nitro-1,2,3,6-tetrahydro-[1,1'-biphenyl]-3-yl)ethan-1-ol 136 (300 mg, 1.15 mmol 1.0 eq.) in 
pyridine (1.0 mL) in a round bottom flask at 0 °C. After addition the mixture was stirred for 72 
hours at room temperature. The reaction mixture was concentrated and the crude product was 
purified by column chromatography (silica gel, 2 cm × 18 cm, cyclohexane:EtOAc = 19:1) to obtain 
the product as a colorless oil (150 mg, 43%). 
 
C17H21NO4 (303.36 g/mol) 
TLC: Rf  = 0.34 (cyclohexane:EtOAc = 4:1, UV). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 7.33-7.30 (m, 2H), 7.27-7.20 (m, 3H), 5.35 (s, 1H), 4.71 
(dd, 3JHH = 11.6 Hz, 
3JHH = 10.1 Hz, 1H), 4.26-4.12 (m, 2H), 3.44 (dt, 
3JHH = 11.6 Hz, 
3JHH = 8.7 Hz, 
1H), 3.07 (brs, 1H), 2.34 (d, 3JHH = 8.7 Hz, 2H), 2.06 (s, 3H), 1.91-1.83 (m, 1H), 1.74 (s, 3H), 1.72-
1.63 (m, 1H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 171.2, 139.6, 134.7, 129.0, 127.9, 127.5, 120.8, 92.9, 
61.0, 45.7, 39.2, 38.4, 31.2, 27.1, 21.1. 
Ph
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GC-MS (Method D, tR = 12.1 min): m/z (%) 256 ([M
+47], 1), 197 (25,), 196 (100), 182 (12), 181 
(75), 169 (31), 168 (17), 167 (12), 155 (16), 154 (10), 141 (15), 129 (11), 128 (11), 115 (11), 105 
(14), 91 (73), 77 (11), 43 (42). 
 
 
Ethyl (2E,4Z)-4-phenylhepta-2,4-dienoate (134) 
Under inert atmosphere (carbethoxymethylene)triphenylphosphorane 129 (6.75 g, 19.4 mmol, 
1.0 eq.) was added to a solution of (E)-2-phenylpent-2-enal 133 (3.00 g, 18.2 mmol, 1.0 eq.) in 
absolute toluene (45 mL) and the solution was stirred under reflux for five hours. Water (60 mL) 
was added to the reaction mixture and the phases were separated. The aqueous phase was extracted 
with ether (3 x 60 mL) and the combined organic phases were dried over sodium sulfate and 
concentrated. The crude product was redissolved in hot cyclohexane (20 mL) and cooled to room 
temperature. The precipitate was filtered off and the filtrate was concentrated. The remaining crude 
product was purified by column chromatography (silica gel, 4 cm × 17 cm, 
cyclohexane:EtOAc = 49:1) to obtain the product as a colorless liquid (3.30 g, 79%). 
 
C15H18O2 (230.31 g/mol) 
TLC: Rf  = 0.52 (cyclohexane:EtOAc = 19:1, UV). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 7.50 (d, 3JHH = 15.6 Hz, 1H), 7.40-7.36 (m, 2H), 7.34-7.29 
(m, 1H), 7.10-7.08 (m, 2H), 6.12 (t, 3JHH = 7.6 Hz, 1H), 5.38 (d, 
3JHH = 15.6 Hz, 1H), 4.16 (q, 
3JHH = 7.1 Hz, 2H), 2.01 (quint, 
3JHH = 7.5 Hz, 2H), 1.25 (t, 
3JHH = 7.1 Hz, 3H), 0.97 (t, 
3JHH = 7.5 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 167.6, 148.8, 144.3, 139.7, 136.7, 129.4, 128.6, 127.5, 
118.9, 60.3, 23.2, 14.4, 13.9. 
GC-MS (Method B, tR = 16.3 min): m/z (%) 230 (M
+, 30), 201 (17), 185 (20), 173 (19), 158 (14), 
157 (100), 156 (60), 155 (31), 142 (35), 141 (57), 129 (72), 128 (31), 127 (11), 115 (53), 91 (21), 77 
(17).  
 
 
O
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(2E,4Z)-4-Phenylhepta-2,4-dien-1-ol 
Under inert atmosphere, DIBALH (1 M in toluene, 31.5 mL, 31.5 mmol, 2.2 eq.) was added to a 
solution of ethyl (2E,4Z)-4-phenylhepta-2,4-dienoate 134 (3.30 g, 14.3 mmol, 1.0 eq.) in absolute 
toluene (150 mL) at 78 °C and stirred for 16 hours at room temperature. Saturated ammonium 
chloride-solution (90 mL) was added and the reaction mixture was filtrated over celite. The aqueous 
phase was separated and extracted with methylene chloride (3 x 90 mL). The combined organic 
phases were washed with brine (120 mL), dried over sodium sulfate and the solvent was removed to 
obtain the product as a colorless liquid (2.26 g, 84%). 
 
C13H16O (188.27 g/mol) 
TLC: Rf  = 0.23 (cyclohexane:EtOAc = 9:1, UV). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 7.39-7.34 (m, 2H), 7.31-7.27 (m, 1H), 7.13-7.10 (m, 2H), 
6.45 (d, 3JHH = 15.5 Hz, 1H), 5.72 (t, 
3JHH = 7.5 Hz, 1H), 5.30 (dt, 
3JHH = 15.5 Hz, 
3JHH = 5.8 Hz, 
1H), 4.15 (d, 3JHH = 5.8 Hz, 2H), 1.93 (quint, 
3JHH = 7.5 Hz, 2H), 1.26 (brs, 1H), 0.93 (t, 
3JHH = 7.5 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 140.0, 138.3, 135.9, 135.8, 129.6, 129.0, 128.3, 127.0, 
63.8, 22.6, 14.4. 
GC-MS (Method D, tR = 7.3 min): m/z (%) 188 (M
+, 25), 170 (10), 157 (63), 155 (28), 144 (21), 
143 (10), 142 (21), 140 (42), 131 (25), 130 (13), 129 (100), 128 (42), 127 (14), 118 (21), 117 (28), 
116 (13), 115 (47), 91 (48), 77 (19). 
IR: ṽ = 3309 (w), 3054 (w), 3021 (w), 2963 (m), 2930 (m), 2871 (m), 1670 (w), 1493 (m), 1441 
(m), 969 (m), 770 (w), 703 (s). 
 
 
(2E,4Z)-4-Phenylhepta-2,4-dienal (135) [69f] 
Dess-Martin-periodinane (8.74 g, 20.0 mmol, 1.8 eq.) was added to a solution of (2E,4Z)-4-
phenylhepta-2,4-dien-1-ol (2.09 g, 11.1 mmol, 1.0 eq.) in DMSO (30 mL) and the reaction mixture 
was stirred overnight at room temperature. Saturated ammonium chloride-solution (90 mL) was 
O
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added and the reaction mixture was filtrated over celite. The aqueous phase was extracted with 
methylene chloride (3 x 90 mL). The combined organic phases were washed with brine (120 mL), 
dried over sodium sulfate and the solvent was removed. The crude product was purified by column 
chromatography (silica gel, 3 cm × 15 cm, pentane:ether = 19:1) to obtain the product as a yellow 
liquid (1.19 g, 58%). 
 
C13H14O (186.25 g/mol) 
TLC: Rf  = 0.24 (pentane:ether = 19:1, UV). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 9.58 (d, 3JHH = 7.9 Hz, 1H), 7.41-7.31 (m, 3H), 7.29 (d, 
3JHH = 15.5 Hz, 1H), 7.10-7.08 (m, 2H), 6.25 (t, 
3JHH = 7.6 Hz, 1H), 5.71 (dd, 
3JHH = 15.5 Hz, 
3JHH = 7.9 Hz, 1H), 2.07 (quint, 
3JHH = 7.5 Hz, 2H), 1.01 (t, 
3JHH = 7.5 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 194.0, 156.7, 146.7, 140.2, 136.1, 129.8, 129.2, 128.7, 
127.8 23.5, 13.7. 
GC-MS (Method B, tR = 13.4 min): m/z (%) 186 (M
+, 18), 158 (14), 157 (100), 142 (15), 141 (15), 
130 (15), 129 (47), 128 (43), 127 (13), 115 (40), 91 (14), 77 (13). 
IR: ṽ = 2967 (w), 2932 (w), 2873 (w), 2812 (w), 2724 (w), 1676 (s), 1618 (m), 1119 (m), 972 (m), 
704 (m). 
 
 
2-((2'S,3'R,4'S,5'R)-5'-Methyl-3'-nitro-2',3',4',5'-tetrahydro-[1,1':4',1''-terphenyl]-2'-
yl)acetaldehyde (127) [69f] 
trans-β-Nitrostyrene 132 (0.48 g, 3.20 mmol, 1.0 eq.), ortho-fluorobenzoic acid (0.09 g, 0.64 mmol, 
0.2 eq.) and (S)-()-α,α-diphenyl-2-pyrrolidinemethanol trimethylsilyl ether 71 (0.21 g, 0.64 mmol, 
0.2 eq.) were added to a solution of (2E,4Z)-4-phenylhepta-2,4-dienal 135 (1.19 g, 6.39 mmol, 
2.0 eq.) in chloroform (16 mL) and stirred for 2 hours at 55 °C under inert atmosphere. The reaction 
mixture was concentrated and purified by column chromatography (silica gel, 3 cm × 17 cm, 
cyclohexane:EtOAc = 49:1) to obtain the product as a yellow liquid (0.68 g, 63%). 
 
Ph
NO2Ph
O
                                                                                                                                           CHAPTER 5 
121 
C21H21NO3 (335.40 g/mol) 
TLC: Rf  = 0.23 (cyclohexane:EtOAc = 49:1, UV). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 9.49 (s, 1H), 7.36-7.27 (m, 6H), 7.24-7.20 (m, 4H), 5.98 
(dd, 3JHH = 5.7 Hz, 
3JHH = 2.4 Hz, 1H), 5.53 (dd, 
3JHH = 12.3 Hz, 
3JHH = 9.4 Hz, 1H), 3.82 (dd, 
3JHH = 12.3 Hz, 
3JHH = 5.7 Hz, 1H), 3.80-3.75 (m, 1H), 2.80-2.70 (m, 2H), 2.56 (dd, 
2JHH = 18.8 Hz, 
3JHH = 3.7 Hz, 1H), 0.99 (d, 
3JHH = 7.2 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 199.1, 140.1, 138.1, 136.1, 132.7, 128.8, 128.7, 128.1, 
127.8, 127.6, 127.2, 87.7, 47.9, 43.4, 39.9, 36.5, 15.7. 
GC-MS (Method D, tR = 18.1 min): m/z (%) 305 ([M
+30], 4), 270 (24), 269 (84), 261 (22), 255 
(14), 254 (24), 245 (38), 244 (60), 230 (16), 229 (17), 215 (18), 169 (11), 167 (13), 165 (14), 155 
(13), 153 (12), 152 (13), 141 (15), 129 (23), 128 (27), 115 (38), 105 (38), 103 (10), 91 (100), 77 
(17). 
HPLC (IC, nheptane:iPrOH 80:20, 1.0 mL/min, 25 °C): tr(major) = 16.5 min, tr(minor) = 12.3 min, 
93% ee, determined for the corresponding alcohol. 
IR: ṽ = 3027 (w), 2957 (w), 2903 (w), 2876 (w), 2735 (w), 1725 (m), 1543 (s), 1370 (w), 749 (m), 
697 (s), 522 (w). 
[α]20D = .2 (c = 0.87, CHCl3). 
 
 
2-((2'S,3'R,4'S,5'R)-5'-Methyl-3'-nitro-2',3',4',5'-tetrahydro-[1,1':4',1''-terphenyl]-2'-yl)ethan-
1-ol (137) 
Sodium borohydride (72.4 mg, 1.91 mmol, 1.4 eq.) was added slowly to a solution of 2-
((2'S,3'R,4'S,5'R)-5'-methyl-3'-nitro-2',3',4',5'-tetrahydro-[1,1':4',1''-terphenyl]-2'-yl)acetaldehyde 
127 (450 mg, 1.34 mmol, 1.0 eq.) in methanol (15 mL) at 0 °C. After addition, the reaction mixture 
was stirred at room temperature for 16 hours. Then, 2 M HCl-solution (15 mL) was added and 
stirred for a few minutes. The aqueous phase was extracted with ether (4 x 20 mL). The combined 
organic phases were washed with saturated NaHCO3-solution (20 mL) and water (20 mL), dried 
over sodium sulfate and concentrated. The product was obtained as a yellow solid (400 mg, 89%). 
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C21H23NO3 (337.42 g/mol) 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 7.38-7.23 (m, 10H), 6.08 (dd, 3JHH = 6.0 Hz, 3JHH = 2.1 Hz, 
1H), 5.75 (dd, 3JHH = 12.5 Hz, 
3JHH = 9.1 Hz, 1H), 3.75 (dd, 
3JHH = 12.5 Hz, 
3JHH = 5.2 Hz, 1H), 
3.69-3.65 (m, 1H), 3.62-3.58 (m, 1H), 3.56-3.51 (m, 1H), 2.70-2.63 (m, 1H), 1.83-1.79 (m, 2H), 
1.23 (brs, 1H), 0.93 (d, 3JHH = 7.2 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 140.5, 138.2, 137.1, 133.4, 128.7, 128.7, 128.3, 127.6, 
127.5, 126.8, 87.8, 59.6, 48.2, 41.8, 36.5, 32.1, 16.1. 
GC-MS (Method D, tR = 18.1 min): m/z (%) 289 ([M
+48], 13), 288 (52), 274 (23), 273 (100), 240 
(12), 239 (11), 115 (11). 
IR: ṽ = 3418 (w), 3029 (w), 2961 (w), 2928 (w), 2876 (w), 1544 (s), 1372 (w), 1095 (w), 751 (m), 
702 (s), 522 (w). 
[α]20D =  (c = 0.68, CHCl3). 
 
 
2-((2'S,3'R,4'S,5'R)-5'-Methyl-3'-nitro-2',3',4',5'-tetrahydro-[1,1':4',1''-terphenyl]-2'-yl)ethyl 
acetate (139) 
Acetic anhydride (89.0 mg, 0.87 mmol, 1.05 eq.) was added to a solution of 2-((2'S,3'R,4'S,5'R)-5'-
methyl-3'-nitro-2',3',4',5'-tetrahydro-[1,1':4',1''-terphenyl]-2'-yl)ethan-1-ol 137 (280 mg, 0.83 mmol 
1.0 eq.) in pyridine (0.5 mL) in a round bottom flask at 0 °C. After addition the mixture was stirred 
for 16 hours at room temperature. The reaction mixture was concentrated and the crude product was 
purified by column chromatography (silica gel, 3 cm × 18 cm, cyclohexane:EtOAc = 9:1) to obtain 
the product as a colorless oil (250 mg, 79%). 
 
C23H25NO4 (379.46 g/mol) 
TLC: Rf  = 0.33 (cyclohexane:EtOAc = 9:1, UV). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 7.38-7.21 (m, 10H), 6.07 (dd, 3JHH = 6.0 Hz, 3JHH = 2.0 Hz, 
1H), 5.51 (dd, 3JHH = 12.4 Hz, 
3JHH = 9.3 Hz, 1H), 3.98-3.92 (m, 2H), 3.75 (dd, 
3JHH = 12.4 Hz, 
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3JHH = 5.2 Hz, 1H), 3.69 (brs, 1H), 2.72-2.64 (m, 1H), 2.06 (s, 3H), 1.97-1.89 (m, 1H), 1.88-1.80 
(m, 1H), 0.92 (d, 3JHH = 7.2 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 170.8, 140.1, 138.0, 136.7, 133.6, 128.8, 128.7, 128.2, 
127.7, 127.6, 126.8, 87.4, 60.9, 48.1, 41.7, 36.4, 28.4, 21.2, 16.1. 
GC-MS (Method D, tR = 22.3 min): m/z (%) 332 ([M
+47], 1), 289 (12), 272 (34), 271 (100), 257 
(23), 256 (13), 245 (20), 244 (25), 243 (12), 215 (11), 181 (23), 167 (13), 165 (13), 155 (12), 153 
(10), 141 (13), 129 (19), 128 (18), 117 (11), 115 (21), 105 (30), 91 (62), 43 (47). 
IR: ṽ = 3031 (w), 2967 (w), 2953 (w), 2924 (w), 2876 (w), 1740 (s), 1552 (s), 1377 (m), 1220 (s), 
1056 (m), 763 (m), 696 (s), 534 (w). 
[α]20D = 9.8 (c = 1.31, CHCl3). 
 
 
 5.5  Synthesis of NeoPHOX catalysts 
 
Methyl (3-chloro-2,2-dimethylpropanoyl)-L-serinate (158) [70] 
Serine methylester hydrochloride 157 (5.00 g, 32.1 mmol, 1.0 eq.) was dissolved in methylene 
chloride (50 mL) and triethylamine (9.74 g, 96.3 mmol, 3.0 eq.) was added at 0 °C followed by 
slow addition of 3-chloropivaloyl chloride 156 (4.98 g, 32.1 mmol, 1.0 eq.). The reaction mixture 
was stirred for 18 hours at room temperature. Saturated NaHCO3-solution (10 mL) was added to the 
mixture and the phases were separated. The aqueous phase was extracted with ether (3 x 30 mL) 
and the combined organic phases were dried over sodium sulfate and concentrated. The crude 
product was purified by column chromatography (silica gel, 7 cm × 15 cm, EtOAc) to obtain the 
product as a pale yellow oil (6.85 g, 90%). 
 
C9H16ClNO4 (237.68 g/mol) 
TLC: Rf  = 0.70 (EtOAc, KMnO4). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 6.71 (d, 3JHH = 5.0 Hz, 1H), 4.66 (dt, 3JHH = 7.0 Hz, 
3JHH = 3.5 Hz, 1H), 4.02-3.93 (m, 2H), 3.80 (s, 3H), 3.68 (d, 
2JHH = 10.7 Hz, 1H), 3.57 (d, 
2JHH = 10.7 Hz, 1H), 2.48 (t, 
3JHH = 6.0 Hz, 1H), 1.35 (s, 3H), 1.33 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 175.4, 171.0, 63.4, 55.1, 53.0, 52.9, 44.5, 23.7, 23.2.
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GC-MS (Method B, tR = 14.9 min): m/z (%) 220 ([M
+, 1), 207 (15), 180 (10), 178 (33), 177 
(10), 175 (31), 160 (20), 136 (23), 121 (14), 119 (45), 118 (10), 93 (31), 91 (100), 88 (25), 86 (17), 
60 (16), 57 (10), 56 (47), 55 (55), 42 (21), 41 (31). 
IR: ṽ = 3359 (w), 2954 (w), 2884 (w), 1739 (s), 1645 (s), 1519 (s), 1438 (m), 1209 (s), 1078 (m). 
[α]20D = 14.5 (c = 1.04, CHCl3). 
 
 
Methyl (S)-2-(1-chloro-2-methylpropan-2-yl)-4,5-dihydrooxazole-4-carboxylate (159) [70] 
Under inert atmosphere methyl (3-chloro-2,2-dimethylpropanoyl)-L-serinate 158 (6.60 g, 
27.8 mmol, 1.0 eq.) was dissolved in absolute methylene chloride (130 mL). DAST (4.93 g, 
30.6 mmol, 1.1 eq.) was added dropwise at 78 °C and the reaction mixture was stirred at this 
temperature for one hour. Anhydrous potassium carbonate (5.76 g, 41.7 mmol, 1.5 eq.) was added 
and the mixture was warmed to room temperature. The reaction mixture was poured into saturated 
NaHCO3-solution (140 mL) and the phases were separated. The aqueous phase was extracted with 
methylene chloride (3 x 140 mL) and the combined organic phases were dried over sodium sulfate 
and concentrated. The product was obtained as a yellow oil (6.00 g, 98%) and was used without 
further purification. 
 
C9H14ClNO3 (219.66 g/mol) 
TLC: Rf  = 0.20 (cyclohexane:EtOAc = 4:1, KMnO4). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 4.75 (dd, 3JHH = 10.5 Hz, 3JHH = 7.7 Hz, 1H), 4.51 (dd, 
2JHH = 8.7 Hz, 
3JHH = 7.7 Hz, 1H), 4.41 (dd, 
3JHH = 10.5 Hz, 
2JHH = 8.7 Hz, 1H), 3.78 (s, 3H), 3.65 
(d, 2JHH = 10.8 Hz, 1H), 3.60 (d, 
2JHH = 10.8 Hz, 1H), 1.33 (s, 3H), 1.32 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 173.4, 171.7, 69.8, 68.3, 52.8, 52.4, 39.2, 23.9, 23.8. 
GC-MS (Method B, tR = 10.8 min): m/z (%) 184 ([M
+35], 11), 162 (32), 160 (100), 132 (17), 70 
(67), 55 (26), 42 (18), 41 (13). 
IR: ṽ = 2977 (w), 2954 (w), 1741 (s), 1651 (s), 1437 (m), 1206 (s), 1180 (s), 1118 (m), 982 (m) 751 
(w). 
[α]20D = 108.4 (c = 0.95, CHCl3). 
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(S)-2-(2-(1-Chloro-2-methylpropan-2-yl)-4,5-dihydrooxazol-4-yl)propan-2-ol (160) [70] 
Under inert atmosphere methyl (S)-2-(1-chloro-2-methylpropan-2-yl)-4,5-dihydrooxazole-4-
carboxylate 159 (785 g, 3.57 mmol, 1.0 eq.) was dissolved in absolute THF (15 mL) and a solution 
of methylmagnesium chloride in THF (3 M, 2.4 mL, 7.14 mmol, 2.0 eq.) was added dropwise at 
0 °C and the reaction mixture was stirred for 1.5 hours at this temperature. Saturated ammonium 
chloride-solution (20 mL) was added and the phases were separated. The aqueous phase was 
extracted with ether (3 x 20 mL) and the combined organic phases were dried over sodium sulfate 
and concentrated. The crude product was purified by column chromatography (silica gel, 
3 cm × 18 cm, cyclohexane:EtOAc = 4:1) to obtain the product as a colorless liquid (500 mg, 64%). 
 
C10H18ClNO2 (219.71 g/mol) 
TLC: Rf  = 0.20 (cyclohexane:EtOAc = 3:1, KMnO4). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 4.27-4.20 (m, 2H), 4.03 (dd, 3JHH = 10.0 Hz, 3JHH = 7.7 Hz, 
1H), 3.64 (d, 2JHH = 10.7 Hz, 1H), 3.60 (d, 
2JHH = 10.7 Hz, 1H), 1.85 (s, 1H), 1.33 (s, 3H), 1.30 (s, 
3H), 1.28 (s, 3H), 1.12 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 171.7, 75.3, 71.5, 69.1, 52.9, 39.2, 27.0, 24.9, 24.1, 23.9. 
GC-MS (Method B, tR = 9.9 min): m/z (%) 204 ([M
+15], 5), 163 (13), 161 (40), 126 (22), 121 
(17), 119 (51), 93 (32), 91 (100), 59 (35), 56 (10), 55 (34), 43 (40), 42 (10), 41 (19). 
IR: ṽ = 3255 (w), 2981 (m), 2965 (w), 2929 (w), 1649 (s), 1470 (m), 1362 (m), 1183 (s), 1145 (s), 
1118 (s), 978 (s), 928 (m), 870 (m), 755 (m), 524 (m), 465 (m). 
[α]20D = 52.2 (c = 1.04, CHCl3). 
 
 
 
 
 
 
 
NCl
O
OH
Experimental part                                                                                                                                     
126 
(S)-2-(2-(1-(Diphenylphosphanyl)-2-methylpropan-2-yl)-4,5-dihydrooxazol-4-yl)propan-2-ol 
(L12) [70] 
Under inert atmosphere (S)-2-(2-(1-chloro-2-methylpropan-2-yl)-4,5-dihydrooxazol-4-yl)propan-2-
ol 160 (520 mg, 2.37 mmol, 1.0 eq.) was dissolved in absolute THF (25 mL) and a solution of n-
butyllithium in THF (1.6 M, 1.48 mL, 2.37 mmol, 1.0 eq.) was added at 0 °C followed by a solution 
of potassium diphenylphosphide in THF (0.5 M, 4.74 mL, 2.37 mmol, 1.0 eq.). The reaction mixture 
was warmed to room temperature and stirred under reflux for 16 hours. The solvent was evaporated 
and the residue redissolved in ether (75 mL) and saturated ammonium chloride-solution (15 mL). 
The phases were separated and the aqueous phase was extracted with ether (3 x 50 mL). The 
combined organic layers were washed with brine (75 mL), dried over sodium sulfate and 
concentrated. The crude product was purified by column chromatography (silica gel, 3 cm × 16 cm, 
cyclohexane:EtOAc = 4:1) to obtain the product as a colorless liquid (400 mg, 46%). 
 
C22H28NO2P (369.44 g/mol) 
TLC: Rf  = 0.33 (cyclohexane:EtOAc = 2:1, UV). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 7.52-7.47 (m, 2H), 7.43-7.39 (m, 2H), 7.35-7.27 (m, 6H), 
4.25 (dd, 2JHH = 8.1 Hz, 
3JHH = 7.0 Hz, 1H), 4.03 (dd, 
3JHH = 10.0 Hz, 
2JHH = 8.1 Hz, 1H), 3.93 (dd, 
3JHH = 10.0 Hz, 
3JHH = 7.0 Hz, 1H), 2.59-2.54 (m, 2H), 2.37 (dd, 
2JHH = 14.1 Hz, 
2JHP = 3.5 Hz, 1H), 
1.32 (s, 3H), 1.27 (s, 3H), 1.23 (s, 3H), 1.11 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 173.9 (d, 3JCP = 1.8 Hz), 139.3 (d, 1JCP = 9.5 Hz), 138.8 
(d, 1JCP = 10.2 Hz), 133.3 (d, 
2JCP = 19.4 Hz), 132.9 (d, 
2JCP = 19.2 Hz), 128.8, 128.6, 128.6, 128.5, 
75.1, 71.7, 68.7, 41.4 (d, 1JCP = 14.0 Hz), 37.4 (d, 
2JCP = 17.6 Hz), 28.1 (d, 
3JCP = 7.4 Hz), 27.6, 
27.5 (d, 3JCP = 9.2 Hz), 25.1. 
31P{1H}-NMR (162 MHz, CDCl3): δ (ppm) = 21.4. 
GC-MS (Method D, tR = 16.4 min): m/z (%) 368 ([M
+1], 2), 311 (37), 310 (100), 292 (26), 228 
(14), 227 (91), 202 (14), 199 (12), 185 (11), 184 (13), 183 (37), 121 (35), 108 (15), 59 (12). 
IR: ṽ = 3370 (w), 3060 (w), 2974 (w), 2929 (w), 1641 (m), 1433 (m), 1370 (w), 1185 (m), 1130 
(m), 969 (m), 747 (m), 697 (s), 505 (m). 
[α]20D = 29.2 (c = 1.09, CHCl3). 
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(S)-4-(2-((tert-Butyldimethylsilyl)oxy)propan-2-yl)-2-(1-(diphenylphosphanyl)-2-
methylpropan-2-yl)-4,5-dihydrooxazole (L13) [70] 
Under inert atmosphere (S)-2-(2-(1-(diphenylphosphanyl)-2-methylpropan-2-yl)-4,5-dihydrooxazol-
4-yl)propan-2-ol L12 (300 mg, 0.81 mmol, 1.0 eq.) was dissolved in absolute methylene chloride 
(15 mL) and 2,6-lutidine (435 mg, 4.06 mmol, 5.0 eq.) was added dropwise. Then tert-
butyldimethylsilyl trifluoromethanesulfonate (429 mg, 1.62 mmol, 2.0 eq.) was added and the 
mixture was stirred for three hours at room temperature. The solvent was removed under high 
vacuum and the residue was redissolved in ether (10 mL). The precipitate was removed and the 
filtrate concentrated. The crude product was purified by column chromatography (silica gel, 
2 cm × 17 cm, cyclohexane:EtOAc = 9:1) to obtain the product as a colorless liquid (322 mg, 82%). 
 
C28H42NO2PSi (483.71 g/mol) 
TLC: Rf  = 0.56 (cyclohexane:EtOAc = 9:1, UV). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 7.47-7.43 (m, 4H), 7.34-7.27 (m, 6H), 4.17 (dd, 
2JHH = 6.9 Hz, 
3JHH = 5.7 Hz, 1H), 3.77-3.68 (m, 2H), 2.50 (dd, 
2JHH = 14.3 Hz, 
2JHP = 3.8 Hz, 1H), 
2.40 (dd, 2JHH = 14.3 Hz, 
2JHP = 3.3 Hz, 1H), 1.33 (s, 3H), 1.28 (s, 3H), 1.24 (s, 3H), 1.12 (s, 3H), 
0.81 (s, 9H), 0.06 (s, 6H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 173.1 (d, 3JCP = 3.3 Hz), 139.9 (d, 1JCP = 13.0 Hz), 139.7 
(d, 1JCP = 12.5 Hz), 133.3 (d, 
2JCP = 19.9 Hz), 132.9 (d, 
2JCP = 19.5 Hz), 128.5-128.4 (m), 76.1, 
74.8, 68.7, 41.2 (d, 1JCP = 16.8 Hz), 36.7 (d, 
2JCP = 16.8 Hz), 28.9, 27.7 (d, 
3JCP = 9.3 Hz), 27.2 (d, 
3JCP = 10.7 Hz), 25.9, 24.6, 18.2,2.0, 2.1. 
31P{1H}-NMR (162 MHz, CDCl3): δ (ppm) = 23.3. 
GC-MS (Method D, tR = 27.9 min): m/z (%) 483 ([M
+1], 1), 426 (29), 406, (32), 311 (23), 310 
(73), 274 (13), 227 (51), 199 (24), 183 (19), 173 (100), 121 (38), 115 (21), 75 (20), 73 (76). 
IR: ṽ = 3054 (w), 2955 (s), 2927 (s), 2897 (m), 2855 (s), 1657 (s), 1471 (m), 1433 (m), 1381 (m), 
1253 (s), 1162 (s), 1053 (s), 907 (w), 835 (s), 774 (s), 742 (m), 696 (s). 
[α]20D = 12.5 (c = 1.05, CHCl3). 
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Methyl (3-chloro-2,2-dimethylpropanoyl)-L-threoninate[70] 
Threonine methylester hydrochloride 161 (5.10 g, 30.1 mmol, 1.0 eq.) was dissolved in methylene 
chloride (50 mL) and triethylamine (9.14 g, 90.3 mmol, 3.0 eq.) was added at 0 °C followed by 
slow addition of 3-chloropivaloyl chloride 156 (4.67 g, 30.1 mmol, 1.0 eq.). The reaction mixture 
was stirred for 18 hours at room temperature. Saturated NaHCO3-solution (10 mL) was added to the 
mixture and the phases were separated. The aqueous phase was extracted with ether (3 x 30 mL) 
and the combined organic phases were dried over sodium sulfate and concentrated. The crude 
mixture was purified by column chromatography (silica gel, 7 cm × 15 cm, EtOAc) to obtain the 
product as a pale yellow oil (6.80 g, 90%). 
 
C10H18ClNO4 (251.71 g/mol) 
TLC: Rf  = 0.77 (EtOAc, KMnO4). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 6.53 (d, 3JHH = 8.3 Hz, 1H), 4.61 (dd, 3JHH = 8.7 Hz, 
3JHH = 2.4 Hz, 1H), 4.40-4.34 (m, 1H), 3.77 (s, 3H), 3.71 (d, 
2JHH = 10.8 Hz, 1H), 3.57 (d, 
2JHH = 10.8 Hz, 1H), 2.34 (d, 
3JHH = 4.8 Hz, 1H), 1.36 (s, 3H), 1.33 (s, 3H), 1.22 (d, 
3JHH = 6.4 Hz, 
3H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 175.5, 171.6, 68.1, 57.3, 52.7, 44.6, 27.0, 23.8, 23.3, 20.2 
GC-MS (Method B, tR = 15.2 min): m/z (%) 209 ([M
+42], 12), 207 (35), 192 (11), 177 (32), 175 
(100), 126 (33), 121 (12), 120 (10), 119 (35), 93 (28), 88 (59), 83 (11), 74 (12), 57 (10), 56 (41), 55 
(48), 45 (15), 41 (24). 
IR: ṽ = 3391 (m), 2975 (m), 1740 (s), 1648 (s), 1521 (s), 1438 (m), 1288 (m), 1209 (s), 1084 (m), 
1020 (m), 731 (w). 
[α]20D = 8.5 (c = 1.16, CHCl3). 
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Methyl (4S,5S)-2-(1-chloro-2-methylpropan-2-yl)-5-methyl-4,5-dihydrooxazole-4-carboxylate 
(162) [70] 
Under inert atmosphere methyl (3-chloro-2,2-dimethylpropanoyl)-L-threoninate (5.51 g, 
21.9 mmol, 1.0 eq.) was dissolved in absolute methylene chloride (100 mL). DAST (4.24 g, 
26.3 mmol, 1.2 eq.) was added dropwise at 78 °C and the reaction mixture was stirred at this 
temperature for one hour. Anhydrous potassium carbonate (4.54 g, 32.8 mmol, 1.5 eq.) was added 
and the reaction mixture was warmed to room temperature. The reaction mixture was poured into 
saturated NaHCO3-solution (100 mL) and the phases were separated. The aqueous phase was 
extracted with methylene chloride (3 x 100 mL) and the combined organic phases were dried over 
sodium sulfate and concentrated. The crude product was purified by column chromatography (silica 
gel, 4 cm × 18 cm, cyclohexane:EtOAc = 4:1) to obtain the product as a colorless liquid (4.48 g, 
88%). 
 
C10H16ClNO3 (233.69 g/mol) 
TLC: Rf  = 0.20 (cyclohexane:EtOAc = 4:1, KMnO4). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 4.92-4.85 (m, 1H), 4.78 (d, 3JHH = 10.0 Hz, 1H), 3.74 (s, 
3H), 3.65 (d, 2JHH = 10.8 Hz, 1H), 3.62 (d, 
2JHH = 10.8 Hz, 1H), 1.34 (s, 3H), 1.34 (s, 3H), 1.27 (d, 
3JHH = 6.4 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 173.3, 170.4, 77.9, 71.4, 52.4, 52.1, 39.1, 23.7, 23.7, 16.1. 
GC-MS (Method B, tR = 11.5 min): m/z (%) 198 ([M
+35], 13), 176 (31), 174 (97), 140 (12), 84 
(100), 57 (21), 55 (23), 41 (11). 
[α]20D = +51,7 (c = 1.12, CHCl3). 
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2-((4S,5S)-2-(1-Chloro-2-methylpropan-2-yl)-5-methyl-4,5-dihydrooxazol-4-yl)propan-2-ol 
(163) [70] 
Under inert atmosphere methyl (4S,5S)-2-(1-chloro-2-methylpropan-2-yl)-5-methyl-4,5-
dihydrooxazole-4-carboxylate 162 (337 mg, 1.44 mmol, 1.0 eq.) was dissolved in absolute THF 
(5 mL) and a solution of methylmagnesium chloride in THF (3 M, 0.96 mL, 2.88 mmol, 2.0 eq.) 
was added dropwise at 78 °C. The reaction mixture was stirred overnight while slowly warming 
up to room temperature in the cooling bath. Saturated ammonium chloride-solution (10 mL) was 
added and the phases were separated. The aqueous phase was extracted with ether (3 x 10 mL) and 
the combined organic phases were dried over sodium sulfate and concentrated. The crude product 
was purified by column chromatography (silica gel, 2 cm × 17 cm, cyclohexane:EtOAc = 3:1) to 
obtain the product as a yellow liquid (235 mg, 70%). 
 
C11H20ClNO2 (233.74 g/mol) 
TLC: Rf  = 0.20 (cyclohexane:EtOAc = 3:1, KMnO4). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 4.79-4.71 (m, 1H), 3.89 (d, 3JHH = 9.2 Hz, 1H), 3.63 (d, 
JHH = 1.7 Hz, 2H), 2.25 (s, 1H), 1.46 (d, 
3JHH = 6.8 Hz, 3H), 1.33 (s, 3H), 1.31 (s, 3H), 1.30 (s, 3H), 
1.27 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 171.1, 79.5, 76.1, 72.0, 52.7, 39.1, 28.5, 26.4, 23.9, 23.8, 
16.2. 
GC-MS (Method B, tR = 11.0 min): m/z (%) 218 ([M
+15], 3), 177 (12), 175 (34), 162 (10), 160 
(33), 119 (29), 93 (31), 91 (100), 84 (15), 83 (11), 59 (29), 57 (26), 56 (17), 55 (31), 43 (19), 41 
(17). 
IR: ṽ = 3427 (w), 2976 (m), 2934 (m), 2873 (w), 1656 (s), 1459 (w), 1385 (s), 1338 (m), 1117 (s), 
1023 (m), 945 (m), 830 (m), 751 (w). 
[α]20D = 14.3 (c = 1.02, CHCl3). 
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2-((4S,5S)-2-(1-(Diphenylphosphanyl)-2-methylpropan-2-yl)-5-methyl-4,5-dihydrooxazol-4-
yl)propan-2-ol (L14) [70] 
Under inert atmosphere 2-((4S,5S)-2-(1-chloro-2-methylpropan-2-yl)-5-methyl-4,5-dihydrooxazol-
4-yl)propan-2-ol 163 (514 mg, 2.20 mmol, 1.0 eq.) was dissolved in absolute THF (25 mL) and a 
solution of n-butyllithium in THF (1.6 M, 1.38 mL, 2.20 mmol, 1.0 eq.) was added at 0 °C followed 
by a solution of potassium diphenylphosphide in THF (0.5 M, 4.4 mL, 2.20 mmol, 1.0 eq.). The 
reaction mixture was warmed to room temperature and stirred under reflux for 16 hours. The 
solvent was evaporated and the residue was purified by column chromatography (silica gel, 
3 cm × 16 cm, cyclohexane:EtOAc = 1:1) to obtain the product as a colorless liquid (480 mg, 57%). 
 
C23H30NO2P (383.47 g/mol) 
TLC: Rf  = 0.18 (cyclohexane:EtOAc = 3:1, UV). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 7.52-7.48 (m, 2H), 7.43-7.39 (m, 2H), 7.34-7.25 (m, 6H), 
4.55-4.48 (m, 1H), 3.74 (d, 3JHH = 9.2 Hz, 1H), 2.69 (brs, 1H), 2.56 (dd, 
2JHH = 14.3 Hz, 
2JHP = 4.9 Hz, 1H), 2.38 (dd, 
2JHH = 14.3 Hz, 
2JHP = 3.4 Hz, 1H), 1.48 (d, 
3JHH = 6.8 Hz, 3H), 1.31 
(s, 3H), 1.29 (s, 3H), 1.26 (s, 3H), 1.24 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 173.2 (d, 3JCP = 2.2 Hz), 139.7 (d, 1JCP = 10.6 Hz), 139.0 
(d, 1JCP = 11.1 Hz), 133.3 (d, 
2JCP = 19.7 Hz), 132.8 (d, 
2JCP = 19.1 Hz), 128.7, 128.5, 128.4, 128.4, 
79.3, 75.6 72.2 41.1 (d, 1JCP = 15.0 Hz), 37.2 (d, 
2JCP = 17.7 Hz), 29.0, 27.7 (d, 
3JCP = 8.2 Hz), 27.4 
(d, 3JCP = 9.7 Hz), 26.3, 16.2. 
31P{1H}-NMR (162 MHz, CDCl3): δ (ppm) = 21.8. 
GC-MS (Method D, tR = 17.4 min): m/z (%) 368 ([M
+15], 3), 325 (13), 324 (59), 306 (11), 284 
(45), 228 (15), 227 (100), 202 (19), 185 (11), 184 (10), 183 (30), 121 (25), 108 (12), 59 (10). 
IR: ṽ = 3424 (w), 3053 (w), 2971 (w), 2928 (w), 1651 (m), 1434 (m), 1383 (m), 1168 (m), 1126 
(m), 1093 (m), 1023 (m), 741 (m), 695 (s), 508 (m). 
[α]20D = 8.4 (c = 0.95, CHCl3). 
 
 
NPh2P
O
OH
Experimental part                                                                                                                                    
132 
(4S,5S)-2-(1-(Diphenylphosphanyl)-2-methylpropan-2-yl)-5-methyl-4-(2-
((triethylsilyl)oxy)propan-2-yl)-4,5-dihydrooxazole (L15) [70] 
Under inert atmosphere 2-((4S,5S)-2-(1-(diphenylphosphanyl)-2-methylpropan-2-yl)-5-methyl-4,5-
dihydrooxazol-4-yl)propan-2-ol L14 (70.0 mg, 0.18 mmol, 1.0 eq.) was dissolved in absolute 
methylene chloride (4 mL) and 2,6-lutidine (98.1 mg, 0.92 mmol, 5.0 eq.) was added dropwise. 
Then, triethylsilyl trifluoromethanesulfonate (96.7 mg, 0.37 mmol, 2.0 eq.) was added and the 
reaction mixture was stirred for three hours at room temperature. The solvent was removed under 
high vacuum and the residue was redissolved in ether (5 mL). The precipitate was removed and the 
filtrate concentrated. The crude product was purified by column chromatography (silica gel, 
2 cm ×17 cm, cyclohexane:EtOAc = 9:1) to obtain the product as a colorless liquid (77.0 mg, 85%).  
 
C29H44NO2PSi (497.73 g/mol) 
TLC: Rf  = 0.52 (cyclohexane:EtOAc = 9:1, UV). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 7.48-7.43 (m, 4H), 7.33-7.27 (m, 6H), 4.36-4.29 (m, 1H), 
3.62 (d, 3JHH = 9.2 Hz, 1H), 2.52 (dd, 
2JHH = 14.4 Hz, 
2JHP = 4.0 Hz, 1H), 2.40 (dd, 
2JHH = 14.4 Hz, 
2JHP = 3.4 Hz, 1H), 1.46 (d, 
3JHH = 6.9 Hz, 3H), 1.33 (s, 3H), 1.31 (s, 3H), 1.27 (s, 3H), 1.23 (s, 3H), 
0.94 (t, 3JHH = 8.0 Hz, 9H), 0.58 (q, 
3JHH = 8.0 Hz, 6H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 172.8 (d, 3JCP = 3.2 Hz), 140.1 (d, 1JCP = 12.7 Hz), 139.9 
(d, 1JCP = 13.0 Hz), 133.3 (d, 
2JCP = 19.8 Hz), 133.0 (d, 
2JCP = 19.5 Hz), 128.5, 128.4, 128.4, 128.4, 
79.9, 76.1, 75.7, 41.1 (d, 1JCP = 16.6 Hz), 36.9 (d, 
2JCP = 17.3 Hz), 30.7, 27.5 (d, 
3JCP = 9.4 Hz), 
27.1 (d, 3JCP = 10.5 Hz), 26.4, 16.3, 7.2, 7.0. 
31P{1H}-NMR (162 MHz, CDCl3): δ (ppm) = 23.0. 
IR: ṽ = 3054 (w), 2956 (w), 2911 (w), 2875 (w), 1655 (w), 1433 (w), 1382 (w), 1236 (w), 1163 
(m), 1037 (m), 857 (w), 738 (s), 694 (s), 506 (w). 
[α]20D = 8.1 (c = 1.06, CHCl3). 
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(4S,5S)-[1,5-Cyclooctadiene-2-(1-(diphenylphosphanyl)-2-methylpropan-2-yl)-5-methyl-4-(2-
((triethylsilyl)oxy)propan-2-yl)-4,5-dihydrooxazole-iridium(I)]-tetrakis[3,5-bis-
(trifluoromethyl)phenyl]borate (C13) [70] 
Chloro(1,5-cyclooctadiene)iridium(I)dimer (20.2 mg, 30.0 µmol, 0.5 eq.) was added to a solution of 
(4S,5S)-2-(1-(diphenylphosphanyl)-2-methylpropan-2-yl)-5-methyl-4-(2-((triethylsilyl)oxy)propan-
2-yl)-4,5-dihydrooxazole L15 (30.0 mg, 60.0 µmol, 1.0 eq.) in absolute methylene chloride (5 mL) 
and heated to reflux for 2.5 hours. After that the reaction mixture was cooled to room temperature, 
sodium tetrakis[3,5-bis(trifluoromethyl)phenyl]borate (69.1 mg, 78.0 µmol, 1.3 eq.) was added and 
the mixture was stirred at room temperature for 30 minutes. The reaction mixture was immobilized 
on silica gel, put on column and washed with ether (100 mL) The solvent was changed to methylene 
chloride and the product was eluted. The product was obtained as an orange solid (84 mg, 84%). 
 
C69H68BF24IrNO2PSi (1661.35 g/mol) 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 7.79-7.74 (m, 10H), 7.60-7.50 (m, 7H), 7.39-7.36 (m, 3H), 
7.05-7.00 (m, 2H), 4.88-4.81 (m, 1H), 4.78 (m, 2H), 3.58-3.56 (m, 2H), 2.64-2.46 (m, 5H), 2.29-
2.27 (m, 2H), 2.19 (s, 3H), 2.12-2.05 (m, 1H), 1.90-1.81 (m, 1H), 1.74 (d, 3JHH = 7.0 Hz, 3H), 1.63-
1.59 (m, 1H), 1.42 (d, 4JHH = 2.8 Hz, 3H), 1.42 (s, 3H), 1.39-1.34 (m, 1H), 0.84-0.80 (m, 12H), 
0.48-0.33 (m, 6H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 180.6 (d, 3JCP = 3.5 Hz), 161.9 (q, 2JCF = 49.9 Hz), 135.1 
(d, JCP = 12.6 Hz), 135.0, 132.8, 132.7. 131.3, 131.2, 129.7 (d, JCP = 10.6 Hz), 129.2 (d, 
JCP = 10.2 Hz), 128.8 (q, 
3JCF = 31.8 Hz), 128.8 (q, 
1JCF = 272 Hz), 117.6, 94.3 (d, JCP = 10.5 Hz), 
93.2 (d, JCP = 13.1 Hz), 84.7, 74.4, 74.2, 63.2, 60.0, 39.0, 39.0, 36.5, 36.4, 33.5 (d, JCP = 6.3 Hz), 
33.3 (d, JCP = 33.0 Hz), 32.3, 32.3, 30.1, 28.5, 28.5, 27.1 (d, JCP = 12.2 Hz), 26.2, 26.0, 26.0, 15.3, 
7.0, 6.6. 
31P{1H}-NMR (162 MHz, CDCl3): δ (ppm) = 8.3. 
11B-NMR (128 MHz, CDCl3): δ (ppm) = 6.6. 
19F-NMR (376 MHz, CDCl3): δ (ppm) = 62.4. 
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IR: ṽ = 2957 (w), 1353 (m), 1275 (s), 1163 (m), 1121 (s), 1027 (w), 887 (m), 838 (w), 744 (m), 733 
(m), 696 (m), 682 (m). 
[α]20D = 17.0 (c = 1.05, CHCl3). 
 
 
(4S,5S)-4-(2-((tert-Butyldimethylsilyl)oxy)propan-2-yl)-2-(1-(diphenylphosphanyl)-2-
methylpropan-2-yl)-5-methyl-4,5-dihydrooxazole (L16) [70] 
Under inert atmosphere 2-((4S,5S)-2-(1-(diphenylphosphanyl)-2-methylpropan-2-yl)-5-methyl-4,5-
dihydrooxazol-4-yl)propan-2-ol L14 (300 mg, 0.81 mmol, 1.0 eq.) was dissolved in absolute 
methylene chloride (15 mL) and 2,6-lutidine (435 mg, 4.06 mmol, 5.0 eq.) was added dropwise. 
Then tert-butyldimethylsilyl trifluoromethanesulfonate (429 mg, 1.62 mmol, 2.0 eq.) was added and 
the mixture was stirred for three hours at room temperature. The solvent was removed under high 
vacuum and the residue was redissolved in ether (10 mL). The precipitate was removed and the 
filtrate concentrated. The crude product was purified by column chromatography (silica gel, 
3 cm × 17 cm, cyclohexane:EtOAc = 9:1) to obtain the product as a colorless liquid (322 mg, 82%). 
 
C29H44NO2PSi (497.73 g/mol) 
TLC: Rf  = 0.39 (cyclohexane:EtOAc = 9:1, UV). 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 7.48-7.42 (m, 4H), 7.33-7.27 (m, 6H), 4.38-4.31 (m, 1H), 
3.60 (d, 3JHH = 9.3 Hz, 1H), 2.51 (dd, 
2JHH = 14.4 Hz, 
2JHP = 4.1 Hz, 1H), 2.40 (dd, 
2JHH = 14.4 Hz, 
2JHP = 3.4 Hz, 1H), 1.45 (d, 
3JHH = 6.8 Hz, 3H), 1.33 (s, 3H), 1.30 (s, 3H), 1.27 (s, 3H), 1.26 (s, 3H), 
0.85 (s, 9H), 0.10 (s, 3H), 0.08 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 172.6 (d, 3JCP = 3.4 Hz), 140.1 (d, 1JCP = 12.7 Hz), 139.9 
(d, 1JCP = 13.1 Hz), 133.3 (d, 
2JCP = 19.8 Hz), 133.0 (d, 
2JCP = 19.4 Hz), 128.5-128.3 (m), 79.7, 
76.2, 76.0, 41.1 (d, 1JCP = 16.5 Hz), 36.8 (d, 
2JCP = 17.2 Hz), 30.7, 27.5 (d, 
3JCP = 9.3 Hz), 27.2 (d, 
3JCP = 10.4 Hz), 26.4, 26.1, 18.3, 16.5, 1.7, 1.7. 
31P{1H}-NMR (162 MHz, CDCl3): δ (ppm) = 22.9. 
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GC-MS (Method D, tR = 31.5 min): m/z (%) 483 ([M
+1], 1), 440 (47), 421 (10), 420 (22), 325 
(16), 324 (87), 288 (11), 284 (27), 228 (10), 227 (100), 199 (23), 185 (20), 184 (11), 183 (23), 174 
(10), 173 (79), 121 (31), 115 (19), 108 (11), 75 (14), 73 (60). 
IR: ṽ = 3054 (w), 2956 (w), 2929 (w), 2856 (w), 1656 (w), 1434 (w), 1383 (w), 1252 (m), 1162 (s), 
1029 (s), 834 (s), 772 (s), 740 (s), 694 (s), 507 (w). 
[α]20D = 6.8 (c = 0.99, CHCl3). 
 
 
(4S,5S)-[1,5-Cyclooctadiene-4-(2-((tert-butyldimethylsilyl)oxy)propan-2-yl)-2-(1-
(diphenylphosphanyl)-2-methylpropan-2-yl)-5-methyl-4,5-dihydrooxazole-iridium(I)]-
tetrakis[3,5-bis-(trifluoromethyl)phenyl]borate (C14) [70] 
Chloro(1,5-cyclooctadiene)iridium(I)dimer (20.2 mg, 30.0 µmol, 0.5 eq.) was added to a solution of 
(4S,5S)-4-(2-((tert-butyldimethylsilyl)oxy)propan-2-yl)-2-(1-(diphenylphosphanyl)-2-methylpropan 
-2-yl)-5-methyl-4,5-dihydrooxazole L15 (30.0 mg, 60.0 µmol, 1.0 eq.) in absolute methylene 
chloride (5 mL) and heated to reflux for 2.5 hours. After that the reaction mixture was cooled to 
room temperature, sodium tetrakis[3,5-bis(trifluoromethyl)phenyl]borate (69.1 mg, 78.0 µmol, 1.3 
eq.) was added and the mixture was stirred at room temperature for 30 minutes. The reaction 
mixture was immobilized on silica, put on column and washed with ether (100 mL) The solvent was 
changed to methylene chloride and the product was eluted. The product was obtained as a orange 
solid (73 mg, 73%). 
 
C69H68BF24IrNO2PSi (1661.35 g/mol) 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 7.77-7.75 (m, 2H), 7.73-7.70 (m, 8H), 7.62-7.58 (m, 1H), 
7.55-7.50 (m, 6H), 7.42-7.35 (m, 3H), 7.04-6.98 (m, 2H), 4.87-4.80 (m, 1H), 4.76-4.72 (m, 2H), 
3.57-3.52 (m, 2H), 2.65-2.56 (m, H), 2.49-2.42 (m, 1H), 2.29-2.26 (m, 2H), 2.19 (s, 3H), 2.11-2.04 
(m, 1H), 1.88-1.79 (m, 1H), 1.77 (d, 3JHH = 7.0 Hz, 3H), 1.65-1.59 (m, 1H), 1.52 (d, 
4JHH = 3.0 Hz, 
3H), 1.40 (s, 3H), 1.38-1.33 (m, 1H), 0.92 (s, 3H), 0.72 (s, 9H), 0.03 (s, 3H), 0.30 (s, 3H).
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13C-NMR (100 MHz, CDCl3): δ (ppm) = 180.6 (d, 3JCP = 3.5 Hz), 161.77 (q, 2JCF = 49.9 Hz), 135.2 
(d, JCP = 12.6 Hz), 134.8, 132.6 (d, JCP = 2.0 Hz), 132.2 (d, JCP = 55.0 Hz), 131.2, 131.1, 129.6 (d, 
JCP = 10.6 Hz), 129.0 (d, JCP = 10.2 Hz), 128.9 (q, 
3JCF = 31.8 Hz), 128.8 (d, JCP = 54.0 Hz), 124.6 
(q, 1JCF = 272 Hz), 117.5, 94.2 (d, JCP = 10.5 Hz), 93.0 (d, JCP = 13.1 Hz), 84.5, 74.4, 74.3, 62.8, 
59.7, 38.9 (d, JCP = 2.1 Hz), 36.4 (d, JCP = 4.8 Hz), 33.7 (d, JCP = 6.3 Hz), 33.0 (d, JCP = 33.0 Hz), 
32.2, 29.7 28.3, 26.8 (d, JCP = 12.2 Hz), 26.1, 25.7, 25.7, 17.8, 15.0, 2.0, 2.4. 
31P{1H}-NMR (162 MHz, CDCl3): δ (ppm) = 8.5. 
11B-NMR (128 MHz, CDCl3): δ (ppm) = 6.6. 
19F-NMR (376 MHz, CDCl3): δ (ppm) = 62.4. 
IR: ṽ = 2957 (w), 1353 (m), 1275 (s), 1163 (m), 1121 (s), 1027 (w), 887 (m), 838 (w), 744 (m), 733 
(m), 696 (m), 682 (m). 
[α]20D = 19.5 (c = 1.10, CHCl3). 
 
 
 5.6  Hydrogenation of cyclohexenes and test substrates 
 
General working procedure for hydrogenations with palladium on charcoal 
In a 2 mL vial with magnetic stirrer, palladium on charcoal (10 mass%) and the substrate 
(0.1 mmol) were suspended in absolute methylene chloride (0.5 mL) and the vial was put in an 
autoclave. The mixture was stirred for 24 hours at room temperature and 50 bar hydrogen pressure 
with 900 rounds per minute. The reaction mixture was concentrated, the residue redissolved in a 
pentane/ether mixture (4:1) and filtered through a pipette with silica gel (0.5 cm × 2 cm). The 
filtrate was concentrated and analyzed. 
 
General working procedure for hydrogenations with iridium catalysts 
 
In a 2 mL vial with magnetic stirrer, the substrate (0.1 mmol) and the catalyst (1 mol%) were 
dissolved in absolute methylene chloride (0.5 mL) and the vial was put in an autoclave. The 
solution was stirred for 24 hours at room temperature at 50 bar hydrogen pressure with 900 rounds 
per minute. The reaction mixture was concentrated, the residue redissolved in a pentane/ether 
mixture (4:1) and filtered through a pipette with silica gel (0.5 cm × 2 cm). The filtrate was 
concentrated and analyzed. 
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2,2,2-Trifluoroethyl 4-methylcyclohexane-1-carboxylate (76) 
 
C10H15F3O2 (224,22 g/mol) 
Analytical data for the major product of the hydrogenation with (R)-C11: 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 4.45 (q, 3JHF = 8.5 Hz, 2H), 2.32 (tt, 3JHH = 12.2 Hz, 
3JHH = 3.6 Hz 1H), 2.01-1.96 (m, 2H), 1.79-1.75 (m, 2H), 1.51-1.40 (m, 2H), 1.39-1.31 (m, 1H), 
1.00-0.92 (m, 2H), 0.90 (d, 3JHH = 6.6 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 174.7, 123.2 (q, 1JCF = 277 Hz), 60.2 (q, 2JCF = 36 Hz), 
42.8, 34.2, 32.0, 29.0, 22.6 (R). 
19F-NMR (376 MHz, CDCl3): δ (ppm) = 73.9. 
GC-MS (Method A, tR = 11.2 min): m/z (%) 224 (M
+, 24), 155 (22), 125 (15), 124 (31), 97 (45), 96 
(14), 95 (19), 83 (26) 82 (52), 81 (57), 70 (71), 69 (16), 67 (22), 56 (10), 55 (100), 42 (12), 41 (35). 
224 (M+, 18), 155 (24), 135 (15), 125 (11), 124 (33), 97 (35), 96 (15), 95 (16), 83 (32), 82 (82), 81 
(59), 70 (87), 69 (23), 67 (26), 56 (13), 55 (100), 54 (10), 43 (14), 42 (11), 41 (33). 
 
Analytical data for the major product of the hydrogenation with (S)-C11: 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 4.48 (q, 3JHF = 8.5 Hz, 2H), 2.63 (quint, 3JHH = 5.0 Hz 1H), 
2.03-1.97 (m, 2H), 1.63-1.51 (m, 5H), 1.25-1.15 (m, 2H), 0.90 (d, 3JHH = 6.6 Hz, 3H). 
19F-NMR (376 MHz, CDCl3): δ (ppm) = 73.9. 
 
 
1,4-Dimethylcyclohexane-1-carbaldehyde (78) 
 
C9H16O (140.23 g/mol) 
GC-MS (Method A, tR(minor) = 8.2 min tR(major) = 9.5 min): m/z (%) 140 (M
+, 4), 111 (74), 69 (100), 
55 (50), 41 (28). 
 
O
O
O
CF3
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2-(1,4-Dimethylcyclohexyl)-1,3-dioxolane (140) 
 
C11H20O2 (184.28 g/mol) 
Analytical data for the main product of the hydrogenation with (R)-C11: 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 4.90 (s, 1H, major), 4.44 (s, 1H, minor), 3.94-3.82 (m, 2H, 
major, 2H, minor), 1.80-1.76 (m, 1H, major, 1H, minor), 1.54-1.02 (m, 8H, major, 8H, minor), 0.90 
(s, 3H, minor), 0.89 (d, 3JHH = 6.7 Hz, 3H, major), 0.89 (d, 
3JHH = 6.7 Hz, 3H, minor), 0.82 (s, 3H, 
minor). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 111.5, 65.3, 37.1, 33.0, 32.0, 30.2, 22.8, 16.8, all major. 
107.0, 65.3, 36.1, 33.3, 31.3, 30.0, 21.7, 21.5, all minor. 
GC-MS (Method B, tR(major) = 8.0 min, tR(minor) = 8.4 min): m/z (%) 110 ([M
+74], 3), 95 (2), 73 
(100), 69 (5), 55 (5), 45 (9), 41 (5). 
 
 
(1,4-Dimethylcyclohexyl)methanol (141) 
 
C9H18O (142.24 g/mol) 
Analytical data for the main product of the hydrogenation with (R)-C11: 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 3.47 (s, 2H, major), 3.28 (s, 2H, minor), 1.60-1.00 (m, 9H, 
major, 9H, minor), 0.90 (d, 3JHH = 5.4 Hz, 3H, minor), 0.89 (s, 3H, major), 0.89 (s, 3H, minor), 0.88 
(d, 3JHH = 7.2 Hz, 3H, major). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 67.8, 34.4, 34.1, 32.3, 30.6, 26.9, 22.2, all major. 
75.0, 35.0, 33.8, 33.1, 30.5, 22.7, 19.6, all minor. 
GC-MS (Method B, tR(major) = 4.9 min, tR(minor) = 5.0 min): m/z (%) 112 (M
+, 8), 111 (82), 110 
(40), 95 (11), 69 (100), 55 (42), 41 (27). 
IR: ṽ = 3326 (w), 2911 (s), 2852 (s), 1455 (m), 1375 (m), 1150 (w), 1045 (s), 1009 (m).
OH
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(1,4-Dimethylcyclohexyl)methyl acetate (142) 
 
C11H20O2 (184.28 g/mol) 
Analytical data for the hydrogenation with (R)-C11: 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 3.94 (s, 2H, major), 3.75 (s, 2H, minor), 2.05 (s, 3H, 
major), 2.05 (s, 3H, minor), 1.63-0.99 (m, 9H, major), 1.53-1.04 (m, 9H, minor), 0.92 (s, 3H, 
minor), 0.90 (s, 3H, major), 0.90 (d, 3JHH = 6.3 Hz, 3H, minor) 0.88 (d, 
3JHH = 6.5 Hz, 3H, major). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 171.6, 68.9, 34.6, 33.0, 32.3, 30.6, 27.4, 22.2, 21.1, all 
major. 
171.5, 75.2, 34.1, 33.6, 32.9, 30.3, 22.6, 21.1, 19.9, all minor. 
GC-MS (Method B, tR(major) = 7.0 min, tR(minor) = 7.4 min): m/z (%) 124 ([M
+, 17), 111 (84), 110 
(32), 109 (19), 96 (16), 95 (24), 82 (14), 81 (16), 69 (100), 68 (17), 67 (13), 55 (43), 43 (36), 41 
(18). 
IR: ṽ = 2912 (w), 2854 (w), 2839 (w), 1739 (s), 1439 (w), 1373 (m), 1240 (s), 1036 (m). 
 
 
tert-Butyl((1,4-dimethylcyclohexyl)methoxy)dimethylsilane (143) 
 
C15H32OSi (256.51 g/mol) 
Analytical data for the hydrogenation with (R)-C11: 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 3.37 (s, 2H, major), 3.27 (s, 2H, minor), 1.60-1.00 (m, 9H, 
major), 1.54-1.04 (m, 9H, minor), 0.89 (2xs, 9H, 3H, major), 0.89 (2xs, 9H, 3H, minor), 0.87 (d, 
3JHH = 5.6 Hz, 3H, major), 0.85 (d, 
3JHH = 5.6 Hz, 3H, minor)0.02 (s, 3H, major), 0.02 (s, 3H, 
minor), 0.01 (s, 3H, major), 0.01 (s, 3H, minor). 
3.27 (s, 2H), 1.54-1.04 (m, 9H), 0.89 (s, 6H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 67.5, 34.6, 34.1, 32.3, 30.8, 27.4, 26.1, 22.3, 18.5, 5.3, 
all major. 
OAc
OTBDMS
Experimental part                                                                                                                                    
140 
74.5, 35.2, 34.4, 33.2, 30.7, 26.1, 22.8, 19.9, 18.5, 5.3, all minor. 
GC-MS (Method B, tR(major) = 10.0 min, tR(minor) = 10.6 min): m/z (%) 241 ([M
+, 1), 200 (12), 
199 (77), 123 (43), 81 (11), 75 (100), 73 (14). 
 
 
Ethyl (1S,2S)-2-formyl-5-methylcyclohexane-1-carboxylate (146) 
 
C11H18O3 (198.26 g/mol) 
Analytical data for hydrogenation with Pd/C: 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 9.65 (s, 1H, major), 9.62 (s, 1H, minor), 4.15 (q, 
3JHH = 7.1 Hz, 2H, minor), 4.12 (q, 
3JHH = 7.1 Hz, 2H, major), 2.63-2.50 (m, 1H, major, minor), 
2.10-2.01 (m, 2H, major, 2H, minor), 1.89-1.70 (m, 2H, major, 2H, minor), 1.46-1.36 (m, 1H, 
major, 1H, minor), 1.27-0.98 (m, 3H, major, 3H, minor), 1.25 (t, 3JHH = 7.1 Hz, 3H, minor), 1.24 (t, 
3JHH = 7.1 Hz, 3H,major), 0.94 (d, 
3JHH = 6.6 Hz, 3H, major), 0.90 (d, 
3JHH = 6.8 Hz, 3H, minor). 
GC-MS (Method B, tR(minor) = 10.0 min, tR(major) = 10.2 min): m/z (%) 171 ([M
+, 10), 170 (86), 
155 (12), 153 (38), 142 (20), 141 (10), 127 (19), 125 (14), 124 (32), 115 (12), 107 (19), 102 (11), 
101 (46), 99 (21), 97 (40), 96 (70), 95 (71), 93 (10), 67 (38), 57 (10), 55 (70), 54 (20), 53 (17), 43 
(28), 41 (47). 
 
 
 
 
 
 
 
 
 
 
Ethyl (1S,2S)-2-(hydroxymethyl)-5-methylcyclohexane-1-carboxylate (147) 
OEt
O
O
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C11H20O3 (200.28 g/mol) 
Analytical data for main product of hydrogenation with (R)-C11: 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 4.12 (q, 3JHH = 7.1 Hz, 2H), 3.53-3.49 (m, 2H), 2.23-2.16 
(m, 1H), 1.93-1.68 (m, 5H), 1.59-1.33 (m, 2H), 1.25 (t, 3JHH = 7.1 Hz, 3H), 1.20-1.09 (m, 1H), 1.03-
0.93 (m, 1H), 0.91 (d, 3JHH = 6.5 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 176.5, 66.7, 60.5, 46.6, 41.7, 38.2, 34.1, 32.0, 28.7, 22.3, 
14.4. 
GC-MS (Method B, tR = 9.7 min): m/z (%) 154 ([M
+, 9), 95 (36), 82 (69), 81 (100), 79 (11), 68 
(29), 67 (51), 55 (24). 54 (43), 53 (11), 41 (30). 
IR: ṽ = 3461 (w), 2923 (m), 2852 (w), 1725 (s), 1553 (m), 1449 (m), 1375 (m), 1254 (m), 1177 (s), 
1097 (m), 1030 (s), 699 (m). 
 
 
Ethyl (1S,2S)-2-(acetoxymethyl)-5-methylcyclohexane-1-carboxylate (148) 
 
C13H22O4 (242.32 g/mol) 
Analytical data for hydrogenation with (R)-C11: 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 4.15-4.07 (m, 2H, major, 2H, minor, 4.02-3.85 (m, 2H, 
major, 2H, minor), 2.22-2.08 (m, 1H major, 1H, minor), 2.03 (s, 3H, minor), 2.01 (s, 3H, major), 
1.94-1.34 (m, 6H, major, 6H, minor), 1.24 (t, 3JHH = 7.1 Hz, 3H, major, 3H, minor), 1.19-0.96 (m, 
2H, major, 2H, minor), 0.94 (d, 3JHH = 7.0 Hz, 3H, minor), 0.90 (d, 
3JHH = 6.5 Hz, 3H, major). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 175.5, 171.1, 67.6, 60.4, 46.6, 38.3, 38.2, 33.9, 31.9, 28.8, 
22.3, 21.0, 14.3, all major. 
175.6, 171.1, 66.9, 60.4, 41.0, 36.9, 34.1, 30.2, 27.4, 23.2, 21.0, 19.2, 14.4, all minor. 
OEt
O
OH
OEt
O
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GC-MS (Method B, tR(major) = 13.5 min, tR(minor) = 13.6 min): m/z (%) 200 ([M
+, 5), 199 (39), 
182 (18), 155 (56), 154 (20), 153 (100), 136 (55), 125 (17). 110 (11), 109 (59), 108 (39), 107 (23), 
101 (22), 97 (17), 95 (33), 94 (13), 93 (13), 82 (11), 81 (29), 79 (14), 73 (17), 67 (33), 55 (23), 43 
(92), 41 (17). 
IR: ṽ = 2925 (w), 2855 (w), 1730 (s), 1450 (w), 1366 (w), 1232 (s), 1179 (m), 1137 (w), 1035 (m). 
 
 
2-((1R,2R,3S)-5-Methyl-2-nitro-3-phenylcyclohexyl)ethan-1-ol (151) 
 
C15H21NO3 (263.34 g/mol) 
Analytical data for major product for the hydrogenation with (S)-C11: 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 7.34-7.21 (m, 3H), 7.19-7.16 (m, 2H), 4.46 (t, 
3JHH = 11.0 Hz, 1H), 3.76-3.62 (m, 2H), 3.24-3.17 (m, 1H), 2.39-2.29 (m, 1H), 2.07-2.02 (m, 1H), 
1.99-1.93 (m, 1H), 1.81-1.74 (m, 1H), 1.67-1.59 (m, 1H), 1.53-1.45 (m, 1H), 1.41 (brs, 1H), 1.38-
1.20 (m, 2H), 0.98 (d, 3JHH = 6.6 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 140.4, 128.9, 127.7, 127.2, 96.7, 59.8, 48.9, 41.4, 38.8, 
38.5, 35.4, 31.7, 21.8. 
GC-MS (Method D, tR = 11.3 min): m/z (%) 217 ([M
+, 6), 216 (34), 198 (30), 171 (39), 169 
(14), 143 (35), 131 (10), 129 (28), 128 (14), 117 (20), 115 (18), 105 (13), 95 (17), 91 (100), 55 (11), 
41 (14). 
 
 
 
 
 
 
 
Ph
NO2
OH
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2-((1S,2R,3S,4R)-4-Methyl-2-nitro-3,6-diphenylcyclohexyl)ethyl acetate (152) 
 
C23H27NO4 (381.47 g/mol) 
Analytical data for major product for the hydrogenation with (R)-C11: 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 7.38-7.21 (m, 10H), 5.43 (t, 3JHH = 9.4 Hz, 1H), 3.79-3.73 
(m, 3H), 3.52 (q, 3JHH = 5.7 Hz, 1H), 2.77-2.72 (m, 1H), 2.36-2.30 (m, 1H), 2.27-2.21 (m, 1H), 
2.14-2.09 (m, 1H), 1.93 (s, 3H), 1.92-1.80 (m, 1H), 1.69-1.61 (m, 1H), 0.64 (d, 3JHH = 7.3 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 170.9, 142.2, 138.7, 128.7, 128.6, 128.5, 127.3, 126.6, 
89.7, 62.2, 49.9, 41.4, 40.6, 36.9, 33.5, 27.7, 20.9, 17.3, 14.3. 
GC-MS (Method D, tR = 22.9 min): m/z (%) 292 ([M
+, 1), 274 (16), 273 (51), 195 (11), 181 
(11), 171 (10), 170 (16), 169 (21), 167 (13), 157 (10), 156 (12), 155 (22), 145 (25), 143 (30), 141 
(17), 131 (38), 129 (35), 128 (25), 117 (37), 115 (23), 105 (47), 91 (100), 43 (49). 
 
 
 5.7  Palladium-catalyzed allylic substitution using 2nd generation of NeoPHOX ligands 
 
General working procedure for allylic substitution 
 
Under inert atmosphere, allyl-Pd chloride dimer (1.87 mg, 0.005 mmol, 0.005 eq) and the 
NeoPHOX ligand (9.19 mg, 0.025 mmol, 0.025 eq) were dissolved in absolute DCM (1.2 mL) in a 
Schlenk tube and stirred for two hours at 50 °C. In a second Schlenk tube, a solution of the substrate 
(1.00 mmol, 1.0 eq), dimethylmalonate (396 mg, 3.00 mmol, 3.0 eq), BSA (610 mg, 3.00 mmol, 
3.0 eq) and dried potassium acetate (1.00 mg, 0.01 mmol, 0.01 eq) in absolute DCM (4 mL) was 
prepared and the Schlenk tube with the solution of the catalyst was added. The resulting mixture 
was stirred for 24 hours at room temperature. Sat. ammonium chloride-solution (20 mL) was added 
and the phases were separated. The aqueous phase was extracted with ether (3 x 15 mL) and the 
combined organic phases were dried over sodium sulfate and concentrated. The crude product was 
Ph
NO2Ph
OAc
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purified by column chromatography (silica gel, 2 cm × 15 cm, cyclohexane:EtOAc = 19:1) to obtain 
the product as a colorless liquid. 
 
 
Dimethyl (E)-2-(1,3-diphenylallyl)malonate (167) 
 
C20H20O4 (324.14 g/mol) 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 7.34-7.18 (m, 10H), 6.48 (d, 3JHH =15.8 Hz, 1H), 6.33 (dd, 
3JHH = 15.8 Hz, 
3JHH = 8.6 Hz, 1H), 4.27 (dd, 
3JHH = 10.8 Hz, 
3JHH = 8.6 Hz, 1H), 3.96 (d, 
3JHH = 10.8 Hz, 1H), 3.71 (s, 3H), 3.52 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 168.3, 167.9, 140.3, 137.0, 132.0, 129.3, 128.9, 128.6, 
128.0, 127.7, 127.3, 126.5, 57.8, 52.8, 52.6, 49.3. 
HPLC (OJH, nheptane:iPrOH 90:10, 0.5 mL/min, 25 °C): tr(major) = 39.0 min, tr(minor) = 44.0 min, 
97% ee. 
 
 
Dimethyl (E)-2-(pent-3-en-2-yl)malonate (169) 
 
C10H16O4 (200.23 g/mol) 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 5.52 (dqd, 3JHH = 15.2 Hz, 3JHH = 6.4 Hz, 4JHH = 0.9 Hz, 
1H), 5.34 (ddq, 3JHH = 15.2 Hz, 
3JHH = 8.2 Hz, 
4JHH = 1.6 Hz, 1H), 3.73 (s, 3H), 3.69 (s, 3H), 3.26 
(d, 3JHH = 9.1 Hz, 1H), 2.94-2.84 (m, 1H), 1.63 (dd, 
3JHH = 6.4 Hz, 
3JHH = 1.2 Hz, 3H), 1.06 (d, 
3JHH = 7.2 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 168.9, 132.4, 126.5, 58.1, 52.5, 52.4, 37.5, 18.5, 18.0. 
 
 
 
 
Ph Ph
MeO2C CO2Me
MeO2C CO2Me
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Dimethyl 2-(cyclohex-2-en-1-yl)malonate (171) 
 
C11H16O4 (212,10 g/mol) 
1H-NMR (400 MHz, CDCl3): δ (ppm) = 5.80-5.75 (m, 1H), 5.54-5.50 (m, 1H), 3.74 (s, 3H), 3.74 
(s, 3H), 3.29 (d, 3JHH = 9.5 Hz, 1H), 2.94-2.87 (m, 1H), 2.02-1.96 (m, 2H), 1.79-1.67 (m, 2H), 1.62-
1.52 (m, 1H), 1.42-1.32 (m, 1H). 
13C-NMR (100 MHz, CDCl3): δ (ppm) = 169.1, 169.0, 129.8, 127.5, 57.0, 52.5, 52.5, 35.5, 26.8, 
25.1, 21.0. 
HPLC (OBH, nheptane:iPrOH 90:10, 0.5 mL/min, 40 °C): tr(major) = 11.8 min, tr(minor) = 14.1 min, 
23% ee.
MeO2C CO2Me
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 6  Appendix 
 
 6.1  List of abbreviations 
 
%     percent 
°C     degree Celsius 
Ac     acetyl 
AcOH     acetic acid 
AIBN     azobisisobutyronitrile 
Alk     alkyl 
aq.     aqueous 
Ar     aryl 
atm     atmosphere 
BArF     tetrakis[3,5-bis(trifluoro-methyl)phenyl]borate 
Bn     benzyl 
br     broad 
BSA     N,O-bis(trimethylsilyl)acetamide 
Bz     benzoate 
c     concentration 
cat.     catalytic 
Cat.     catalyst 
COD     cyclooctadiene 
conv.     conversion 
Cy     cyclohexyl 
δ (NMR)    chemical shift 
d     doublet 
DAST     diethylaminosulfur trifluoirde 
DDQ     2,3-dichloro-5,6-dicyano-1,4-benzoquinone 
DIBAL    diisobutylaluminium hydride 
DMAP    4-dinmethylaminopyridine 
DMF     dimethylformamide 
DMP     Dess-Martin periodinane 
DMPU    1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidone 
DMSO    dimethyl sulfoxide 
dr     diastereomeric ratio 
ee     enantiomeric excess 
EI     electron-imp 
eq.     equivalents 
EtOAc     ethyl acetate 
EtOH     ethanol 
eV     electron Volts 
g     gram 
GCMS     gas chromatography mass spectometry 
h     hours 
HMPA     hexamethylphosphoramide 
HOMO    highest occupied molecular orbital
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HPLC     high performance liquid chromatography 
HWE     Horner-Wadsworth-Emmons 
Hz     Hertz 
iPr     2-propyl 
IR     infrared 
J      coupling constante 
KOtBu    potassium tert-butoxide 
kPa     kilo Pascal 
l     length 
LUMO    lowest unoccupied molecular orbital 
μ     micro 
m     meta 
m     multiplet (NMR) or medium (IR) 
M     molar 
m-CPBA    3-chloroperbenzoic acid 
Me     methyl 
MeOH     methanol 
min     minutes 
mL     milliliter 
mm     millimeter 
mmol     millimol 
m.p.     melting point 
Ms     mesyl 
MTBE     methyl tert-butyl ether 
MTO     methyltrioxorhenium 
NBS     N-bromosuccinimide 
n-BuLi    n-butyllithium 
n.d.     not determined 
nm     nanometer 
NMR     nuclear magnetic resonance 
nPrOH     1-propanol 
OFBA     2-fluorobenzoic acid 
o-Tol     ortho-tolyl 
p     para 
Ph     phenyl 
PHOX     phosphinooxazoline 
pin     pinacol 
ppm     parts per million 
p-TsOH    p-toluenesulfonic acid 
py     pyridine 
q     quartet 
quint     quintet 
rac     racemic 
Rf     retention factor 
rt     room temperature 
s     singlet (NMR) or strong (IR) 
sat.     saturated 
T     temperature
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t     time or triplet (NMR) 
TBDMS    tert-butyldimethylsilyl 
tBu     tert-butyl 
TES     triethylsilyl 
TFAA     trifluoroacetic anhydride 
THF     tetrahydrofuran 
THP     tetrahydropyran 
TLC     thin layer chromatography 
TMS     trimethylsilyl 
TOF     turnover frequency 
tR     retention time 
w     weak
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